rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACGGGGGGCAACAATGAGCAGTTCTTCGGGCCA	CASTGGNNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	5	0	2	23	-1	40	33	42			01,02										Vb 1	CASTGGNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGGACTTCACTGGACTACAATGAGCAGTTCTTCGGGCCA	CASSVGTSLDYNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	3	1	8	23	37	44	38	52			01,02			01,02							Vb 1	CASSVGTSLDYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTAGTGATTCTGGAAACACCATATATTTTGGAGAG	CASSSDSGNTIYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	8	1	0	4	23	-1	37	34	41			01,02			01,02							Vb 1	CASSSDSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGATGGTATGATCAATCAGCCCCAGCATTTTGGTGAT	CASSEDGMINQPQHF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	5	0	10	3	7	6	23	34	43	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEDGMINQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGGGACAGGGGGCAACGAACAGTACTTCGGGCCG	CASRGTGGNEQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	10	1	6	23	34	47	35	53			01,02										Vb 1	CASRGTGGNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGACAGGGGCCCGCCACTGAAGCTTTCTTTGGACAA	CASSARQGPATEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	4	3	5	23	36	47	39	52			01,02										Vb 1	CASSARQGPATEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGAGGAGGGACAACTAAACGAGCAGTACTTCGGGCCG	CASSEEEGQLNEQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	3	0	6	5	7	5	23	36	49	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSEEEGQLNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCCCAGGAGCGGGACATCTGAAGATACGCAGTATTTTGGCCCA	CASSAPRSGTSEDTQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	3	5	8	7	23	36	51	44	58			01,02										Vb 1	CASSAPRSGTSEDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAACCGGGACTAGCGGGGGAGGTGAGCAGTTCTTCGGGCCA	CASSPTGTSGGGEQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	9	6	3	23	35	55	41	58			01,02										Vb 1	CASSPTGTSGGGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGAGCGGGAGAAGAGCACAGATACGCAGTATTTTGGCCCA	CASEREKSTDTQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	6	2	0	1	3	23	32	41	33	44			01,02										Vb 1	CASEREKSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTCAGGACGAACAGATACGCAGTATTTTGGCCCA	CASSVDSGRTDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	1	7	3	5	2	23	39	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDSGRTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTACCAGCAGCGCCCAGCGGGACTCCTTAGGGGAGCTGTTTTTTGGAGAA	CTSSAQRDSLGELFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	6	3	8	3	7	23	36	46	39	53			01,02										Vb 1	CTSSAQRDSLGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGGAGGGACGGTGGAAACACCATATATTTTGGAGAG	CASSARRDGGNTIYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	10	0	3	3	4	23	36	45	39	49			01,02										Vb 1	CASSARRDGGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGACAGGGGGCCTATGGCTACACCTTCGGTTCG	CASSGQGAYGYTF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	0	4	0	0	23	-1	-1	36	46			01,02										Vb 1	CASSGQGAYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGCGGGAGGGCCTACCTGGAGACCCAGTACTTCGGGCCA	CASSVEGGRAYLETQYF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	7	0	5	3	8	23	39	51	42	59			01,02										Vb 1	CASSVEGGRAYLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGATAGGGTCGGGAGAGTTAGATACGCAGTATTTTGGCCCA	CASSVEIGSGELDTQYF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	2	5	9	4	23	39	54	48	58			01,02										Vb 1	CASSVEIGSGELDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAATAAGGCGATGGGGCAAGGGTGCCTACGAGCAGTACTTCGGGCCG	CASSVIRRWGKGAYEQYF	In	VDJ	1	39	6.227047740699345E-4	7.687910268288356E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	2	10	7	23	38	53	48	60			01,02										Vb 1	CASSVIRRWGKGAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGGGACAGGGGGCAACGAGCAGTACTTCGGGCCG	CASRGTGGNEQYF	In	VDJ	9	271	0.004326999840332109	0.005342112006938832	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	5	1	1	23	34	47	35	48			01,02										Vb 1	CASRGTGGNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGTGTGGTCAGGAGTGGGACCCGGGGAGCTGTTTTTTGGAGAA	CASSLVWSGVGPGELFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	51	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-02	01	1	0	7	6	13	0	19	35	-1	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVWSGVGPGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCGACCCCGGGGGAGTCAACGAGCAGTACTTCGGGCCG	CASSDPGGVNEQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	5	5	5	19	31	42	36	47														CASSDPGGVNEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCACTGTAGTCAGCCCCCCCCCAGATACGCAGTATTTTGGCCCA	CASSTVVSPPPDTQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-03	01	5	4	5	4	8	8	19	31	42	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTVVSPPPDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCTCTGTGCCAGAAGCCAAGGACAGGGAATGTTAGTCATTCAGTACTTCGGCGCC	CARSQGQGMLVIQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	3	9	3	9	19	31	42	34	51														CARSQGQGMLVIQYF+TCRBV11-01+TCRBJ02-04	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTTATGAACACTGAAGCTTTCTTTGGACAA	CASSQFMNTEAFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	5	9	0	2	0	29	44	-1	46	48						01,02							Vb 16	CASSQFMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGAAGACTACCTCAACAGGGCAACCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	17	2.714354143381766E-4		56	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	0	12	5	25	36	54	48	59													Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGTTTATTTCTGTGCCAGCAGCCAAGAGCGGACAGGTCGATTTACTAGCGGGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.714354143381766E-4		61	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	3	2	2	16	0	10	27	-1	43	54													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGGAACGAGCAATACTTCGGGCCG	CASSQGNEQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	8	13	1	8	29	43	48	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGNEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGCGGTCGAGGACAGTGGCGGCTACACCTTCGGTTCG	CASSQEAVEDSGGYTF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	8	9	4	29	46	61	55	65													Vb 16	CASSQEAVEDSGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGTACAGGGGGCAGGCTACGAGCAGTACTTCGGGCCG	CASSVQGAGYEQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	3	2	3	29	41	52	43	55													Vb 16	CASSVQGAGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGGGTTGAGCAGTTCTTCGGGCCA	CASSHRVEQFF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	33	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	9	0	1	29	-1	48	43	49													Vb 16	CASSHRVEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTCCGGGACTGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLPGLAYNEQFF	In	VDJ	2	55	8.781733993293949E-4	0.0010841924737329733	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	2	4	2	29	42	52	46	54						01,02							Vb 16	CASSLPGLAYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGAGACTAGCGAGCAGTACTTCGGGCCG	CASSQDETSEQYF	In	VDJ	2	56	8.941401884081111E-4	0.0011039050641644817	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	8	6	3	0	29	46	-1	49	55						01,02							Vb 16	CASSQDETSEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCAGGAGATGCGCAGTATTTTGGCCCA	CASSSGDAQYF	In	VDJ	2	65	0.0010378412901165576	0.0012813183780480593	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	4	4	10	1	5	29	41	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSSGDAQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCCCGGGACAGCCCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	80	0.0012773431262973016		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	5	2	5	4	29	46	58	51	62													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTTTCGGACAGGAGGATGAAAAACTGTTTTTTGGCAGT	CASSQVFGQEDEKLFF	In	VDJ	3	96	0.001532811751556762	0.001892408681424826	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	4	6	5	3	29	45	57	50	60													Vb 16	CASSQVFGQEDEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGCCCCCGGTGGACTAGTAGGCGGGGAGCTGTTTTTTGGAGAA	CASSQAPGGLVGGELFF	In	VDJ	5	141	0.002251317260098994	0.0027794752508427134	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	1	8	7	10	4	29	43	60	53	64						01,02							Vb 16	CASSQAPGGLVGGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACAGGGGGCGCGGCACTGAAGCTTTCTTTGGACAA	CASSADRGRGTEAFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	0	4	2	4	24	36	49	38	53														CASSADRGRGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGATTTGGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSDLGVNTEAFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	0	5	1	24	36	45	41	46														CASSDLGVNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCGGGACTCAGAATGGGGTGAGCAGTTCTTCGGGCCA	CASSGRDSEWGEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	9	4	10	24	36	46	40	56						01,02								CASSGRDSEWGEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGACTAGCGGGTGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGLAGASYNEQFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	1	4	0	2	3	24	31	44	33	47						01,02								CASGLAGASYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGCCTTTGGGCTAAGGGTGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	28	4.4707009420405557E-4		59	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-06	01	1	5	3	1	13	2	22	38	55	51	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGCAGGACAGGGGAACGTCCTGACTTTCGGGGCC	CASSPAGQGNVLTF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	2	10	6	0	24	36	-1	42	51														CASSPAGQGNVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGACCTCGGCCATGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASTTSAMSE*KTYGYTF	Stop	VDJ	1	30	4.790036723614881E-4		54	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	10	2	7	4	4	24	24	31	38	35	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTSAMSE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTACCAGCAGTGAAGCCCCAGCGGGAGTGGTGTGGAATGAGCAGTTCTTCGGGCCA	CTSSEAPAGVVWNEQFF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	7	9	8	24	35	52	44	60														CTSSEAPAGVVWNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTGACGGGACAGGGATAGGGGAGACCCAGTACTTCGGGCCA	CASSVGDGTGIGETQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	9	6	24	36	54	45	60														CASSVGDGTGIGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTGGGGCACCGACAGGAGAGAGACCCAGTACTTCGGGCCA	CASSWGTDRRETQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	4	4	8	2	18	31	45	39	47														CASSWGTDRRETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAATTGCCCGACAGGAAAGTAATCAGCCCCAGCATTTTGGTGAT	CASSLIARQESNQPQHF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	4	4	7	5	18	33	46	40	51														CASSLIARQESNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACGTCGGTGGGACTTAGGGGAAGATACGCAGTATTTTGGCCCA	CASSLRRWDLGEDTQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	10	5	7	7	18	33	46	40	53						01,02								CASSLRRWDLGEDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTTTAGTGGGATCTTACGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASSLVGSYGSYNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	2	4	10	1	18	34	50	44	51														CASSLVGSYGSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTCAAACCAGGACTAGCGGGAAGGAGCAGTACTTCGGGCCG	CASSSQTRTSGKEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	3	7	9	2	18	31	52	40	54														CASSSQTRTSGKEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGTAATCCGGGACTAGCGGGAGGAATCACAGATACGCAGTATTTTGGCCCA	CASSNPGLAGGITDTQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	54	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	1	2	6	3	18	29	50	35	53														CASSNPGLAGGITDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGAAGCTGAGAGCGGGAGGTCGAGGACATTCAGTACTTCGGCGCC	CARS*EREVEDIQYF	Stop	VDJ	1	16	2.554686252594603E-4		45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	6	1	8	3	6	18	31	43	34	49														CARS*EREVEDIQYF+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCTGCCCCTCGGCCGGCTCCTACGAGCAGTACTTCGGGCCG	CASCPSAGSYEQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	8	9	0	0	8	3	18	27	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASCPSAGSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCTTCCGGGACTAGCGAAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	2.714354143381766E-4		52	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	6	1	5	2	18	31	46	36	48						01,02								X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGCGAAATAGGGCAGCTACGAGCAGTACTTCGGGCCG	CASSAK*GSYEQYF	Stop	VDJ	1	19	3.033689924956091E-4		42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	5	5	3	3	7	3	18	30	41	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAK*GSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGGAGACCCCCCAAAACATTCAGTACTTCGGCGCC	CASSLGETPQNIQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	9	2	5	0	7	18	-1	39	34	46														CASSLGETPQNIQYF+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTATACCGAGACCCCGAAGTAGATGAAAAACTGTTTTTTGGCAGT	CASSLYRDPEVDEKLFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	51	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-04	01	1	2	7	6	6	10	19	34	43	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYRDPEVDEKLFF+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGACAGGGAAGAGGATACGCAGTATTTTGGCCCA	CASSEGDREEDTQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	6	0	5	23	-1	48	39	53														CASSEGDREEDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCGACAGGCTCCTCAGAAGGGAGCTGTTTTTTGGAGAA	CASSDRLLRRELFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	4	9	0	10	22	-1	40	34	50														CASSDRLLRRELFF+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTGGACCTAGTAACTGATACGCAGTATTTTGGCCCA	CASSLDLVTDTQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-03	01	3	1	7	6	0	9	22	-1	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDLVTDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGACGGGGACTAGCGGACGAGCAGTTCTTCGGGCCA	CASRRGLADEQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	10	3	2	22	33	47	36	49						01,02								CASRRGLADEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGTTTAGCGGGGTCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLAGSYQETQYF	In	VDJ	2	49	7.823726648570973E-4	9.659169311439217E-4	45	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-05	01	0	6	2	0	0	4	22	-1	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGSYQETQYF+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAGGGACTCCATCATCTATACGAGCAGTACTTCGGGCCG	CAWSEGLHHLYEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	4	3	10	26	37	46	40	56						01,02							Vb 20	CAWSEGLHHLYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGACAGGGGGCAATGAGCAGTTCTTCGGGCCA	CAWTTGGNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	1	6	1	0	26	36	-1	37	46													Vb 20	CAWTTGGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGTCAAACCCCTACGAGCAGTACTTCGGGCCG	CAWSVSNPYEQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	0	3	7	2	5	1	26	40	47	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSNPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGACAGGGGGTCACTATGGCTACACCTTCGGTTCG	CAWSVLTGGHYGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	1	3	3	2	26	40	52	43	54													Vb 20	CAWSVLTGGHYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCTAGCAGGTTTGAACACTGAAGCTTTCTTTGGACAA	CAWSVLAGLNTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	7	0	1	5	26	40	46	41	51						01,02							Vb 20	CAWSVLAGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCTAAGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWLRGSSYNEQFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	0	3	2	26	35	44	38	46			unresolved										Vb 20	CAWLRGSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGAGGGGTGAAGCTTTCTTTGGACAA	CAWSRRGEAFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	0	7	1	1	26	38	45	39	46													Vb 20	CAWSRRGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGATGTCGGGAGCCGAACCAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	3.353025706530417E-4		50	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	2	8	7	8	26	40	53	47	61													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACGTGGCACAGATACGCAGTATTTTGGCCCA	CAWGRGTDTQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	5	1	7	1	0	3	26	-1	39	35	42			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCAACATTCCAGGAGTTCTATGGGGCTACACCTTCGGTTCG	CACNIPGVLWGYTF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	6	4	4	8	8	10	26	34	46	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACNIPGVLWGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCACCGGGACTGGATATACGCAGTATTTTGGCCCA	CAWSTGTGYTQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	7	4	4	26	37	47	41	51						01,02							Vb 20	CAWSTGTGYTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACAGTTACGAGCAGTACTTCGGGCCG	CAWGDSYEQYF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	4	1	1	26	35	43	36	44													Vb 20	CAWGDSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATAGGGTTCAACGAGCAGTACTTCGGGCCG	CAWIGFNEQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	4	5	3	5	1	4	26	36	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIGFNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTACCTGGAGTGATGCAGCGGGACAGAGCACAGATACGCAGTATTTTGGCCCA	CTWSDAAGQSTDTQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	48	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	1	0	5	0	7	0	26	39	-1	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CTWSDAAGQSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTCCCTCGGGGGAGGGACTGAAGCTTTCTTTGGACAA	CAWTSLGGGTEAFF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	0	5	10	0	26	36	-1	46	53			unresolved										Vb 20	CAWTSLGGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCCGGGACACAGGAACACTGAAGCTTTCTTTGGACAA	CAWNPGHRNTEAFF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	1	4	3	26	36	46	40	49													Vb 20	CAWNPGHRNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATTTGGAAACCTACGAGCAGTACTTCGGGCCG	CAWSDLETYEQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	1	1	8	2	4	2	26	39	46	43	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDLETYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGAGTACGAGCAGTACTTTGGGCCG	CAWSVQEYEQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	4	19	0	17	26	-1	45	40	62													Vb 20	CAWSVQEYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACGAGCACCCGAACACTGAAGCTTTCTTTGGACAA	CAWNEHPNTEAFF	In	VDJ	2	47	7.504390866996647E-4	9.264917502809045E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	7	1	3	4	26	36	42	39	46			unresolved			01,02							Vb 20	CAWNEHPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCGCACACTTGCGGGAACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	71	0.0011336420245888553		49	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	3	2	11	2	26	37	54	48	56													Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGACAGGGGGCTATGGCTACACCTTCGGTTCG	CAWTPTGGYGYTF	In	VDJ	4	124	0.0019798818457608175	0.002444361213507067	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	4	4	0	26	36	-1	40	49													Vb 20	CAWTPTGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGGGGCAGGCTACGAGCAGTACTTCGGGCCG	CASSGAGYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	3	0	3	23	-1	40	35	43														CASSGAGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATAAAGAGACCCAGTACTTCGGGCCA	CTSSQDKETQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	9	3	0	0	23	-1	-1	40	42						01,02								CTSSQDKETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATTGGGCTAGCGGGCTTATATCCTACAATGAGCAGTTCTTCGGGCCA	CTSSQDWASGLISYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	4	1	5	6	23	40	53	45	59						01,02								CTSSQDWASGLISYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAGACTCGACAGGGCTTGGCTACACCTTCGGTTCG	CASSQGDSTGLGYTF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	7	7	2	23	39	53	46	55														CASSQGDSTGLGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCAACCTCCAGGGAAAGCAGTTCTTCGGGCCA	CASSNLQGKQFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	11	6	2	23	35	46	41	48														CASSNLQGKQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTGACATCCCTTCTCCTACGAGCAGTACTTCGGGCCG	CASSQE*HPFSYEQYF	Stop	VDJ	1	17	2.714354143381766E-4		48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	6	0	2	6	23	40	46	42	52														CASSQE*HPFSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTTGCGGGGCTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQLAGLNTGELFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	3	2	3	3	23	38	47	41	50														CASSQLAGLNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATACAGCGAGACTAGCGGGAAAGAGTACGCAGTATTTTGGCCCA	CASSQDTARLAGKSTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	2	3	8	8	5	23	40	59	48	64														CASSQDTARLAGKSTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCACGATCGTCCGGGGCCAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	3.512693597317579E-4		40	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	12	7	0	3	8	3	23	28	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGGGACAGGGAAACAATGAGCAGTTCTTCGGGCCA	CASSLGQGNNEQFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	5	1	2	23	36	46	37	48														CASSLGQGNNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTCCGATTGGTTTGTGCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSPIGLCTKRANVLTF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	54	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	3	6	5	16	4	23	34	53	50	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSPIGLCTKRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGGCCCTCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGALTGELFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	6	0	4	0	3	23	-1	43	37	46														CASSQGALTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTAGGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQVRTSGQETQYF	In	VDJ	2	55	8.781733993293949E-4	0.0010841924737329733	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	1	5	1	3	0	23	39	-1	42	52						01,02								CASSQVRTSGQETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCGGGGGACTACTCAACCCGAGATACGCAGTATTTTGGCCCA	CASSAGDYSTRDTQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	5	4	9	19	31	42	35	51						01,02							Vb 5.1	CASSAGDYSTRDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGATAGCGGGAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	9	1.4370110170844642E-4		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	5	1	1	3	0	19	35	-1	38	48													Vb 5.1	X+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTGGGGGCCCGAGGCACTGAAGCTTTCTTTGGACAA	CASSLVGARGTEAFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	4	1	6	19	35	42	36	48													Vb 5.1	CASSLVGARGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTCACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLVHSSYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	5	0	3	0	19	35	-1	38	42													Vb 5.1	CASSLVHSSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGACAGGACTCTGGAAACACCATATATTTTGGAGAG	CASSSGQDSGNTIYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	4	0	2	1	19	32	41	34	42													Vb 5.1	CASSSGQDSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACTGATTACAATGAGCAGTTCTTCGGGCCA	CASSPGTDYNEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	4	3	3	19	31	40	34	43						01,02							Vb 5.1	CASSPGTDYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGACCCGGGACAGAAGAATGAAAAACTGTTTTTTGGCAGT	CASSWDPGQKNEKLFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	5	5	7	3	19	32	46	39	49													Vb 5.1	CASSWDPGQKNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGCGACTAGCGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.7563467986587896E-4		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	5	0	4	0	19	35	-1	39	48						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGGGAGAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	12	1.9160146894459524E-4		44	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	9	2	2	2	2	19	31	38	33	40													Vb 5.1	X+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGACGGTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGRSSGANVLTF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-06	01	3	0	7	0	1	4	19	32	38	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSGRSSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTTTTAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSFLGENTEAFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	6	1	19	30	41	36	42													Vb 5.1	CASSFLGENTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGGTTCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAGSTNEKLFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	5	2	1	4	19	35	39	36	43						01,02							Vb 5.1	CASSLAGSTNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGGACAGGGAATATCCAGATACGCAGTATTTTGGCCCA	CASSPEDREYPDTQYF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	4	5	6	19	31	44	36	50													Vb 5.1	CASSPEDREYPDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGGGACTCAGCCGTGTATCTCTACGCCTTAAACCGGGACTTTACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	5.748044068337857E-4		41	TCRBV17	TCRBV17-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	11	0	10	3	10	3	22	25	41	35	44						01,02								X+TCRBV17-01+TCRBJ01-05	TCRBV17-01*01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCAGTTAGCGTATTCTGGGAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	55	8.781733993293949E-4		46	TCRBV17	TCRBV17-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	6	4	3	13	22	31	39	34	52						01,02								X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01	TCRBD02-01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTCGACAGGGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSSSTGGGETQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	0	5	4	3	25	38	52	42	55													Vb 3	CASSSSTGGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACCTCCGGGGGAACTGAAGCTTTCTTTGGACAA	CASSLTSGGTEAFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	5	5	1	25	40	51	45	52													Vb 3	CASSLTSGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGAATATCGCACTGAAGCTTTCTTTGGACAA	CASSEYRTEAFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	2	8	4	1	6	25	36	39	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSEYRTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGACTAGCGGGAGGTGGGACCAATGAGCAGTTCTTCGGGCCA	CASRGLAGGGTNEQFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	1	6	1	6	25	36	51	37	57													Vb 3	CASRGLAGGGTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATGCAGGGGGCCTGGGACGAGCAGTACTTCGGGCCG	CASSMQGAWDEQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	5	3	5	25	37	48	40	53													Vb 3	CASSMQGAWDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGTACAGGGTTATAACTATGGCTACACCTTCGGTTCG	CASSLRVQGYNYGYTF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	1	5	3	25	40	51	45	54													Vb 3	CASSLRVQGYNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTATACAGGGGAGGTTACGAGCAGTACTTCGGGCCG	CASSLYRGGYEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	2	4	0	4	25	-1	48	41	52													Vb 3	CASSLYRGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGACTACCCGGCGGGGGGGCGGAGACCCAGTACTTCGGGCCA	CASRGLPGGGAETQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	0	5	11	2	25	36	56	47	58													Vb 3	CASRGLPGGGAETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTTCAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFVQSSYEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	4	5	0	4	2	25	39	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFVQSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTACTAGGGGCAGGGTAAGGAGCAGCGAAAAACTGTTTTTTGGCAGT	CASSSTRGRVRSSEKLFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	54	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	4	4	3	8	10	11	25	38	53	48	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSTRGRVRSSEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGGGAGTGGACTGAAGCTTTCTTTGGACAA	CASSSGEWTEAFF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	5	0	5	25	-1	44	38	49													Vb 3	CASSSGEWTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTATGACGGGGCCTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	33	5.269040395976369E-4		41	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	4	7	0	5	5	3	25	38	48	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTTTAACAGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASTLTDSYNEQFF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	0	0	1	25	-1	44	40	45													Vb 3	CASTLTDSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLEGNQPQHF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	2	5	2	4	1	0	25	40	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLEGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSLWGSTEAFF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	4	0	2	25	-1	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWGSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTGGCGGAGACCCAATACTTCGGGCCA	CASSPLAETQYF	In	VDJ	2	46	7.344722976209484E-4	9.067791598493958E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	5	14	6	8	25	37	47	43	55						01,02							Vb 3	CASSPLAETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTACAGGCGTTTACCTCGGAAACACCATATATTTTGGAGAG	CASSSTGVYLGNTIYF	In	VDJ	2	52	8.30273032093246E-4	0.0010250547024384475	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	4	4	2	10	25	38	45	40	55													Vb 3	CASSSTGVYLGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCTCTAGCGGGAGGGGGAGGTCGCGGGAGCAGTACTTCGGGCCG	CASSLFSSGRGRSREQYF	In	VDJ	2	71	0.0011336420245888553	0.001399593920637111	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	0	7	3	11	25	41	56	44	67													Vb 3	CASSLFSSGRGRSREQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAAGGTGGGGAAACCGGTACGCAGTATTTTGGCCCA	CASSLEGGETGTQYF	In	VDJ	3	98	0.0015647453297141945	0.0019318338622878433	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	0	8	8	8	6	25	39	51	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLEGGETGTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACCGGACTAGCGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRTGLAGGTGELFF	In	VDJ	4	123	0.0019639150566821014	0.0024246486230755583	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	1	4	4	0	25	36	-1	40	54													Vb 3	CASRTGLAGGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCGTGGACTAGCGGGAGGAGGATCGGAGACCCAGTACTTCGGGCCA	CATRGLAGGGSETQYF	In	VDJ	19	559	0.008925435095002395	0.01101933805121331	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	1	1	5	5	7	25	32	51	37	58													Vb 3	CATRGLAGGGSETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAAACATAATTGAGCGGGAGGGCCGCAAAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	35	997	0.01591888871148012		59	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	0	6	14	8	22	33	57	47	65													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCACAGGGGACGGAGGGGGAGCAGTACTTCGGGCCG	CASSAQGTEGEQYF	In	VDJ	47	1338	0.02136356378732237	0.026375445997358513	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	7	2	9	25	37	46	39	55													Vb 3	CASSAQGTEGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCACTCGGCTAGCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CATRLAGDTGELFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	4	2	3	7	0	18	23	-1	30	40														CATRLAGDTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGCAAGCCACGTTTGGTGGGACTCGGCCSTGTATGTCTGTGCAAGTCGGAAGGGGCAGCGGGAATCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	3	5	8	4	18	29	44	37	48														X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGGGCCAGGGGCTTTTCCTACGAGCAGTACTTCGGGCCG	CASRARGFSYEQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	1	3	4	18	29	38	32	42														CASRARGFSYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CSVRGVQETQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	1	0	1	25	-1	41	34	42													Vb 4	CSVRGVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGAAGCAGCATATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVAGGGVEQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	45	55	65	59	69													Vb 4	CSVAGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTTCGGGGGCGGCCGAGCAGTACTTCGGGCCG	CSVVSGAAEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	4	6	0	6	4	3	25	35	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVSGAAEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGTGCCATATTTAGCGGGAGGGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.9160146894459524E-4		47	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	21	5	0	5	25	2	34	27	63	52	65													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCATCGGGACAGCTTCCTCCTACGAGCAGTACTTCGGGCCG	CSGIGTASSYEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	5	4	25	32	44	37	48													Vb 4	CSGIGTASSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGAGCGCCCGGGATACGCAGTATTTTGGCCCA	CSVASARDTQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	6	6	2	5	25	35	41	37	46						01,02							Vb 4	CSVASARDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATTAGGACAGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CSIRTGGNQPQHF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	4	2	4	2	25	31	42	35	44													Vb 4	CSIRTGGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCATCACCTACGAACACTGAAGCTTTCTTTGGACAA	CSASPTNTEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	4	9	1	6	1	25	32	41	38	42						01,02							Vb 4	CSASPTNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCGCATATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVAGGGVEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	45	55	65	59	69													Vb 4	CSVAGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGCCCTTGGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CSVEGGPWTGGTEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	1	4	9	0	25	38	-1	47	57													Vb 4	CSVEGGPWTGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGGAGGAGTAGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.3950183618074404E-4		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	3	4	25	35	44	38	48													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATWATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.554686252594603E-4		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	21	9	1	7	20	4	46	39	65	59	69													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACAGGGCTTACCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEGTGLTSYNEQFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	0	0	5	25	-1	46	38	51													Vb 4	CSVEGTGLTSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATTCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.714354143381766E-4		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	19	9	1	7	18	4	46	41	65	59	69													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVAGGGVEQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	45	55	65	59	69													Vb 4	CSVAGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACGGGGCTCTACAATGAGCAGTTCTTCGGGCCA	CSVTGLYNEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	5	7	0	3	2	1	25	34	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVTGLYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTACCCCGGGTGGCTACACCTTCGGTTCG	CSVEVTPGGYTF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	7	6	0	25	38	-1	44	48						01,02							Vb 4	CSVEVTPGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGTGGGGCTCAGGGAAGACGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.193357815743254E-4		55	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	0	9	8	25	39	53	48	61													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGACAGGGTAAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	3.353025706530417E-4		35	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	4	1	4	25	32	40	33	44													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGATATGCGGGGCTACCTTTGCGGGAGCAGTTCTTCGGGCCA	CSVGYAGLPLREQFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	10	5	12	25	35	46	40	58													Vb 4	CSVGYAGLPLREQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCACAGGGGGCGCAGGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.512693597317579E-4		35	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	0	7	3	4	25	32	44	35	48													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTGGCGGACCCGAAGGGTACGCAGTATTTTGGCCCA	CSVLADPKGTQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	5	1	7	8	5	8	25	34	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLADPKGTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCAACTCCTACACGTTGGGGCGAGCAGTACTTCGGGCCG	CSVSTPTRWGEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	5	6	2	6	16	0	25	34	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSTPTRWGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCAGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	3.672361488104742E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	1	0	25	39	-1	40	45													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGTAGGCGGGAGTCCCGCAGATACGCAGTATTTTGGCCCA	CSVEGVGGSPADTQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	2	4	6	5	25	38	51	44	56													Vb 4	CSVEGVGGSPADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCTCGGTGGTAGCTCCACCGGGGAGCTGTTTTTTGGAGAA	CSALGGSSTGELFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	5	7	4	10	2	25	32	46	42	48						01,02							Vb 4	CSALGGSSTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACGGGACCCCTCTTCGCTGAAGCTTTCTTTGGACAA	CSVTGPLFAEAFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	0	7	6	2	9	25	34	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVTGPLFAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGGGGACACTCAATTCCTACGAGCAGTACTTCGGGCCG	CSAGTLNSYEQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	1	2	6	25	32	40	34	46													Vb 4	CSAGTLNSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACCAGAACACAGATACGCAGTATTTTGGCCCA	CSVEDQNTDTQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	5	2	1	2	25	39	43	40	45													Vb 4	CSVEDQNTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGACGGCCCTGAACACTGAAGCTTTCTTTGGACAA	CSVRTALNTEAFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	1	7	0	1	5	25	34	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRTALNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CSVGTSGGYEQYF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	3	2	0	25	35	-1	37	48													Vb 4	CSVGTSGGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGTAGCGGGCGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	4.949704614402044E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	4	2	2	4	25	33	42	35	46						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGGGGACTAGCGGGAGGGTATCGCACAGATACGCAGTATTTTGGCCCA	CSVERGLAGGYRTDTQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	0	1	2	4	25	37	55	39	59													Vb 4	CSVERGLAGGYRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGCAAGGGGATAAGCAGTATTTTGGCCCA	CSVEGQGDKQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	11	6	4	25	36	47	42	51													Vb 4	CSVEGQGDKQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTACCGCCAGGGGGCAATCCCCGGGGAGCTGTTTTTTGGAGAA	CSVYRQGAIPGELFF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	6	7	5	25	33	48	40	53													Vb 4	CSVYRQGAIPGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGGGGTCTTACACTGAAGCTTTCTTTGGACAA	CSVRGSYTEAFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	3	0	4	25	-1	40	34	44													Vb 4	CSVRGSYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTGGCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	5.748044068337857E-4		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	22	9	1	7	21	4	46	38	65	59	69													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAAGACAGCAGCATATATCTCTGCAGCGTATACAGGGGGACAACCCTACCCCCGTTGGGGTGAAACACTGAAGCTTTCTTTGGACAA	CSVYRGTTLPPLG*NTEAFF	Stop	VDJ	1	37	5.90771195912502E-4		60	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	2	2	24	21	29	39	31	63													Vb 4	CSVYRGTTLPPLG*NTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGCAGGCCCATCTCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	6.067379849912182E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	2	2	10	25	33	39	35	49													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGTAGTGTATGGAGGCGCGGTGAAGCTTTCTTTGGACAA	CSVSSVWRRGEAFF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	7	10	5	25	34	49	44	54													Vb 4	CSVSSVWRRGEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGCCCACTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVEEPTGANVLTF	In	VDJ	1	39	6.227047740699345E-4	7.687910268288356E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	0	4	6	2	3	0	25	39	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEEPTGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGACTAGCGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSGTSGGSYNEQFF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	1	2	0	0	0	25	-1	-1	32	45													Vb 4	CSGTSGGSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGATCCGGGACACTGACTAACTATGGCTACACCTTCGGTTCG	CSVGSGTLTNYGYTF	In	VDJ	2	47	7.504390866996647E-4	9.264917502809045E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	0	7	4	25	33	46	40	50													Vb 4	CSVGSGTLTNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGCCAGGGCTATGGGAATCAGCCCCAGCATTTTGGTGAT	CSVSQGYGNQPQHF	In	VDJ	2	54	8.622066102506786E-4	0.0010644798833014646	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	4	4	7	25	33	42	37	49													Vb 4	CSVSQGYGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGATCGGAGCGGAACGACGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEIGAERRSYNEQFF	In	VDJ	2	55	8.781733993293949E-4	0.0010841924737329733	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	1	6	8	25	36	47	42	55						01,02							Vb 4	CSVEIGAERRSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGCGGGTAGTGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	58	9.260737665655437E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	7	4	6	2	5	25	35	42	37	47						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACTGGCCCAGGGGACCCAGATGGAAAGCACAGATACGCAGTATTTTGGCCCA	CSVELAQGTQMESTDTQYF	In	VDJ	2	65	0.0010378412901165576	0.0012813183780480593	57	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	0	6	12	24	36	48	42	60													Vb 4	CSVELAQGTQMESTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCACTCGAAGGGGGGACTGAAGCTTTCTTTGGACAA	CSALEGGTEAFF	In	VDJ	2	67	0.0010697748682739901	0.0013207435589110766	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	5	1	5	7	1	25	32	45	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSALEGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCTTTACCTTACAGGGACCCTCACAGATACGCAGTATTTTGGCCCA	CSVVLYLTGTLTDTQYF	In	VDJ	3	89	0.001421044228005748	0.0017544205484042658	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	2	11	5	25	35	52	46	57													Vb 4	CSVVLYLTGTLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCCGGGGTTGGGGGACATGAGCAGTTCTTCGGGCCA	CSAPGVGGHEQFF	In	VDJ	4	121	0.0019319814785246686	0.002385223442212541	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	7	0	7	8	13	0	25	32	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAPGVGGHEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGCCATATTTAGCGGGAGGGCAAGATACGCAGTATTTTGGCCCA	CSVVPYLAGGQDTQYF	In	VDJ	34	961	0.015344084304646335	0.01894379940467977	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	0	5	9	2	25	35	55	44	57													Vb 4	CSVVPYLAGGQDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTGGGGGAGGAGTAGAGCAGTACTTCGGGCCG	CSVAGGGVEQYF	In	VDJ	175	5015	0.08007344722976209	0.09885864101401565	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	1	7	4	4	25	35	45	39	49													Vb 4	CSVAGGGVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGCGGGACTAGCGGGAGAGTACGAGCAGTACTTCGGGCCG	CASRAGLAGEYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	2	4	3	2	23	34	51	37	53													Vb 22	CASRAGLAGEYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCTGGGAGGGTCCTATGGCTACACCTTCGGTTCG	CASSLGGSYGYTF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	4	3	2	23	34	44	37	46													Vb 22	CASSLGGSYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGTTTCTGCTTTCCCTGAGCAGTTCTTCGGGCCA	CASSEVSAFPEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	1	10	0	9	5	6	23	39	46	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEVSAFPEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGTGGGAGGGAGACCCAGTACTTCGGGCCA	CASSGGRETQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	1	5	2	0	23	36	-1	38	44													Vb 22	CASSGGRETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCAGTGACTAGCGGAGCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	2.075682580233115E-4		49	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	2	6	3	23	34	49	40	52						01,02							Vb 22	X+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCATTTCAGGGGTGACCTACAATGAGCAGTTCTTCGGGCCA	CAISGVTYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	4	2	2	3	3	23	30	39	33	42													Vb 22	CAISGVTYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTGGGACGGTCTCAATGAGCAGTTCTTCGGGCCA	CASWDGLNEQFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	8	0	7	6	1	5	23	32	38	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASWDGLNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATGATACGCCCTCCTCACTTGAACACTGAAGCTTTCTTTGGACAA	CASMIRPPHLNTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	3	10	0	15	0	23	33	-1	48	51						01,02							Vb 22	CASMIRPPHLNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATTTCGAGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSDFEGYNEQFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	0	4	4	1	23	37	46	41	47													Vb 22	CASSDFEGYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGACTAGCGGGAGGGCCGCTGAGCAGTACTTCGGGCCG	CASKTSGRAAEQYF	In	VDJ	6	181	0.002889988823247645	0.0035679788681030576	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	2	0	7	1	5	23	33	48	34	53													Vb 22	CASKTSGRAAEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGTGGGCGGAGCCAAATCCTACGAGCAGTACTTCGGGCCG	CASSEVGGAKSYEQYF	In	VDJ	9	249	0.003975730480600351	0.004908435017445642	48	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	1	8	0	1	1	9	23	39	44	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEVGGAKSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGAGAACTAGCTATCCATGAGCAGTTCTTCGGGCCA	CASRELAIHEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	7	8	3	5	28	39	48	42	53			01,02			01,02								CASRELAIHEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACAGTGGAACTGAAGCTTTCTTTGGACAA	CASSYSGTEAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	5	1	4	28	40	45	41	49			01,02											CASSYSGTEAFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCCGCTTTGGACTAGTCCTACATGAGCAGTTCTTCGGGCCA	CASRFGLVLHEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	1	8	8	6	6	28	37	50	43	56			01,02			01,02								CASRFGLVLHEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGTGAGTCGTGGGGGGAATGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAISESWGEWGTGELFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	51	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	9	1	4	5	7	28	42	53	47	60			01,02											CAISESWGEWGTGELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTAGTTCATACCAAGAGACCCAGTACTTCGGGCCA	CASSSSYQETQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	39	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-05	01	5	4	6	0	4	1	28	40	46	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSYQETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAAAGTTCTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAKVLGTGELFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	36	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-02	01	10	0	9	4	7	0	28	35	-1	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAKVLGTGELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCCCCCTACGGGACTCCCCTACGAGCAGTACTTCGGGCCG	CASSPPTGLPYEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	2	9	2	26	37	52	46	54						01,02								CASSPPTGLPYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCAGGCCAGGGGATAGGAAGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.9160146894459524E-4		46	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	8	4	7	26	43	53	47	60														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTAAGGGGGACAGGGTCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	2.2353504710202778E-4		47	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	5	4	3	26	42	55	46	58														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACGGTGAGTTATAAGAGACCCAGTACTTCGGGCCA	CASSDGEL*ETQYF	Stop	VDJ	1	19	3.033689924956091E-4		42	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	5	2	7	3	0	10	26	-1	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGEL*ETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTCCCTCCATAGCGGGAGAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	3.193357815743254E-4		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	5	2	3	8	2	26	35	52	43	54														X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCTCAATACAGGGGAGGGAACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	5.109372505189206E-4		50	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	6	3	2	3	7	6	26	37	51	44	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCGGTGGAGCGGGAGGAAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	33	5.269040395976369E-4		41	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	6	1	8	6	2	26	35	50	41	52														X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTTAACATGATCTAAGGGCGCTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	5.588376177550695E-4		50	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	1	5	3	6	12	5	26	42	58	54	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACATTGGGCAGATGTTTTTATGGCTACACCTTCGGTTCG		Out	VDJ	2	55	8.781733993293949E-4		46	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	5	3	9	26	41	48	44	57														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCGGGCACAGGGGGGAGAAGGAGACTTGGAACACTGAAGCTTTCTTTGGACAA	CAGHRGEKETWNTEAFF	In	VDJ	2	62	9.899409228804087E-4	0.0012221806067535335	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	3	1	1	4	14	26	32	44	36	58														CAGHRGEKETWNTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTAAGGGGAGCGGGAGGGCCGACCGAGCAGTTCTTCGGGCCA	CASSLRGAGGPTEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	10	8	6	19	31	49	39	55														CASSLRGAGGPTEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCTCCGGCGGGTCTAGCGGGAGGGCCCTGAATGAGCAGTTCTTCGGGCCA	CASSSGGSSGRALNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	54	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	0	7	9	5	19	32	53	41	58														CASSSGGSSGRALNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCATCAACTAGCGGGCCCACCCGTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	9	1.4370110170844642E-4		41	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	3	4	6	3	9	27	34	46	37	55						01,02								X+TCRBV26-01+TCRBJ02-07	TCRBV26-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACATCTGTGTATCTCTATGCCAGCAGCCCAAACATAATTGAGTGGGAGGGCCGCAAAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.596678907871627E-4		59	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	6	17	8	16	27	51	44	59														X+TCRBV26-01+TCRBJ02-01	TCRBV26-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASGACTCSGCYGTGTATCTCTGTGCCAGCAGCTTAAGCACGGGTGGGGATACGCAGTATTTTGGCCCA	CASSLSTGGDTQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	8	4	6	4	4	19	34	42	38	46		TCRBV07-05,TCRBV07-08				01,02								CASSLSTGGDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCAAGCCTACAGCCGACGGGAGACCCAGTACTTCGGGCCA	CASSQAYSRRETQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	5	5	7	7	18	30	41	37	48		TCRBV11-01,TCRBV11-03												CASSQAYSRRETQYF+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTTGGCAGGAACTCCTACGAGCAGTACTTCGGGCCG	CASSFGRNSYEQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	4	0	3	2	19	33	40	36	42		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSFGRNSYEQYF+TCRBV05-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGACTGGACTACGAGCAGTACTTCGGGCCG	CASSESGLDYEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	10	3	0	3	23	-1	46	40	49		TCRBV10-01,TCRBV10-02				01,02								CASSESGLDYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGACGTGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLDVGAGTGELFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	6	0	4	4	3	19	35	45	39	48		TCRBV07-05,TCRBV07-06												CASSLDVGAGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACCGGGCACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.9160146894459524E-4		41	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	5	8	0	1	4	2	26	38	46	42	48		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCCGGACAGGGGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.9160146894459524E-4		40	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	2	1	1	1	23	32	42	33	43		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGAGGGGGGAACGATGAGCAGTTCTTCGGGCCA	CASSGGGNDEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	5	5	1	8	2	5	23	35	43	37	48		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGGNDEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGTATTCGTCATTGTGCGGGAGGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	2.2353504710202778E-4		53	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	2	13	1	18	29	50	42	51		TCRBV07-01,TCRBV07-02												X+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTAGATTCACTATCCTACGAGCAGTACTTCGGGCCG	CASSLDSLSYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	9	1	3	0	19	36	-1	39	43		TCRBV11-01,TCRBV11-03				01,02								CASSLDSLSYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCGGCCTAGCGGGAGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	2.3950183618074404E-4		47	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	1	4	7	1	26	37	55	44	56		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTATTCCAGCGAGGACTAGCTACTTCGGGCCA		Out	VDJ	1	16	2.554686252594603E-4		37	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	7	14	9	0	24	38	-1	47	55		TCRBV06-05,TCRBV06-06,TCRBV06-08,TCRBV06-09				01,02								X+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCAACGGTGGGGGGGCCTTCAGAGAGAACTGAAGCTTTCTTTGGACAA	CASSPTVGGPSERTEAFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	54	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	5	8	12	19	31	46	39	58		TCRBV11-01,TCRBV11-03												CASSPTVGGPSERTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCATCGGAGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	2.714354143381766E-4		37	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	2	2	2	1	23	33	39	35	40		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCGGTGCAGGCACCAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	2.714354143381766E-4		47	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	4	1	6	5	26	36	46	42	51		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGRGGACTCMGCYGTGTATCTCTGTGCCAGCAGCCCCGCTGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPAGAGELFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-02	01	5	6	2	6	6	0	22	34	-1	40	44		TCRBV07-04,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAGAGELFF+TCRBV07-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTAGTGACAGGCCGTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	3.033689924956091E-4		47	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	4	0	3	4	28	40	49	43	53		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCCGTACTAGCGGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSPRTSGSGELFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	5	6	7	2	23	34	49	41	51		TCRBV06-07,TCRBV06-08				01,02								CASSPRTSGSGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCACAGGGGCCTCGGAAGGGCCCCAGCATTTTGGTGAT	CASTGASEGPQHF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	9	0	10	23	-1	39	33	49		TCRBV06-04,TCRBV06-08												CASTGASEGPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTATAAGGTAGCGGGCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.512693597317579E-4		43	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	4	3	6	2	26	38	51	44	53		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACCAAGGGACTAGCAACGAGCAGTACTTCGGGCCG	CASSYQGTSNEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	7	5	3	1	26	41	53	44	54		TCRBV06-04,TCRBV06-07				01,02								CASSYQGTSNEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGAGTAGTCCAGCCAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.512693597317579E-4		44	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	2	4	5	4	7	4	23	38	48	45	52		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGACAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSEGQGADTQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	1	4	3	0	26	38	-1	41	51		TCRBV06-01,TCRBV06-07												CASSEGQGADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTTTGGACAGGTTAAAGAGACCCAGTACTTCGGGCCA	CASSFGQVKETQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	4	3	2	3	26	39	48	41	51		TCRBV06-04,TCRBV06-07												CASSFGQVKETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCGCCCAAGGACTAGCGGGAACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRPRTSGNPNTGELFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	57	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	3	0	7	3	19	31	50	38	53		TCRBV07-05,TCRBV07-07												CASSRPRTSGNPNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACGACGGCCCCTCTGGGCAGTACTTCGGGCCG	CASSDDGPSGQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	5	2	7	9	0	14	23	-1	38	35	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDDGPSGQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGCTGCCAGGGGAGGGGCTGAAGCTTTCTTTGGACAA	CASSAARGGAEAFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	6	8	1	23	35	50	43	51		TCRBV06-07,TCRBV06-08												CASSAARGGAEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAGAAGCGGGACAGGGGGCATTTTACTTCGGGCCG	CASREAGQGAFYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	13	6	4	26	37	55	43	59		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASREAGQGAFYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTYGGCYRTGTATCKCTGTGCCAGCAGCATTAACAGGGGCTCGGGTGGAAACACCATATATTTTGGAGAG	CASSINRGSGGNTIYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	2	3	4	6	18	30	41	34	47		TCRBV07-01,TCRBV07-06												CASSINRGSGGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTTCTGCGCCAGCAGGGAGAACCGGGGAGTCTAGAGGGGCTTGTGCGGGAGAGAATTCGACGAGCAGTACTTCGGGCCG	CASRENRGV*RGLCGREFDEQYF	Stop	VDJ	1	32	5.109372505189206E-4		69	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	2	5	25	8	4	19	51	44	59		TCRBV10-01,TCRBV10-02												CASRENRGV*RGLCGREFDEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCTCGGGGGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	33	5.269040395976369E-4		46	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	8	1	0	2	0	28	43	-1	45	52		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTGCAGGGGACGTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLQGTLAKNIQYF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	2	0	1	5	19	33	40	34	45		TCRBV07-05,TCRBV07-07												CASSLQGTLAKNIQYF+TCRBV07-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCACCCCGGGGCCGGATAACTCCTACGAGCAGTACTTCGGGCCG	CASTPGPDNSYEQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	7	7	0	0	4	7	19	29	38	33	45		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPGPDNSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTGGGACAGTGCTCGCGAGCAGTACTTCGGGCCG	CASSWDSAREQYF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	6	0	6	18	-1	38	31	44		TCRBV07-02,TCRBV07-08												CASSWDSAREQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACTCTTCAGGGTATGAGCAGTTCTTCGGGCCA	CASSDSSGYEQFF	In	VDJ	2	54	8.622066102506786E-4	0.0010644798833014646	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	8	5	1	23	37	47	42	48		TCRBV10-01,TCRBV10-02												CASSDSSGYEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCTTGAACAGGGGAAGGGCAGATACGCAGTATTTTGGCCCA	CASTLNRGRADTQYF	In	VDJ	2	71	0.0011336420245888553	0.001399593920637111	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	2	4	6	5	23	33	46	39	51		TCRBV06-07,TCRBV06-08												CASTLNRGRADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTGCACAGGGGACGGAGGGGGAGCAGTACTTCGGGCCA	CASSAQGTEGEQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	13	3	2	11	11	12	25	28	46	39	58														CASSAQGTEGEQYF+TCRBV22-01+TCRBJ02-05	TCRBV22-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGTAGCGGGGTTGGATACGCAGTATTTTGGCCCA	CASSLVAGLDTQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	3	6	3	3	22	35	46	38	49														CASSLVAGLDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGGCATACTAGCAGCTACGAGCAGTACTTCGGGCCG	CASRHTSSYEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	7	3	4	2	22	33	43	37	45						01,02								CASRHTSSYEQYF+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGTGAGCTTCGGGGAGGAAATGAGCAGTTCTTCGGGCCA	CASSELRGGNEQFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	7	9	1	22	33	48	42	49														CASSELRGGNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGGGCCCCGAAAGACCTATGGCTACACCTTCGGTTCG	CASSGPRKTYGYTF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	4	0	10	22	-1	38	34	48														CASSGPRKTYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCTAACAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	YASSLTGYTGELFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	42	TCRBV07	TCRBV07-03	01				TCRBJ02	TCRBJ02-02	01	0	5	3	3	0	1	22	-1	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSLTGYTGELFF+TCRBV07-03+TCRBJ02-02	TCRBV07-03*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTCGGACTAGCGGAGCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.075682580233115E-4		47	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	2	1	4	20	33	44	34	48			01,02			01,02								X+TCRBV07-08+TCRBJ02-03	TCRBV07-08	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGACGGCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	9	1.4370110170844642E-4		41	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	4	0	7	2	0	4	23	-1	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCCCGACTAGCGGGAGATCTATGGACATTCAGTACTTCGGCGCC		Out	VDJ	1	12	1.9160146894459524E-4		50	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	2	2	8	4	8	23	35	51	39	59													Vb 12	X+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGCCGGGACAGCGGACGAGCAGTACTTCGGGCCG	CASRAGTADEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	5	4	3	23	34	45	38	48													Vb 12	CASRAGTADEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAGTTTAGCAGCTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.714354143381766E-4		43	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	7	2	1	5	23	39	44	40	49						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAATGGGCGGGAGGATCATACGCAGTATTTTGGCCCA	CASNGREDHTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	1	7	4	3	23	33	45	37	48													Vb 12	CASNGREDHTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGGGACTAGCGGGAGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASTGLAGEDTGELFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	0	2	3	1	3	23	33	48	34	51													Vb 12	CASTGLAGEDTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATTAGCCGGGAGAACGGAGATACGCAGTATTTTGGCCCA	CASISRENGDTQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	8	2	5	5	5	23	33	44	38	49													Vb 12	CASISRENGDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTAGAGGGGGCGGACACTGAAGCTTTCTTTGGACAA	CASSELEGADTEAFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	0	3	3	2	23	39	49	42	51													Vb 12	CASSELEGADTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCAACTCCCAGCGGGGTGGAGGTTTTGAGACCCAGTACTTCGGGCCA	CATNSQRGGGFETQYF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	6	3	5	9	10	23	30	46	39	56													Vb 12	CATNSQRGGGFETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGGCCCTCCACAAGGACTAGCGGGAGGCCCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	6.067379849912182E-4		53	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	13	1	1	2	11	5	23	27	52	38	57													Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGCCGACTAGCGGGAGCGATGAGCAGTTCTTCGGGCCA	CASSGPTSGSDEQFF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	8	4	2	23	36	52	40	54													Vb 12	CASSGPTSGSDEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGACAGCTATCAGCCCCAGCATTTTGGTGAT	CASSEDSYQPQHF	In	VDJ	2	51	8.143062430145298E-4	0.0010053421120069389	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	5	5	0	2	23	-1	43	38	45													Vb 12	CASSEDSYQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCCCAGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESPGNSNQPQHF	In	VDJ	8	233	0.003720261855340891	0.0045930335705415045	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	0	2	2	23	40	47	42	49													Vb 12	CASSESPGNSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACTAGCGGAAGTTGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISETSGSWENTGELFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	5	1	0	9	23	-1	46	38	55						01,02							Vb 12	CAISETSGSWENTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGTTCCCAGCCCCAGCATTTTGGTGAT	CAISESGSQPQHF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	0	0	9	7	0	4	23	-1	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGSQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAACCTAAACTAAACCACTCAAGAGACCCAGTACTTCGGGCCA	CAINLN*TTQETQYF	Stop	VDJ	1	16	2.554686252594603E-4		45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	3	9	2	6	7	24	34	44	40	51						01,02							Vb 12	CAINLN*TTQETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCGGGGACTAGCGGGAGCCCCGAGCAGTACTTCGGGCCG	CAISEPGTSGSPEQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	2	6	3	3	23	38	55	41	58													Vb 12	CAISEPGTSGSPEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCGGGCGTGGGGGGCTGTACGAGCAGTACTTCGGGCCG	CAISESGRGGLYEQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	48	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	0	6	0	4	8	2	23	40	54	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGRGGLYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAACAAGAAGATGAACACTGAAGCTTTCTTTGGACAA	CANKKMNTEAFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	3	6	0	0	6	24	-1	34	31	40													Vb 12	CANKKMNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGTCTAAACACTGAAGCTTTCTTTGGACAA	CAISESSLNTEAFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	9	2	4	0	23	40	-1	44	47						01,02							Vb 12	CAISESSLNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACTAGCGGGAGAGGGGACACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	4.790036723614881E-4		47	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	2	5	0	7	23	-1	49	38	56													Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTTTAGGGGCCCAGTACTTCGGGCCA	CAISESLGAQYF	In	VDJ	2	53	8.462398211719623E-4	0.001044767292869956	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	9	3	0	23	40	-1	43	48													Vb 12	CAISESLGAQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACTAGCGGGAGTTGGGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CAISETSGSWEDTGELFF	In	VDJ	6	166	0.002650486987066901	0.003272290011630428	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	3	2	3	0	8	23	-1	49	38	57													Vb 12	CAISETSGSWEDTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCAAGGAACCGGGACTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASNQGTGTSGSSYNEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	2	0	11	0	24	34	-1	45	59			01,02										Vb 17	CASNQGTGTSGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATACAGGCAACATTCAGTACTTCGGCGCC	CASSIYTGNIQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	4	7	4	1	27	41	50	45	51			01,02										Vb 17	CASSIYTGNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTCGCGGGACTAGCGGAGTCGAGCAGTACTTCGGGCCG	CASSLRGTSGVEQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	5	6	6	3	27	39	56	45	59			01,02			01,02							Vb 17	CASSLRGTSGVEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTGGGCAGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSFGQFSYEQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	0	3	4	27	39	46	42	50			01,02										Vb 17	CASSFGQFSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATACAGGGGGCGCTTAACTACAATGAGCAGTTCTTCGGGCCA	CASSIIQGALNYNEQFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	0	3	2	6	27	42	53	44	59			01,02										Vb 17	CASSIIQGALNYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	2.075682580233115E-4		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	5	2	0	27	41	-1	43	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCGCCGCCGGGGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.075682580233115E-4		46	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	7	0	4	9	1	27	41	55	50	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCGGGAGGCGATGAGCAGTTCTTCGGGCCA	CASSMSGGDEQFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	1	8	2	2	27	41	50	43	52			01,02										Vb 17	CASSMSGGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCAAGAAAGAGAGGGACTTCAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.2353504710202778E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	12	0	10	0	10	4	27	32	48	42	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGCCCGGGACACCCTTGGGGGCACTGAAGCTTTCTTTGGACAA	CASIARDTLGGTEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	4	6	10	27	37	49	43	59			01,02										Vb 17	CASIARDTLGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTACCAACGCCCGGAGGACGTATGAAAAACTGTTTTTTGGCAGT	CTNARRTYEKLFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	10	10	1	6	6	4	27	34	45	40	49			01,02										Vb 17	CTNARRTYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCGACAGGCGCCTATGGCTACACCTTCGGTTCG	CASNPTGAYGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	4	4	4	3	27	37	47	41	50			01,02										Vb 17	CASNPTGAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTCCCTGGGGGGCGTTAGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	15	2.3950183618074404E-4		47	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	6	0	8	9	6	27	38	53	47	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGGTGGCACAGATACGCAGTATTTTGGCCCA	CASSIFGGTDTQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	0	10	1	4	2	27	41	47	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGGTCTATAACTACGAGCAGTACTTCGGGCCG	CASSISVYNYEQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	9	3	6	3	27	41	50	47	53			01,02			01,02							Vb 17	CASSISVYNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTATAAACGAGGGGGCGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASYKRGGADTGELFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	5	0	3	9	4	27	35	51	44	55			01,02										Vb 17	CASYKRGGADTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGGACTAGCGGGAGATGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASTPGLAGDGAGELFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	0	2	6	4	6	27	37	55	41	61			01,02										Vb 17	CASTPGLAGDGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGACAGGGGCCGAGGGCAGTTCTTCGGGCCA	CASTDRGRGQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	2	12	1	6	27	37	47	38	53			01,02										Vb 17	CASTDRGRGQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGTGACTACCACAGATACGCAGTATTTTGGCCCA	CASSRVTTTDTQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	9	2	4	1	27	40	49	44	50			01,02			01,02							Vb 17	CASSRVTTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCTCTACGGGGAGGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASRPSTGRGSGELFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	0	6	10	3	27	38	55	48	58			01,02										Vb 17	CASRPSTGRGSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGCAGGTACGAGCAGTACTTCGGGCCG	CASSIEGRYEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	4	3	0	27	44	-1	47	51			01,02										Vb 17	CASSIEGRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGGAGGGACCAGATACGCAGTATTTTGGCCCA	CASSKGEGPDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	4	3	2	27	40	50	43	52			01,02										Vb 17	CASSKGEGPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGACGGATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	3.353025706530417E-4		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	1	7	0	3	4	27	39	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCACAGCGCAAATCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	22	3.512693597317579E-4		55	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	4	3	5	5	2	16	26	39	45	41	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCGGGACAGGGATGTACTGAAGCTTTCTTTGGACAA	CASPGQGCTEAFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	3	5	2	4	27	36	47	38	51			01,02										Vb 17	CASPGQGCTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCATGGGCAGGGAGGGGATCAGACACTGAAGCTTTCTTTGGACAA	CASNPWAGRGSDTEAFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	9	0	3	11	6	27	37	55	48	61			01,02										Vb 17	CASNPWAGRGSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGCGGGGAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	3.672361488104742E-4		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	3	3	2	3	27	37	45	39	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCATTTAGTGAGACCCAGTACTTCGGGCCA	CASSMAFSETQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	9	0	5	0	7	27	-1	44	41	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMAFSETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTTGGAGTTACGAGCAGTACTTCGGGCCG	CASSIGWSYEQYF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	2	4	5	1	27	41	50	46	51			01,02										Vb 17	CASSIGWSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAACTCCCCAGGTTACGAGCAGTACTTCGGGCCG	CASSMNSPGYEQYF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	4	8	1	27	41	53	49	54			01,02										Vb 17	CASSMNSPGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCTACGAACACTGAAGCTTTCTTTGGACAA	CASSISTNTEAFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	9	1	2	1	27	41	46	43	47			01,02			01,02							Vb 17	CASSISTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTCAGACACCATACCGTTATGGAAAACTGTTTTTTGGCAGT	CATQTPYRYGKLFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	2	6	10	4	14	27	34	42	38	56			01,02										Vb 17	CATQTPYRYGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCCCAGGAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASNPQESYNEQFF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	4	4	1	5	2	27	37	46	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNPQESYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGCGGGAGGCTACGAGCAGTACTTCGGGCCG	CASSIGAGGYEQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	1	3	1	0	27	43	-1	44	53			01,02										Vb 17	CASSIGAGGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTGGACAGGGTCGGGCTGAAGCTTTCTTTGGACAA	CASSVGQGRAEAFF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	6	3	5	27	39	50	42	55			01,02										Vb 17	CASSVGQGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCAGGGACGGAACACTGAAGCTTTCTTTGGACAA	CASSIAQGRNTEAFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	7	1	4	1	27	43	52	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAQGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGTCTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSIWSSGQETQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	4	2	4	0	27	42	-1	46	54			01,02			01,02							Vb 17	CASSIWSSGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGGAATTGGAAACACCATATATTTTGGAGAG	CASSIWGIGNTIYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	3	0	8	3	3	2	27	41	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWGIGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACAGGGTGGGGAGAGACCCAGTACTTCGGGCCA	CASSPGTGWGETQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	4	3	5	27	39	51	42	56			01,02										Vb 17	CASSPGTGWGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACCGTGGAAGCTTTCTTTGGACAA	CASSITVEAFF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	3	7	8	1	4	27	41	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSITVEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTGGGGACGACCTGAACACTGAAGCTTTCTTTGGACAA	CASSVGDDLNTEAFF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	0	7	0	4	4	27	39	48	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGDDLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGGGCCGGGCCACAGGGCTATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	33	5.269040395976369E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	3	3	6	10	2	27	35	51	45	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTGTTGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSILLGSTEAFF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	4	7	0	27	41	-1	48	53			01,02										Vb 17	CASSILLGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGAGAACGGCTGGAAACACCATATATTTTGGAGAG	CASSIGRTAGNTIYF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	8	2	2	0	5	27	-1	47	41	52			01,02										Vb 17	CASSIGRTAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTTATAAATACGAGCAGTACTTCGGGCCG	CASSMGYKYEQYF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	9	4	0	7	27	-1	44	41	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGYKYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACAGGTTTTTAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	36	5.748044068337857E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	4	4	0	5	27	-1	48	44	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAATGAGGGGACCCGACCTACAATGAGCAGTTCTTCGGGCCA	CASSQ*GDPTYNEQFF	Stop	VDJ	1	36	5.748044068337857E-4		48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	0	7	2	7	4	27	39	51	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSQ*GDPTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAATGGCGGAGAACACTGAAGCTTTCTTTGGACAA	CASKMAENTEAFF	In	VDJ	1	39	6.227047740699345E-4	7.687910268288356E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	7	5	1	5	1	27	37	46	42	47			01,02			01,02							Vb 17	CASKMAENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCCGACGACACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	6.386715631486508E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	6	2	7	0	27	38	-1	45	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCCCCCTACGAGCAGTACTTCGGGCCG	CASSPSPYEQYF	In	VDJ	1	40	6.386715631486508E-4	7.885036172603442E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	10	2	2	3	27	39	43	41	46			01,02			01,02							Vb 17	CASSPSPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGAGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIGETATNEKLFF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	2	5	0	6	0	27	41	-1	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGETATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTCCGGAACACTGAAGCTTTCTTTGGACAA	CASSILRNTEAFF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	10	1	1	3	27	41	44	42	47			01,02			01,02							Vb 17	CASSILRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGTTAGAGGCAGGGCGTTCGCAGTACTTCGGCGCC	CASSSLEAGRSQYF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	13	10	6	27	39	54	49	60			01,02										Vb 17	CASSSLEAGRSQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAATCGGCCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSIESATSTDTQYF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	9	0	0	6	4	27	41	50	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIESATSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGAGCGGGGCTTCACAGATACGCAGTATTTTGGCCCA	CASMERGFTDTQYF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	3	2	3	3	27	37	47	40	50			01,02										Vb 17	CASMERGFTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTTTCTATCTCTGTGCCAGTAGTATAATCTCCCCCCGCTAGCCCGAGTTGGAAGGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	43	6.865719303847997E-4		61	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	4	7	6	11	14	12	27	43	38	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATCGACAGGGTAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSIDRVDTGELFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	3	4	3	27	38	49	42	52			01,02										Vb 17	CASSIDRVDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCTCAGATACGCAGTATTTTGGCCCA	CASRPSDTQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	10	0	4	0	3	27	-1	40	38	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGGGAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSTPGGMNTEAFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	0	0	3	1	27	40	51	43	52			01,02										Vb 17	CASSTPGGMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSIRGGGETQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	2	5	1	4	5	0	27	42	-1	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRGGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGGACAGGCCTACGAGCAGTACTTCGGGCCG	CASSTGQAYEQYF	In	VDJ	2	46	7.344722976209484E-4	9.067791598493958E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	2	1	0	27	40	-1	41	49			01,02										Vb 17	CASSTGQAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCAAGCGGGGCTGCGGCTGTTTTTTGGAGAA	CASQAGLRLFF	In	VDJ	2	47	7.504390866996647E-4	9.264917502809045E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	6	3	13	3	5	27	35	45	38	50			01,02										Vb 17	CASQAGLRLFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSIDPSSGNTIYF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	11	2	0	3	0	27	44	-1	47	50			01,02										Vb 17	CASSIDPSSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAATGGGCCGGCTGAAGCTTTCTTTGGACAA	CASSINGPAEAFF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	6	4	3	27	41	49	45	52			01,02										Vb 17	CASSINGPAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGAGCGGGAGGGAAGGAATGAGCAGTTCTTCGGGCCA	CASTEREGRNEQFF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	6	0	7	3	4	27	37	50	40	54			01,02										Vb 17	CASTEREGRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTCCCCTTAGGGGTGGTTGAGCAGTACTTCGGGCCG		Out	VDJ	2	51	8.143062430145298E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	2	7	8	5	27	37	50	45	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGGGACTAGCGACCGGGGAGCTGTTTTTTGGAGAA	CASSTPGLATGELFF	In	VDJ	2	53	8.462398211719623E-4	0.001044767292869956	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	6	5	4	0	27	40	-1	44	54			01,02			01,02							Vb 17	CASSTPGLATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCAGGGGATCTGGGTGAGCAGTACTTCGGGCCG	CASSISGDLGEQYF	In	VDJ	2	53	8.462398211719623E-4	0.001044767292869956	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	7	2	8	27	41	49	43	57			01,02										Vb 17	CASSISGDLGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACATAAACAGCTACGAGCAGTACTTCGGGCCG	CASSIDINSYEQYF	In	VDJ	2	59	9.4204055564426E-4	0.0011630428354590077	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	5	3	5	0	27	44	-1	49	53			01,02										Vb 17	CASSIDINSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAACAGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSIQQGGTEAFF	In	VDJ	2	59	9.4204055564426E-4	0.0011630428354590077	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	1	5	3	2	27	41	52	44	54			01,02										Vb 17	CASSIQQGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGAGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMEGSNQPQHF	In	VDJ	2	61	9.739741338016924E-4	0.0012024680163220248	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	0	1	0	1	27	-1	47	41	48			01,02										Vb 17	CASSMEGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACGCAGCCCACTCAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKRSPLNSGANVLTF	In	VDJ	2	64	0.0010218745010378413	0.0012616057876165506	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	7	4	5	0	4	9	27	37	44	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKRSPLNSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCCGGGACAGTAAACATTCAGTACTTCGGCGCC	CASSMAGTVNIQYF	In	VDJ	2	64	0.0010218745010378413	0.0012616057876165506	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	5	6	4	1	27	41	52	45	53			01,02										Vb 17	CASSMAGTVNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGAGGGAGGGATTTTTCAATGAGCAGTTCTTCGGGCCA	CASSGREGFFNEQFF	In	VDJ	2	65	0.0010378412901165576	0.0012813183780480593	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	6	0	10	27	-1	46	39	56			01,02										Vb 17	CASSGREGFFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCCAGGGGGGCCTACCTACAATGAGCAGTTCTTCGGGCCA	CASSHPGGPTYNEQFF	In	VDJ	2	68	0.0010857416573527064	0.001340456149342585	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	2	4	5	27	39	50	43	55			01,02										Vb 17	CASSHPGGPTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCCTTAGGACAGGCCAAACTCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	69	0.0011017084464314227		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	9	1	4	0	7	9	27	35	49	42	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTTGCCGATCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTLPISNQPQHF	In	VDJ	2	71	0.0011336420245888553	0.001399593920637111	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	2	8	1	7	2	27	40	49	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTLPISNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACTAGCGGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	71	0.0011336420245888553		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	1	2	5	0	0	27	-1	-1	40	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTAGCGGGACGTTCGGATCAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSIGLAGRSDQAGELFF	In	VDJ	3	73	0.0011655756027462876	0.0014390191015001281	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	2	3	6	0	13	24	-1	51	40	64			01,02										Vb 17	CASSIGLAGRSDQAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASEGAGELFF	In	VDJ	3	73	0.0011655756027462876	0.0014390191015001281	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	5	1	6	1	0	27	36	-1	37	43			01,02										Vb 17	CASEGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATCGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIIGYSNQPQHF	In	VDJ	3	79	0.0012613763372185853	0.0015572946440891799	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	8	5	0	2	3	27	42	47	44	50			01,02			01,02							Vb 17	CASSIIGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAGGTGGCGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEVAGSGANVLTF	In	VDJ	3	80	0.0012773431262973016	0.0015770072345206883	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	7	4	0	7	0	27	38	-1	45	50			01,02			01,02							Vb 17	CASSEVAGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGTCATCTACGGAACAGGGGTATGGAAACACCATATATTTTGGAGAG	CASSASSTEQGYGNTIYF	In	VDJ	3	81	0.001293309915376018	0.001596719824952197	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	2	3	14	2	27	39	60	53	62			01,02										Vb 17	CASSASSTEQGYGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTAGCGGGACGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGRPYNEQFF	In	VDJ	3	83	0.0013252434935334505	0.001636145005815214	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	2	1	4	27	38	48	39	52			01,02										Vb 17	CASSLAGRPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCCGGGCGTAGCACAGATACGCAGTATTTTGGCCCA	CASAGRSTDTQYF	In	VDJ	3	84	0.0013412102826121668	0.0016558575962467227	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	8	0	0	3	2	27	36	43	39	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAGRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATAGGGGAAATGAGCAGTTCTTCGGGCCA	CASSNRGNEQFF	In	VDJ	3	85	0.001357177071690883	0.0016755701866782314	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	7	2	1	27	40	47	42	48			01,02										Vb 17	CASSNRGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATGAACTACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSP*TTSSYNEQFF	Stop	VDJ	3	85	0.001357177071690883		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	0	9	0	27	39	-1	48	53			01,02			01,02							Vb 17	CASSP*TTSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCAGGGTACGGAAACACCATATATTTTGGAGAG	CASSIDAGYGNTIYF	In	VDJ	3	86	0.0013731438607695993	0.00169528277710974	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	4	2	3	27	44	51	46	54			01,02										Vb 17	CASSIDAGYGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGGACAGGGAGTTTGGGAAAGAGACCCAGTACTTCGGGCCA	CASSSRDREFGKETQYF	In	VDJ	3	95	0.0015168449624780457	0.0018726960909933173	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	3	4	9	27	39	52	43	61			01,02										Vb 17	CASSSRDREFGKETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGACAGGCCACACAGATACGCAGTATTTTGGCCCA	CASGTGHTDTQYF	In	VDJ	4	119	0.0019000479003672363	0.002345798261349524	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	4	2	0	3	27	-1	44	36	47			01,02										Vb 17	CASGTGHTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGAGCCCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIEPDSNQPQHF	In	VDJ	5	144	0.0022992176273351427	0.002838613022137239	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	6	7	0	2	4	27	41	46	43	50			01,02			01,02							Vb 17	CASSIEPDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAAGAGGGCCGGGAATAATGAAAAACTGTTTTTTGGCAGT	CASKRAGNNEKLFF	In	VDJ	5	147	0.0023471179945712918	0.002897750793431765	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	8	3	4	9	1	27	35	49	44	50			01,02										Vb 17	CASKRAGNNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCCTGCGGTCTGGGTTTCACAATATGAGCAGTTCTTCGGGCCA	CAPAVWVSQYEQFF	In	VDJ	5	148	0.002363084783650008	0.0029174633838632735	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	7	5	8	3	15	27	33	40	36	55			01,02			01,02							Vb 17	CAPAVWVSQYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGTCAGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAGQGSGANVLTF	In	VDJ	5	148	0.002363084783650008	0.0029174633838632735	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	11	4	3	1	3	1	27	33	41	36	42			01,02										Vb 17	CAGQGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTAGCGGGAGCGCCCCAAAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	12	340	0.005428708286763532		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	5	2	0	0	9	27	-1	42	33	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGGGTAGGATACCGATCGGACTGCTTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	14	391	0.0062430145297780616		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	2	3	1	23	25	32	39	33	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCAGGGCGTGACTGAAGCTTTCTTTGGACAA	CASSQGVTEAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	5	0	4	23	-1	40	35	44													Vb 11	CASSQGVTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACTCTACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSTANTGELFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	5	0	4	0	23	37	-1	41	45													Vb 11	CASSDSTANTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTTTAACTCAAAGTCCCTAATAAGGTACAATGAGCAGTTCTTCGGGCCA	CASSFNSKSLIRYNEQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	54	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	5	5	4	4	21	0	23	35	-1	56	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSFNSKSLIRYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCTTCTGGACAGGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSFWTGLNTEAFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	0	5	2	23	34	46	39	48													Vb 11	CASSFWTGLNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAAACCGGCCCTAGCGGGTGGATCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	3.512693597317579E-4		53	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	4	4	9	5	23	35	52	44	57						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACACAGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSETQGSTDTQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	0	2	0	23	38	-1	40	47													Vb 11	CASSETQGSTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGATAGTGAGGGAGCAGTTCTTCGGGCCA	CASSAIVREQFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	1	10	7	0	23	36	-1	43	47													Vb 11	CASSAIVREQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGCGTTAGTAGGGACAGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSGVSRDRGYNEQFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	4	9	1	23	36	55	45	56													Vb 11	CASSGVSRDRGYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTAGCGGGAGCGGTAAGCGAGACCCAGTACTTCGGGCCA	CASSELAGAVSETQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	2	5	0	8	23	-1	48	38	56													Vb 11	CASSELAGAVSETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGGGGGACAGGGGGCTTTTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	48	7.66405875778381E-4		37	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	0	9	1	3	23	31	44	32	47													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTAAGTCTAAGGGCGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	49	7.823726648570973E-4		50	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	4	4	12	0	23	38	-1	50	55						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCTCTCGGGACAGGGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLGTGDSSYNEQFF	In	VDJ	3	74	0.001181542391825004	0.0014587316919316368	54	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	0	6	4	23	35	51	41	55													Vb 11	CASSPLGTGDSSYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGCGGGACTAGCGGGGTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		49	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	3	3	3	23	37	53	40	56													Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
RRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGCATTCGGACAGGGGGACCCTACCATCTCCTATGAGCAGTACTTCGGGCCG	XASSQAFGQGDPTISYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	60	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	1	7	5	17	21	37	52	42	69													Vb 7.1	XASSQAFGQGDPTISYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGTAACAGAAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDVTEASTDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	5	0	4	5	23	40	48	44	53													Vb 7.1	CASSQDVTEASTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTCGGGGACACAGATACGCAGTATTTTGGCCCA	XASSQVGDTDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	2	1	1	23	39	45	40	46													Vb 7.1	XASSQVGDTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCTCTACGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSQDLYGSYNEQFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	3	6	0	23	40	-1	46	52													Vb 7.1	CASSQDLYGSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCCTTGGCGGGAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSQALAGGEETQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	0	3	5	1	23	39	53	44	54													Vb 7.1	CASSQALAGGEETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCAACAGCACAGATACGCAGTATTTTGGCCCA		Out	VJ	1	23	3.672361488104742E-4		37	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	2	0	0	0	0	1	23	-1	38	-1	39													Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATCTGGTTGCAGCCTACGAGCAGTACTTCGGGCCG	XASSQDLVAAYEQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	2	8	0	22	39	-1	47	50													Vb 7.1	XASSQDLVAAYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCACCGGCGACCCATGGCTACACCTTCGGTTCG	CASSPPATHGYTF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	4	2	7	6	7	2	23	36	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPPATHGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACGGGACTAGCGGGACTCGCGAGCAGTACTTCGGGCCG	CASSQDGTSGTREQYF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	0	3	6	1	4	23	40	54	41	58													Vb 7.1	CASSQDGTSGTREQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAGGTTCCGCTAGCGGGGTGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	52	8.30273032093246E-4		50	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	5	8	2	23	38	55	46	57													Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGAGCGACCGGGACTAGCTATCCTGAGCAGTTCTTCGGGCCA	CASSRATGTSYPEQFF	In	VDJ	2	61	9.739741338016924E-4	0.0012024680163220248	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	7	9	8	5	23	36	53	44	58						01,02							Vb 7.1	CASSRATGTSYPEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGTCGCGGGACATCCTAATGAAAAACTGTTTTTTGGCAGT	CASSVAGHPNEKLFF	In	VDJ	4	108	0.0017244132205013571	0.0021289597666029293	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	5	0	6	3	5	2	23	35	46	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSVAGHPNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTTTGGAGGAAACACCATATATTTTGGAGAG	CASSFGGNTIYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	36	TCRBV06	TCRBV06-09	01				TCRBJ01	TCRBJ01-03	01	4	1	8	4	2	0	26	39	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSFGGNTIYF+TCRBV06-09+TCRBJ01-03	TCRBV06-09*01		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGCCTCCGGGACAGTCAAAAACATTCAGTACTTCGGCGCC	CASSASGTVKNIQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	45	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	5	3	5	1	26	39	51	44	52			01,02										Vb 12	CASSASGTVKNIQYF+TCRBV10-01+TCRBJ02-04	TCRBV10-01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGACCCTACAGGGTATGAGCAGTTCTTCGGGCCA	CASSDPTGYEQFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	8	4	1	26	40	50	44	51			01,02										Vb 12	CASSDPTGYEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCTTAGCGGGAGGAATACCTACGAGCAGTACTTCGGGCCG	CASLSGRNTYEQYF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	5	1	2	2	4	26	35	47	37	51			01,02										Vb 12	CASLSGRNTYEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGAACGCTTCAGGAGGCTAGCGGCCCGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	59	9.4204055564426E-4		59	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	7	15	5	22	39	61	54	66			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTGACAGACCGCTCTGGAAACAACATATATTTTGGAGAG	CASSLTDRSGNNIYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	45	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	12	2	16	22	34	41	36	57														CASSLTDRSGNNIYF+TCRBV12-01+TCRBJ01-03	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATCACCGGGACAGGGGCGGAACTGTTTTTGGCAGT		Out	VDJ	1	19	3.033689924956091E-4		44	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	18	6	8	18	33	49	39	57														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGCGGGAGGTTTTGACGCAGATACGCAGTATTTTGGCCCA	CATSRDAGGFDADTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	1	4	1	8	18	35	44	36	52														CATSRDAGGFDADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGAGGGCGTGACAGGGGGCGAAAGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	3.672361488104742E-4		58	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	0	4	8	7	18	32	50	40	57														X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAATTAGACAGCTTCTATGGCTACACCTTCGGTTCG	CATSRELDSFYGYTF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	4	4	3	18	35	44	39	47														CATSRELDSFYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGCGACAGGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	4.790036723614881E-4		50	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	0	5	1	18	35	48	40	49														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTCTCGCTGACGCTGACCTAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	4.790036723614881E-4		53	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	8	3	17	0	18	34	-1	51	55						01,02								X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAATCCTGACAGAGGGCATTCGGTACTATGGCTACACCTTCGGTTCG	CATSRGILTEGIRYYGYTF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	57	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	1	2	5	3	7	12	18	34	46	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGILTEGIRYYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGGTGGCTATGGCTACACCTTCGGTTCG	CATSRDRGGYGYTF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	4	0	3	18	-1	41	35	44														CATSRDRGGYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGAAGCACAGATACGCAGTATTTTGGCCCA	CATSRDRSTDTQYF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	5	0	0	1	18	-1	38	35	39														CATSRDRSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATAACGGGGGTGGGTAATGAGCAGTTTTTCGGGCCA	CATSRITGVGNEQFF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02			2	8	2	19	4	17	18	33	43	37	60								TCRBJ02-01,TCRBJ02-05						CATSRITGVGNEQFF+TCRBV15-01+TCRBJ02-X	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CATSRGTANYGYTF	In	VDJ	2	58	9.260737665655437E-4	0.001143330245027499	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	0	0	0	18	-1	-1	34	40														CATSRGTANYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCGGTAGGCCTGATCAGCCCCAGCATTTTGGTGAT	CATSRVGRPDQPQHF	In	VDJ	2	59	9.4204055564426E-4	0.0011630428354590077	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	1	5	4	5	5	4	18	34	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVGRPDQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACTAGCGGGGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CATSRTSGVNTGELFF	In	VDJ	2	61	9.739741338016924E-4	0.0012024680163220248	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	2	3	2	0	2	18	-1	43	32	45														CATSRTSGVNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGCTAGCGGGAGGGCCCTCAGAACTTCGGGCCG		Out	VDJ	2	63	0.001005907711959125		41	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	14	2	8	18	32	46	34	54														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGAACTAACGGGGCCTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	64	0.0010218745010378413		44	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	6	7	0	5	7	3	18	29	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAATCCGACTCCCAACTAAAGCCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	76	0.0012134759699824365		53	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	2	10	6	5	13	18	33	42	38	55						01,02								X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCACCCCGTCCGGGGGAAGGGGGTATGAAAAACTGTTTTTTGGCAGT	CATTPSGGRGYEKLFF	In	VDJ	4	110	0.0017563467986587897	0.0021683849474659466	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	7	5	1	6	14	1	18	28	48	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATTPSGGRGYEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTCGGAGGGGGCTACGAGCAGTACTTCGGGCCG	CATSRDLGGGYEQYF	In	VDJ	4	121	0.0019319814785246686	0.002385223442212541	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	5	1	3	6	0	18	35	-1	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLGGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTAACAGGGATCCCGTGGATCAGCCCCAGCATTTTGGTGAT	CATSSNRDPVDQPQHF	In	VDJ	4	125	0.001995848634839534	0.0024640738039385757	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	3	5	2	9	18	32	40	34	49														CATSSNRDPVDQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCACGGGGTAGCGGGAGTTTACTCCTACGAGCAGTACTTCGGGCCG	CATSRDHGVAGVYSYEQYF	In	VDJ	5	141	0.002251317260098994	0.0027794752508427134	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	0	8	4	18	35	52	43	56														CATSRDHGVAGVYSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAATTTATAGGGACAGGGGGCGACGAGCAGTACTTCGGGCCG	CATSKFIGTGGDEQYF	In	VDJ	5	143	0.0022832508382564266	0.0028189004317057302	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	0	5	8	1	18	31	51	39	52														CATSKFIGTGGDEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATAACGGGGGTGGGTAATGAGCAGTTCTTCGGGCCA	CATSRITGVGNEQFF	In	VDJ	5	157	0.0025067858853584546	0.003094876697746851	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	2	7	4	5	18	33	43	37	48														CATSRITGVGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCGAAGTTGGAGCGGGAGGGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	12	342	0.005460641864920964		50	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	0	6	10	3	18	30	50	40	53														X+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACGAAACCGGGACTAGCGGGAGGAGCAGATACGCAGTATTTTGGCCCA	CATKPGLAGGADTQYF	In	VDJ	28	814	0.012996966310075044	0.016046048611248004	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	0	1	4	6	2	18	26	47	32	49														CATKPGLAGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATCACCGGGACAGGGGCGGAACTGTTTTTTGGCAGT	CATSRITGTGAELFF	In	VDJ	130	3733	0.05960402363084784	0.07358710008082162	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	12	6	3	18	33	49	39	52														CATSRITGTGAELFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGAAGCTTGTAGGAGCGGGAGTGACAGACCCAGTACTTCGGGCCA	CARSL*ERE*QTQYF	Stop	VDJ	1	18	2.8740220341689284E-4		45	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	2	6	4	4	18	33	45	37	49			01,02											CARSL*ERE*QTQYF+TCRBV05-03+TCRBJ02-05	TCRBV05-03	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTATGGGGCTCCGATAATGAAAAACTGTTTTTTGGCAGT	CASSLWGSDNEKLFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	7	0	4	1	5	18	33	39	34	44														CASSLWGSDNEKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAGACTCGGGGTACTGAAGCTTTCTTTGGACAA	CASSQTRGTEAFF	In	VDJ	2	67	0.0010697748682739901	0.0013207435589110766	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	6	1	18	30	41	36	42														CASSQTRGTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGGGACTTTACTGAAGATACGCAGTATTTTGGCCCA	CASRDFTEDTQYF	In	VDJ	2	70	0.001117675235510139	0.0013798813302056023	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	10	5	0	7	18	-1	34	29	41						01,02								CASRDFTEDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCAAGCGGGAGCTGGGAACGAGCAGTACTTCGGGCCG	CASSSQAGAGNEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	2	5	4	6	18	31	43	35	49														CASSSQAGAGNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTACACAGGGTCGGGTAAACACCATATATTTTGGAGAG	CASSSTQGRVNTIYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	6	4	6	18	31	41	35	47														CASSSTQGRVNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACAGGGGGCCGGAGGTGAAGCTTTCTTTGGACAA	CASSQQGAGGEAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	7	2	6	18	30	41	32	47														CASSQQGAGGEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCCGGGACTAGCTTAAATGAGCAGTTCTTCGGGCCA	CASSQAGTSLNEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	7	6	3	18	30	45	36	48						01,02								CASSQAGTSLNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAAACCCCGCGAGTACAGATACGCAGTATTTTGGCCCA	CASSLNPASTDTQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	6	3	6	3	18	33	42	39	45						01,02								CASSLNPASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTCATTTGGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.596678907871627E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	6	2	1	6	0	18	32	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGATGGCATTCGGGACAATGAGCAGTTCTTCGGGCCA	CASSADGIRDNEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	5	0	12	18	-1	34	30	46						01,02								CASSADGIRDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGLAAYNEQFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	2	2	0	18	30	-1	32	43						01,02								CASSQGLAAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTCTTAGCGGGAGGGGCTACGAGCAGTACTTCGGGCCG	CASSFLSGRGYEQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	0	3	3	1	18	32	46	35	47														CASSFLSGRGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGAACCGGACTGGCGACCTACGAGCAGTACTTCGGGCCG	CASSRTGLATYEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	2	6	5	18	30	41	36	46						01,02								CASSRTGLATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAACACGGTTACTAGCGCAAGGGGGGTGTCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.075682580233115E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	6	6	9	14	18	31	47	40	61						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAAAGTGGCAGGGAGTCTGGCTACACCTTCGGTTCG		Out	VDJ	1	14	2.2353504710202778E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	2	4	3	7	6	4	18	33	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGGGACTAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRGTSGGNTGELFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	1	3	0	18	30	-1	33	47														CASSRGTSGGNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTAATAGACAGGGATTCACTATGGCTACACCTTCGGTTCG	CASS**TGIHYGYTF	Stop	VDJ	1	16	2.554686252594603E-4		45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	3	4	4	18	31	42	35	46														CASS**TGIHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTACCGGGAGTTAATTGGCTACACCTTCGGTTCG	CASSSYRELIGYTF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	2	7	5	5	18	31	42	36	47														CASSSYRELIGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACTAGCGGGAGGTGGCAGTACTTCGGGCCG	CASSPGTSGRWQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	1	9	3	2	18	30	48	33	50														CASSPGTSGRWQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGTAGTAAGGTACACTGAAGTTTTCTTTGGACAA	CASSPVVRYTEVFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	3	6	13	13	7	18	30	46	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPVVRYTEVFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTCCTTGCCGCTCCGGGAATTCTTCAGTTCTTCGGGCCA	CASTLLAAPGILQFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	3	13	15	6	18	28	48	43	54														CASTLLAAPGILQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGAGGACTAGCGGGAGGGAGGAGACCCAGTACTTCGGGCCA	CASSKRTSGREETQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	0	5	4	2	18	30	49	34	51														CASSKRTSGREETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTACCGGGACACCTGTAGATACGCAGTATTTTGGCCCA	CASSATGTPVDTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	5	6	5	18	30	42	36	47														CASSATGTPVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCATCCCGGACTAGCGGGAGGTATAGATACGCAGTATTTTGGCCCA	CASSLDHPGLAGGIDTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	1	1	5	7	3	18	35	56	42	59														CASSLDHPGLAGGIDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCGGGAGTTCGATACGCAGTATTTTGGCCCA	CASSLGREFDTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	6	3	3	18	32	42	35	45														CASSLGREFDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACGCTGGGCCGCACAGATACGCAGTATTTTGGCCCA	CASSPTLGRTDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	1	8	1	18	30	42	38	43														CASSPTLGRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGTGGGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	3.672361488104742E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	4	5	0	18	30	-1	35	41														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCACCGGTCGGCTAGCGGGGGGGAGACCCAGTACTTCGGGCCA	CASSHRSASGGETQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	1	5	11	0	18	29	-1	40	51														CASSHRSASGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGGGACACCCACCCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	24	3.832029378891905E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	6	2	3	6	18	33	42	36	48														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCACAGCGGGAGGGAAAAGAGACCCAGTACTTCGGGCCA	CASTSQREGKETQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	6	0	3	6	2	18	28	44	34	46														CASTSQREGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATACACTAGCGGGAGGGAGAACATTCAGTACTTCGGCGCC	CASSQYTSGRENIQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	3	0	7	6	2	18	30	49	36	51														CASSQYTSGRENIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTCATTATACACAGATACGCAGTATTTTGGCCCA	CASSLSLYTDTQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	6	2	4	5	18	30	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCTGGCAGGGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSLPWQGFQETQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	1	6	3	18	33	44	39	47														CASSLPWQGFQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGCTAGCGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSLRLADSTDTQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	5	0	3	2	18	33	43	36	45						01,02								CASSLRLADSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACGAAGGACAGGGGAGGACACTGAAGCTTTCTTTGGACAA	CASSQRRTGEDTEAFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	3	7	3	18	30	46	37	49														CASSQRRTGEDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAACCGGGACAAGGTATGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	4.790036723614881E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	5	5	9	18	33	44	38	53														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTCGTCTAGCGGGCCGCCAAGAGACCCAGTACTTCGGGCCA	CASSLSRLAGRQETQYF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	4	1	6	3	18	33	47	39	50						01,02								CASSLSRLAGRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGACTAGCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGLAGSYNEQFF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	4	0	3	0	18	30	-1	33	44						01,02								CASSLGLAGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTCCGGGACGGCCCAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	5.428708286763532E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	0	7	2	5	6	18	30	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTTTTGGTGGAAACACTGAAGCTTTCTTTGGACAA	CASSLSFGGNTEAFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	1	8	2	9	0	18	33	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSFGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCCGGGGTCAGCCCTCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	6.067379849912182E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	2	3	10	18	33	41	36	51														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCAGGGGGGGTAGCGGGAGAGGAGAGACCCAGTACTTCGGGCCA	CASSPRGGSGRGETQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	2	4	11	3	18	30	50	41	53														CASSPRGGSGRGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTCAGCGGGGCTGGGGAATGAGCAGTTCTTCGGGCCA	CASSLSAGLGNEQFF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	7	5	6	18	30	42	35	48														CASSLSAGLGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACACCGGGACAGCGATTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	46	7.344722976209484E-4		59	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	5	0	4	6	18	35	46	39	52														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGGGTAGCGGACCCAATGAGCAGTTCTTCGGGCCA	CASSFWGSGPNEQFF	In	VDJ	2	46	7.344722976209484E-4	9.067791598493958E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	5	6	6	3	18	32	44	38	47						01,02								CASSFWGSGPNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGGATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	55	8.781733993293949E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	2	0	2	18	-1	43	34	45														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAACTGTTACCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTVTYNEQFF	In	VDJ	2	69	0.0011017084464314227	0.0013601687397740937	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	10	2	2	4	18	34	39	36	43						01,02								CASSLGTVTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACGGCGGGTGGCGGCACCGGGGAGCTRTTTTTTGGAGAA	CASTAGGGTGELFF	In	VDJ	3	82	0.0013092767044547342	0.0016164324153837056	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	7	4	4	2	6	18	28	35	30	41						01,02								CASTAGGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGTCAGGGGTCGGTAACACTGAAGCTTTCTTTGGACAA	CASSFGSGVGNTEAFF	In	VDJ	3	86	0.0013731438607695993	0.00169528277710974	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	2	5	5	18	32	43	37	48														CASSFGSGVGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTATTGGGCAGGGTCGGCAGCCCCAGCATTTTGGTGAT	CASSFIGQGRQPQHF	In	VDJ	4	124	0.0019798818457608175	0.002444361213507067	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	7	7	4	18	32	44	39	48														CASSFIGQGRQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGGGGGGGGCATCTCCTACGAGCAGTACTTCGGGCCG	CASSLGGGISYEQYF	In	VDJ	7	203	0.003241258182979403	0.004001655857596246	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	9	0	0	0	3	18	-1	41	34	44														CASSLGGGISYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTTGGGACTCCGGGGGATGAGCAGTTCTTCGGGCCA	CASSSLGTPGDEQFF	In	VDJ	14	409	0.006530416733194954	0.00806244948648702	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	8	5	7	18	31	42	36	49						01,02								CASSSLGTPGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCGAGGAGGGACAGGGACATCACTAGCGGGAGATGAGCAGTTCTTCGGGCCA		Out	VDDJ	42	1214	0.01938368194156155		58	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	8	5	0	18	46	-1	51	62														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCCCCCCCGCGGGGAACTATGGCTACACCTTCGGTTCG	CASGLAPPAGNYGYTF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	7	3	2	8	0	26	42	-1	50	56														CASGLAPPAGNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACCTCAGGGGGGGAGCTCAAGGAGATACGCAGTATTTTGGCCCA	CASNLRGGAQGDTQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	12	4	1	5	9	11	26	31	47	40	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNLRGGAQGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGACTAGGGGATTCCAAAAACATTCAGTACTTCGGCGCC	CASGLGDSKNIQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	12	1	8	2	4	6	26	31	42	35	48						01,02								CASGLGDSKNIQYF+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTATTGAGGGGGATAACTATGGCTACACCTTCGGTTCG	CASIEGDNYGYTF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	5	1	1	4	1	26	35	45	39	46														CASIEGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACCCCCACGTGCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	35	5.588376177550695E-4		50	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	0	3	7	0	0	11	26	-1	45	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGAACACGGAGCTGTTTTTTGGAGAA	CASGLVNTELFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	6	10	2	1	26	43	48	45	49														CASGLVNTELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCCCTCCTCATAAATGAGCAGTTCTTCGGGCCA	CASGLSLLINEQFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	2	4	6	7	8	2	26	41	51	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLSLLINEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTACAGACCTCTATCGGGAGGGGATCGGATACGCAGTATTTTGGCCCA		Out	VDJ	2	46	7.344722976209484E-4		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	0	6	12	5	26	38	58	50	63														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCTCCTTAGGAGCGGAGGGGCCCGCGGGACCCAGTACTTCGGGCCA		Out	VDJ	2	66	0.0010538080791952739		50	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	7	12	8	26	37	55	49	63														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGATACTAGCGGGACCCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	72	0.0011496088136675714		44	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	3	3	1	5	4	26	31	46	36	50														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGCCAGATTGGAATGAGCAGTTCTTCGGGCCA	CASGPDWNEQFF	In	VDJ	3	83	0.0013252434935334505	0.001636145005815214	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	5	7	2	5	26	37	42	39	47														CASGPDWNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCTCCAGGTGGGGGGCGGGGGATACGCAGTATTTTGGCCCA	CASTSRWGAGDTQYF	In	VDJ	4	129	0.0020597157911543987	0.00254292416566461	45	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	12	6	0	6	15	4	26	31	52	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSRWGAGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTGCTTGGGGATACAATGAGCAGTTCTTCGGGCCA	CATAWGYNEQFF	In	VDJ	6	168	0.0026824205652243335	0.0033117151924934455	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	10	0	8	4	7	0	26	33	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATAWGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTCCAGGGACAGGGGGCGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.596678907871627E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	0	1	4	1	20	37	53	41	54														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCAACGGGGGCCGGACGCGGGGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	1	6	15	0	20	31	-1	46	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTACGGGGAGCGGCAGCTATCTCTGGAAACACCATATATTTTGGAGAG	CASSLRGAAAISGNTIYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	6	5	0	9	7	20	31	45	40	52						01,02								CASSLRGAAAISGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGGTGTAGGACAGCCCCAGCATTTTGGTGAT	CASSLGVGQPQHF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	6	1	8	7	10	0	20	31	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAACAGTCAATCGAACTAGCGGGAGGAATCAGGACAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	15	2.3950183618074404E-4		58	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	3	1	3	2	8	20	37	51	39	59														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTTGGCAGGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLGRGEETQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	3	4	1	20	33	44	37	45														CASSLGRGEETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGCCGCTCATGACACACCAACCTACCATGAACACTGAAGCTTTCTTTGGACAA	CASSQPLMTHQPTMNTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	60	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	0	9	13	20	34	47	43	60														CASSQPLMTHQPTMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCCGCGGGATGTGGACACTGAAGCTTTCTTTGGACAA	CASSPPRDVDTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	7	3	3	4	5	20	33	43	37	48														CASSPPRDVDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCCCGGCGGGAAGGTCTACGAGCAGTACTTCGGGCCG	CASSPPGGKVYEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	3	3	6	4	20	33	45	39	49														CASSPPGGKVYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAAGACAGAACCTACGAGCAGTACTTCGGGCCG	CASS*DRTYEQYF	Stop	VDJ	1	20	3.193357815743254E-4		39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	2	3	2	20	32	40	35	42														CASS*DRTYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGCCCCGGGACTTGGCAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	26	4.15136516046623E-4		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	0	10	5	5	4	20	33	44	38	48						01,02								X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD02-01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACTAGACATGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	4.949704614402044E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	2	6	1	3	2	20	35	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGCCCGAACGGACTAGCGGGAGAGACCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	5.748044068337857E-4		58	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	1	2	5	8	5	20	37	58	45	63														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGGGAGGGGGAGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	6.067379849912182E-4		44	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	1	0	4	20	-1	41	34	45														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAACGGACACAGGGGATGGGGGTTACACCTTCGGTTCG	CASSQTDTGDGGYTF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	11	6	8	20	35	48	41	56														CASSQTDTGDGGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCAATTCAGGGGCCTATTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	60	9.580073447229762E-4		50	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	0	6	6	20	33	45	39	51														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCCTATTTGAGGGCGGGTCTAAGTTTACGGAGCAGTACTTCGGGCCG	CASTLFEGGSKFTEQYF	In	VDJ	2	66	0.0010538080791952739	0.001301030968479568	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	7	4	7	12	12	20	30	47	42	59						01,02								CASTLFEGGSKFTEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTTTCCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFSSSYEQYF	In	VDJ	2	71	0.0011336420245888553	0.001399593920637111	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	5	0	6	0	20	31	-1	37	40														CASSFSSSYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGTCCCTTTTAACCCTCCTTAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	90	0.0014370110170844642		52	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	3	3	7	3	10	10	20	34	46	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAACTAGCGGGAGGAATCAGGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	15	440	0.007025387194635159		58	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	3	1	3	2	8	20	37	51	39	59														X+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAAAATGGGGCGGGGGACACCATATATTTTGGAGAG	CASSENGAGDTIYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	2	8	9	0	26	38	-1	47	54		TCRBV12-03,TCRBV12-04												CASSENGAGDTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGGGCCAGTTACGAGCAGTACTTCGGGCCG	CASSWGASYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	6	0	4	1	4	26	39	46	40	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGASYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACGGCCTACGAGCAGTACTTCGGGCCG	CASSLGTAYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	1	1	7	2	0	2	26	-1	46	42	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGAGCAAGAGACCCAGTACTTCGGGCCA	CASSLGEQETQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	2	2	0	0	26	-1	-1	42	47		TCRBV12-03,TCRBV12-04												CASSLGEQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGATTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGISGNTGELFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	5	2	4	1	26	42	52	46	53		TCRBV03-01,TCRBV03-02				01,02								CASSQGISGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGGGAATCTGGAAACACCATATATTTTGGAGAG	CASSQVGESGNTIYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV03						TCRBJ01	TCRBJ01-03	01	1	6	1	1	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGESGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATAATCCGGACTAGCGGGAACTACGAGCAGTACTTCGGGCCG	CSAIIRTSGNYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	3	3	8	1	26	34	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSAIIRTSGNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTACCCGCACCTACAATGAGCAGTTCTTCGGGCCA	CSAPTRTYNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	9	2	2	6	26	34	39	36	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPTRTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTGTGAGACTAGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CSALVRLAGDNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	5	8	0	26	34	-1	42	54		TCRBV20-01,TCRBV20-or09_02												CSALVRLAGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCAGGGGCGGGCATGAGCAGTTCTTCGGGCCA	CSARDGRGGHEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	8	3	5	26	40	49	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDGRGGHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTGGGGGGACCACTGAAGCTTTCTTTGGACAA	CSARSGGTTEAFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	4	4	2	26	37	47	41	49		TCRBV20-01,TCRBV20-or09_02												CSARSGGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACTGGGCTAGCGGGAGATTGACGCAGTATTTTGGCCCA	CSASDWASGRLTQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	9	8	4	26	37	55	45	59		TCRBV20-01,TCRBV20-or09_02												CSASDWASGRLTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSEGTANTGELFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	0	1	0	24	38	-1	39	46		TCRBV24-01,TCRBV24-or09_02												CATSEGTANTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCGTCACAGGCTCCGGACACAGATACGCAGTATTTTGGCCCA	CASSASQAPDTDTQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	4	2	4	7	24	37	46	41	53		TCRBV24-01,TCRBV24-or09_02												CASSASQAPDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGGCTTAGTCGAGGTTACGAGCAGTACTTCGGGCCG	CASSFRLSRGYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	1	4	13	1	24	36	53	49	54		TCRBV24-01,TCRBV24-or09_02												CASSFRLSRGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGTCGGGACGCAACCTACGAGCAGTACTTCGGGCCG	CASSLGRDATYEQYF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV05						TCRBJ02	TCRBJ02-07	01	2	0	7	2	5	4	19	33	43	38	47		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRDATYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAAGCGGATCGGTCGCCCATGAGCAGTTCTTCGGGCCA	CASSVSGSVAHEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	5	8	4	11	26	37	46	41	57		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVSGSVAHEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGGCCAAGGGGCCTTGTGGGGACAA	CASSLGQGALW	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	33	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	20	4	8	26	42	51	46	59		TCRBV12-03,TCRBV12-04												CASSLGQGALW+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGATCATGAACACTGAAGCTTTCTTTGGACAA	CASSLIMNTEAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	2	8	0	0	3	26	-1	42	40	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGTCCCTAGTGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSQVPSGTYNEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	1	0	8	2	8	0	23	39	-1	47	51	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVPSGTYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCCAAGAAGGGGACTCCTACGAGCAGTACTTCGGGCCG	CASSQEGDSYEQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	0	0	1	26	-1	48	43	49	TCRBV03,TCRBV09													CASSQEGDSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCTAAGACTAGCGGAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQA*D*RRSSYEQYF	Stop	VDJ	1	10	1.596678907871627E-4		54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	5	0	5	5	26	42	56	47	61		TCRBV03-01,TCRBV03-02				01,02								CASSQA*D*RRSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCAAGCCACGTTTGRKGGGACTCRGCCSTGTATSTYTGTGCCAGCAGCTCGTTACTAGCGGGAGACAATGAGCAGTTCTTCGGGCCA	CASSSLLAGDNEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	5	7	0	22	32	-1	39	50	TCRBV05,TCRBV11													CASSSLLAGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGGGGACAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.596678907871627E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	4	1	26	35	46	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGACACCTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDTSSYNEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	0	2	4	26	35	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSAEDTSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAACTTTGGGGGCCGCTATGGCTACACCTTCGGTTCG	CASNFGGRYGYTF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	6	0	4	5	2	22	32	43	37	45		TCRBV12-03,TCRBV12-04												CASNFGGRYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCCAGCAAGGTCGGACAGGGGGGATCTATGGCTACACCTTCGGTTCG	CAQQGRTGGIYGYTF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	1	1	4	10	3	22	28	48	38	51	TCRBV09,TCRBV12													CAQQGRTGGIYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTYGGSCSTRTATKTCTGTGCCAGCAGCATCACAGGGGGCCTTGGAAACACCATATATTTTGGAGAG	CASSITGGLGNTIYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	0	3	3	2	22	34	46	37	48	TCRBV11,TCRBV12													CASSITGGLGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTYGGSCMTRTATYTCTGTGCCAGCAGCGAATAGCGGGAGGCCCAGGTCGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	1.596678907871627E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	1	7	3	10	22	34	47	37	57	TCRBV11,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGAACAGGGGGGAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	1.596678907871627E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	1	8	3	3	24	39	50	42	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCCGGGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.596678907871627E-4		49	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	5	1	4	0	24	39	-1	43	54		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSVTGELFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	39				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	5	4	4	1	24	36	43	40	44	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSVTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCGGGACAGGAGGTTTTTCGGCCCATGAGCAGTTCTTCGGGCCA	CASSPGTGGFSAHEQFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	8	3	14	18	30	41	33	55	TCRBV07,TCRBV11													CASSPGTGGFSAHEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCATTCCCTGGACTAGCGACCCTAGGAACAGATACGCAGTATTTTGGCCCA	CASSPFPGLATLGTDTQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	6	3	9	9	18	30	48	39	57	TCRBV07,TCRBV11					01,02								CASSPFPGLATLGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCATCCCTAGGGGGACAGCAGCCTACGAGCAGTACTTCGGGCCG	CASIPRGTAAYEQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	2	8	3	18	28	43	36	46	TCRBV05,TCRBV11													CASIPRGTAAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGCGGGGTTTTTGAACGAGCAGTACTTCGGGCCG	CASSLAGFLNEQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	0	6	2	5	0	7	19	-1	40	36	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGFLNEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTACCAGGGAGGGGAGAGACCCAGTACTTCGGGCCA	CASSLPGRGETQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	0	4	4	1	19	33	44	37	45	TCRBV05,TCRBV11													CASSLPGRGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGGCTAGCGGGTGAATCTACCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	10	1.596678907871627E-4		59	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	4	4	0	4	11	19	33	45	37	56		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-04	TCRBV05	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGGACTCGAACCAGATACGCAGTATTTTGGCCCA	CASSLGLEPDTQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	10	4	0	5	19	-1	39	35	44	TCRBV05,TCRBV07					01,02								CASSLGLEPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCRGCYSTGTATCTCTGTGCCAGCAGCACCGCACAGGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.596678907871627E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	1	5	5	0	22	34	-1	39	47	TCRBV05,TCRBV07													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTACCAGCAGGAGGGGGACTTTCAATCAGCCCCAGCATTTTGGTGAT	CTSRRGTFNQPQHF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	5	5	1	3	1	5	23	34	41	35	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSRRGTFNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTTAGGGGGATCTGAAGCTTTCTTTGGACAA	CASSLGGSEAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	6	3	2	23	34	43	37	45	TCRBV02,TCRBV09													CASSLGGSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACGCCGGGGGCATGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.7563467986587896E-4		40	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	6	0	6	5	3	26	37	48	42	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTTACCGGGACAGGGAGAACCGGGGAGCTGTTTTTTGGAGAA	CASSVTGTGRTGELFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	5	7	3	26	37	53	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVTGTGRTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCAGACAGGGCATCTATGGCTACACCTTCGGTTCG	CASSSRQGIYGYTF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	5	3	26	37	49	42	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSRQGIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTCAGAGCTACGAGCAGTACTTCGGGCCG	CASSSQSYEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	36	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	4	5	3	2	2	26	39	44	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACGGGGGGTGGTCAGCCCCAGCATTTTGGTGAT	CASSQTGGGQPQHF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	1	6	1	3	26	41	49	42	52		TCRBV03-01,TCRBV03-02												CASSQTGGGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTAGCGGGAGTCAATGAGCAGTTCTTCGGGCCA	CASSQELAGVNEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	2	6	2	1	26	43	54	45	55		TCRBV03-01,TCRBV03-02												CASSQELAGVNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVANTGELFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	9	0	2	1	1	26	42	46	43	47		TCRBV03-01,TCRBV03-02												CASSQVANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCCAGGGATGGCTAGCGGGGAGGATGAGCAGTTCTTCGGGCCA	CASSQPGMASGEDEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	8	11	3	26	40	60	51	63		TCRBV03-01,TCRBV03-02												CASSQPGMASGEDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTTGACTAGCGGGAGTAAAAGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.7563467986587896E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	7	4	5	26	34	50	38	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCGGGACAACTCGTTATGGCTACACCTTCGGTTCG	CSAPGTTRYGYTF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	5	4	6	26	34	44	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPGTTRYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTCAGGAAGCTCCTACGAGCAGTACTTCGGGCCG	CSARDSGSSYEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	0	2	3	26	40	46	42	49		TCRBV20-01,TCRBV20-or09_02												CSARDSGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTCAGGGGCACTGAAGCTTTCTTTGGACAA	CSARDFRGTEAFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	4	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDFRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCATACAGGGGTGGAGAGCAGTACTTTGGGCCG	CASSPYRGGEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	19	5	16	22	33	45	38	61		TCRBV12-03,TCRBV12-04												CASSPYRGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCACTGGGACTAGCGGGCCGTGACAGATACGTAGTATTTTGGCCCA		Out	VDJ	1	11	1.7563467986587896E-4		52	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	13	5	15	22	34	51	39	66		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCTTCTCGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPSRSTDTQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	5	0	7	0	24	35	-1	42	45		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPSRSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAATGGGGGGCTTTACGAAAAACTGTTTTTTGGCAGT	CASSLNGGLYEKLFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	45	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	6	0	8	7	5	24	36	49	43	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGGLYEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAACAGAGAGCATGGAGCAGTTCTTCGGGCCA	CASSLTESMEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	5	10	2	8	23	36	42	38	50	TCRBV06,TCRBV24													CASSLTESMEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCATCATGGGCGTAATCAGGCGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	1.7563467986587896E-4		58							TCRBJ01	TCRBJ01-05	01	0	4	4	4	16	3	18	35	55	51	58	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05			TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACCACCTCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSTTSSGSTDTQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	0	7	0	26	38	-1	45	53		TCRBV12-03,TCRBV12-04				01,02								CASSTTSSGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTTCACTTCTGCGGGGACGTATGGCTACACCTTCGGTTCG	CASSFTSAGTYGYTF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	3	5	7	3	22	36	49	43	52	TCRBV05,TCRBV11													CASSFTSAGTYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTCAGGGGAACAGCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.9160146894459524E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	2	1	6	23	36	43	37	49	TCRBV04,TCRBV07,TCRBV17													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCTCCGACTGGGGGGAGACCCAGTACTTCGGGCCA	CASSSDWGETQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	6	6	1	5	8	0	22	33	-1	41	46	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDWGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTACCGGGACCCGTCACAGGGACTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		52	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	3	3	4	15	3	24	37	58	52	61		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGGTGGGGGTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.9160146894459524E-4		37	TCRBV24						TCRBJ02	TCRBJ02-05	01	10	6	1	2	4	2	24	32	41	36	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATAAAGGTGCTTAGGGTATGAGCAGTTCTTCGGGCCA	CASSE*RCLGYEQFF	Stop	VDJ	1	12	1.9160146894459524E-4		45	TCRBV06						TCRBJ02	TCRBJ02-01	01	2	5	3	8	11	1	23	38	53	49	54		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSE*RCLGYEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GARGACTCGGCCCTSTATCTCTGTGCCAGCAGTGGGAGGGTCCCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.9160146894459524E-4		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	5	1	6	21	32	40	33	46	TCRBV04,TCRBV05													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATSTCTGTGCCAGCACCCCGGGCTAGCGGGATTTGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	3	7	7	3	18	28	44	35	47	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGAGGCCGAGACAGGGGGCGCGAGGGCTACACCTTCGGTTCG	CASRGRDRGREGYTF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	8	7	5	18	29	46	36	51	TCRBV07,TCRBV11													CASRGRDRGREGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGACTCRGCCSTGTAYKTCTGTGCCAGCAGGGCCCGGGAGAATGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.9160146894459524E-4		55	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	2	4	4	18	18	29	39	33	57	TCRBV11,TCRBV13													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGACTCSGCCRTGTATCTCTGTGCCAGCAGCTTAGGATCCAGGTAGGGTAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGSR*GRSNQPQHF	Stop	VDJ	1	12	1.9160146894459524E-4		54	unresolved						TCRBJ01	TCRBJ01-05	01	1	4	4	1	4	9	19	35	43	39	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSR*GRSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGTGTATATCGGGCGACGGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLVYIGRRGEETQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	1	3	16	0	19	33	-1	49	56	TCRBV05,TCRBV07													CASSLVYIGRRGEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCGGCTACGAGGGGGTAGTTGAGACCCAGTACTTCGGGCCA	CASGYEGVVETQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	1	5	3	5	19	32	41	35	46	TCRBV05,TCRBV07													CASGYEGVVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCCTCAGCGGGGGGCGGGGACCCAGTACTTCGGGCCA	CASSPQRGAGTQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	1	7	4	4	19	31	44	35	48	TCRBV05,TCRBV11													CASSPQRGAGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCRGCYRTGTATCTCTGTGCCAGAAAATCAGGGACAGTCGATCATTGGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	1.9160146894459524E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	0	5	8	7	10	22	30	44	37	54	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCCAGGACAGGGGGACTGAAGCTTTCTTTGGACAA	CASSQDRGTEAFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	5	2	0	22	34	-1	36	46	TCRBV07,TCRBV23													CASSQDRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGRRGACTCRGCYSTGTATCTCTGTGCCAGCAGCGATTTAGCGGGAGGGGCAGGGGCCAACGTCCTGACTTTTGGGGCC	CASSDLAGGAGANVLTF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	5	0	25	4	24	22	34	49	38	73	TCRBV04,TCRBV07													CASSDLAGGAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGTAGCGGGAGAGGAGCAGACCCAGTACTTCGGGCCA	CASSLVAGEEQTQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	2	6	3	6	22	35	47	38	53	TCRBV07,TCRBV11													CASSLVAGEEQTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTTGGACTAGCGGGAGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.9160146894459524E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	2	3	2	2	23	34	49	36	51	TCRBV09,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGAGAGCCTGTTTCCGGCCGAGCAGTACTTCGGGCCG	CASSPESLFPAEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	9	0	6	18	0	26	37	-1	55	58		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPESLFPAEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCCTACACAGGGACAGCCAGTAATGAAAAACTGTTTTTTGGCAGT	CASSSYTGTASNEKLFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	4	10	4	26	37	54	47	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSYTGTASNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCGCGCCAATGAGCAGTTCTTCGGGCCA	CASRRANEQFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	6	6	0	3	26	-1	40	37	43		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRRANEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCATTAGCGGGAGATCAGATACGCAGTATTTTGGCCCA	CASSFISGRSDTQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	4	3	2	26	40	52	43	54		TCRBV12-03,TCRBV12-04												CASSFISGRSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAACTACAGACAGGGGGCAGGCAATCAGCCCCAGCATTTTGGTGAT	CASNYRQGAGNQPQHF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	0	2	6	2	24	34	50	40	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASNYRQGAGNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGTAAGGGGGCCACTGAAGCTTTCTTTGGACAA	CASSQDGKGATEAFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	4	5	0	26	43	-1	48	55		TCRBV03-01,TCRBV03-02												CASSQDGKGATEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGCCGCATTCAGTACTTCGGCGCC	CASSQGGRIQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	7	0	9	0	2	26	-1	47	42	49		TCRBV03-01,TCRBV03-02												CASSQGGRIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGCACGGCAGTACTACGAGCAGTACTTCGGGCCG	CASSLARQYYEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	7	3	1	9	26	38	43	39	52		TCRBV03-01,TCRBV03-02				01,02								CASSLARQYYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGCAGCTATGAACACTGAAGCTTTCTTTGGACAA	CSARDRAAMNTEAFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	8	0	0	2	5	26	40	46	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRAAMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGGGATAGAGTACGAGCAGTACTTCGGGCCG	CASSGIEYEQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	8	4	0	5	23	-1	39	35	44	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGIEYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCCGTGGACTAGCGGGAGGAGGATCGGAGACCCAGTACTTCGGGCCA	CATRGLAGGGSETQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	1	1	5	3	7	33	42	59	45	66	TCRBV23,TCRBV24,TCRBV25,TCRBV27,TCRBV28	TCRBV23-or09_02,TCRBV24-01,TCRBV24-or09_02,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CATRGLAGGGSETQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACCGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.075682580233115E-4		38	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	2	8	2	5	0	24	36	-1	41	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTAATCAATACGAAGAGACCCAGTACTTCGGGCCA	CASSNQYEETQYF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	6	3	7	3	8	1	24	35	45	43	46	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNQYEETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAACGTCAGGGGGAATTGAAGCTTTCTTTGGACAA	CASSPTSGGIEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	7	8	3	26	37	52	45	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPTSGGIEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGATACAGAACTCCTACGAGCAGTACTTCGGGCCG	CASSEIQNSYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	0	2	2	24	39	45	41	47	TCRBV06,TCRBV10													CASSEIQNSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGAACTAGCGGCTACGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSLELAATVYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	3	5	7	26	38	51	43	58		TCRBV03-01,TCRBV03-02				01,02								CASSLELAATVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGATTTGGGGGGACAGATACGCAGTATTTTGGCCCA	CSARFGGTDTQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	1	3	3	0	26	38	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSARFGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAAGGGGACAGGGGGCGGTGGCTGAAGCTTTCTTTGGACAA	CSAQRGQGAVAEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	6	6	5	26	34	52	40	57		TCRBV20-01,TCRBV20-or09_02												CSAQRGQGAVAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTCACGCCCGGAGACCCAGTACTTCGGGCCA	CSARGSRPETQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	0	10	5	0	9	26	-1	41	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGSRPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTCGAGTAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSARGSSSGSSYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	5	2	0	7	0	26	39	-1	46	55		TCRBV20-01,TCRBV20-or09_02												CSARGSSSGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACCGACTGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSAPPTGGNTEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	6	1	1	9	0	26	35	-1	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPPTGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGACTAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CSAWTSGSYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	4	1	1	26	35	49	36	50		TCRBV20-01,TCRBV20-or09_02												CSAWTSGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGCGTTCGGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CSGRSGGGTEAFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	1	4	6	3	26	33	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSGRSGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CRGGRGACWCAGCWSKGTATYTCTGTGCCAGCAGCTTATGGGTTAAGGTTTGCGGACATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	2.2353504710202778E-4		58	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	6	1	18	1	23	35	58	53	59	TCRBV07,TCRBV21													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCTCCTCGACTAGCGGGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSSTSGGPTDTQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	2	2	2	5	3	22	31	48	36	51		TCRBV12-03,TCRBV12-04												CASSSTSGGPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSGYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	3	0	0	23	-1	-1	35	40	TCRBV06,TCRBV10					01,02								CASSSGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGCGGGGCTAGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSELAGLASYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	51	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	1	0	6	23	-1	47	38	53		TCRBV06-01,TCRBV06-08												CASSELAGLASYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATCACCCGGGACAGGGGGTCGGGGCCAACGTCCTGACTTTCGGGGCC	CAISDHPGQGVGANVLTF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	1	4	8	2	23	35	54	43	56	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDHPGQGVGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTAAGGACAGGGGGGGACTACGAGCAGTACTTCGGGCCG	CASSLRTGGDYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	1	3	1	3	18	33	44	34	47	TCRBV07,TCRBV11													CASSLRTGGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAGTTTCTAGCGGGAGTAAGGGGAGATACGCAGTATTTTGGCCCA	YASSQFLAGVRGDTQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	5	4	7	22	36	50	40	57	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												YASSQFLAGVRGDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGACTCRGCCMTGTAYYTCTGTGCCAGCAGAGACGCACAGTGAGTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASRDAQ*VQSRANVLTF	Stop	VDJ	1	14	2.2353504710202778E-4		54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	5	5	6	13	19	30	40	36	53	TCRBV11,TCRBV13													CASRDAQ*VQSRANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGACTCRGCCCTSTAYYTCTGTGCCAGCAGCATGCGATATGTCTGAGTGAAAGACCTATGGCGGTTCG		Out	VDJ	1	14	2.2353504710202778E-4		43	unresolved						TCRBJ01	TCRBJ01-02	01	4	2	7	19	21	6	19	31	55	52	61	TCRBV05,TCRBV13			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTCAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFSGGTDTQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	3	1	1	0	19	33	-1	34	41	TCRBV05,TCRBV07													CASSFSGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCCTGGACCTCCCCCCACTACTAACTATGGCTACACCTTCGGTTCG	CASSPGPPPTTNYGYTF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	51	unresolved						TCRBJ01	TCRBJ01-02	01	5	1	7	0	3	12	22	34	41	37	53	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPPPTTNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCTGGTATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWYSYNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	4	0	10	1	0	3	22	-1	37	35	40	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWYSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCTACATCTGCAGTGCTAGAGAAGGAGGGACAGGTAGTGGAGTAGCGGGAGGGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	2.2353504710202778E-4		64	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	5	0	4	20	2	8	22	53	42	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGAGGGCCGGCAATGAGCAGTTCTTCGGGCCA	CASRRAGNEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	0	6	0	4	23	-1	39	34	43	TCRBV02,TCRBV09													CASRRAGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGAGACTAGTAAGTTTCAGGGAGAATGAGCAGTTCTTCGGGCCA	CASSERLVSFRENEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	7	5	14	23	34	45	39	59	TCRBV02,TCRBV09					01,02								CASSERLVSFRENEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCAGGGGCAGGCGTATGAAAAACTGTTTTTTGGCAGT	CASSQGQAYEKLFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	2	6	1	7	26	37	44	38	51	TCRBV09,TCRBV12													CASSQGQAYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGCAGGGGGACAGGGGGCGCTGGGCGGGAGTGTAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	2.3950183618074404E-4		64				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	7	8	16	17	30	50	38	66	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACAGGCAAGGGCAGTTCTTCGGGCCA		Out	VDJ	1	15	2.3950183618074404E-4		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	4	12	1	5	26	43	49	44	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTCCAGTGGTATTGAGACCCAGTACTTCGGGCCA	CASSHSSGIETQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	5	3	7	26	40	46	43	53		TCRBV03-01,TCRBV03-02												CASSHSSGIETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCGGGACAGGGGGTTAAGGTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	2.3950183618074404E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	1	4	1	7	26	35	47	36	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACAAGGGCCCGATGAACACTGAAGCTTTCTTTGGACAA	CSANKGPMNTEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	5	3	0	3	5	26	36	43	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANKGPMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCGGGACACGATACGCGGCTACACCTTCGGTTCG	CSARPRDTIRGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	8	4	8	26	38	48	42	56		TCRBV20-01,TCRBV20-or09_02												CSARPRDTIRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTACAGGGAAGTGAACACTGAAGCTTTCTTTGGACAA	CSARDYREVNTEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	0	2	3	26	40	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSARDYREVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGGGGATCCCACCGGGGAGCTGTTTTTTGGAGAA	CSARDMGDPTGELFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	6	1	4	3	4	26	40	48	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDMGDPTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGACGGGAGGGCTTAAATGGGAAATGAGCAGTTCTTCGGGCCA	CATSDLDGRA*MGNEQFF	Stop	VDJ	1	15	2.3950183618074404E-4		54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	0	7	2	11	24	42	52	44	63		TCRBV24-01,TCRBV24-or09_02												CATSDLDGRA*MGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGCCCAGGGTTGTATGGCTACACCTTCGGTTCG	CASSFGPGLYGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	5	7	3	24	36	48	43	51		TCRBV24-01,TCRBV24-or09_02												CASSFGPGLYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGTTCCCCGGACAGTGAAGCTTTCTTTGGACAA	CASRSPDSEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	1	5	7	10	0	24	31	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CASRSPDSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGGGCTAGCGGGCCCATGGGGGGACCCAGTACTTCGGGCCA	CASSLAG*RAHGGTQYF	Stop	VDJ	1	15	2.3950183618074404E-4		51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	4	7	3	10	18	35	46	38	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAG*RAHGGTQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGATATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGYSYNEQFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45							TCRBJ02	TCRBJ02-01	01	0	0	8	1	0	3	18	-1	39	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGYSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTATGGGGCAGCGAGGGGCTGCCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	2.3950183618074404E-4		56	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	5	2	3	13	5	25	41	59	54	64		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGAAGCTTGGTGGACTAGCGGGATGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.3950183618074404E-4		47	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	3	5	1	4	19	35	48	36	52		TCRBV05-03,TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGATCCCCGGGACAGGCGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.554686252594603E-4		47	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	3	8	3	26	38	54	46	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGTGAAAGGGCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSERADTGELFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	5	5	3	3	3	3	26	38	45	41	48	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERADTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCCTAGCGGTAGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	2.554686252594603E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	2	2	4	26	40	49	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGTAGCATGAACACTGAAGCTTTCTTTGGACAA	CSARGDSSMNTEAFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	0	0	5	26	-1	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGDSSMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGCGAAATGGACCAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	2.554686252594603E-4		44	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	1	7	5	10	2	26	39	53	49	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACAGGGTAGATACGCAGTATTTTGGCCCA	CSADRVDTQYF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	5	0	1	26	-1	42	35	43		TCRBV20-01,TCRBV20-or09_02												CSADRVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGGGGGTTGGACAGGGATTCGCAATGAGCAGTTCTTCGGGCCA	CATSAGGWTGIRNEQFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	6	9	5	24	37	54	46	59		TCRBV24-01,TCRBV24-or09_02												CATSAGGWTGIRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACTGTAGCTAGCGGGAGGGAATGCCGCGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	2.554686252594603E-4		58	TCRBV25			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	0	4	6	9	23	37	55	43	64		TCRBV25-01,TCRBV25-or09_02												X+TCRBV25-X+TCRBJ02-03	TCRBV25	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAACAGCTTATTGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CANSLLGSSYNEQFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	2	0	3	0	18	33	-1	36	41	TCRBV05,TCRBV11													CANSLLGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAGGGGCTGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLARGWDTGELFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	3	0	5	18	-1	41	35	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARGWDTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGGAGCAAGGGTGCCAGATACGCAGTATTTTGGCCCA	CASSVGARVPDTQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	5	3	4	10	3	26	37	51	47	54		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGARVPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTCCCAGGGACGGTAAGGAAACACCATATATTTTGGAGAG	CASSSSQGR*GNTIYF	Stop	VDJ	1	17	2.714354143381766E-4		48	TCRBV12						TCRBJ01	TCRBJ01-03	01	4	0	7	4	7	5	26	39	51	46	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSQGR*GNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCTCACAGGGCGCGGTGAAAAACTGTTTTTTGGCAGT	CASSLTGRGEKLFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	7	4	5	24	35	45	39	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSLTGRGEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAAGACCCTAGGCGACACTGAAGCTTTCTTTGGACAA	CASSKTLGDTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	8	3	6	3	24	36	46	42	49	TCRBV06,TCRBV10					01,02								CASSKTLGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGACCATCCAAGAGACCCAGTACTTCGGGCCA	CASSRTIQETQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	1	7	1	1	3	26	38	43	39	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGTATGCATCAAAACACCGGGGAGCTGTTTTTTGGAGAA	CSARDWGMHQNTGELFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	51	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	6	2	2	2	10	26	40	46	42	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDWGMHQNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGTAGCGGGATGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARVGSGMVSYNEQFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	3	0	4	4	26	39	51	43	55		TCRBV20-01,TCRBV20-or09_02												CSARVGSGMVSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGACAGGGTTCTTGTCGCGCTATGGCTACACCTTCGGTTCG	CSARRTGFLSRYGYTF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	4	2	11	26	37	47	39	58		TCRBV20-01,TCRBV20-or09_02												CSARRTGFLSRYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGACTCCATAAATGAGCAGTTCTTCGGGCCA	CSARDSINEQFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	7	1	5	26	35	42	36	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGGACAGGGGCGATTAGCAATCAGCCCCAGCATTTTGGTGAT	CSAGGTGAISNQPQHF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	2	0	0	4	26	-1	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSAGGTGAISNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGCCCGGCTAGCGGGAGCAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	2.714354143381766E-4		50	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	7	10	4	22	33	53	43	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGTCTACAGGAGAAAAACATTCAGTACTTCGGCGCC	CASSLQEKNIQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	4	4	2	2	22	34	41	36	43	TCRBV07,TCRBV12													CASSLQEKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGGCGGGACAGGGCAGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	2.714354143381766E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	3	8	4	4	24	35	48	39	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTAGCATGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.714354143381766E-4		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	7	3	0	6	24	-1	45	41	51		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTCCGACACAGATACGCAGTATTTTGGCCCA	CASSSDTDTQYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	36	unresolved						TCRBJ02	TCRBJ02-03	01	4	2	8	2	2	0	23	36	-1	38	40	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATGGCACTGGGGGTTGAAACATTCAGTACTTCGGCGCC	XASSQDGTGG*NIQYF	Stop	VDJ	1	17	2.714354143381766E-4		48	unresolved						TCRBJ02	TCRBJ02-04	01	0	6	1	6	7	3	22	39	51	46	54	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQDGTGG*NIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TRGRGGACTCAGCCMTGTAYYTCTGTGCCAGCAGTGAAGGGCCCTTCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	2.714354143381766E-4		43	unresolved						TCRBJ01	TCRBJ01-01	01	1	9	0	3	0	7	23	-1	42	39	49	TCRBV02,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAAGGGACTAGCGCCCTTACCTACGAGCAGTACTTCGGGCCG	CASSQGTSALTYEQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	6	2	4	6	26	37	51	41	57		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSQGTSALTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTGAGGGGTACTAGCGGGGAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSVRGTSGEGYNEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	4	10	5	26	37	57	47	62		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVRGTSGEGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACTAGCGGGAGAGAATGAGCAGTTCTTCGGGCCA	CASSLGLAGENEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	2	7	0	2	26	-1	54	42	56		TCRBV12-03,TCRBV12-04												CASSLGLAGENEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGGGAAGCTTTCTTTGGACAA	CASSQGREAFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	8	1	0	26	42	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSQGREAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTTAGGGGCAGGGACCTATGGCTACACCTTCGGTTCG	CASSLGAGTYGYTF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	7	4	10	0	26	37	-1	47	52	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAGTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCAGAACTATACGAGCAGTACTTCGGGCCG	CSAAELYEQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	9	4	6	0	26	34	-1	40	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSAAELYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCCCGGCGACTGAAGCTTTCTTTGGACAA	CSASPATEAFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	9	0	5	6	1	26	34	43	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTAAAACGCACAGCGGCGAGCTGTTTTTTGGAGAA	CSASPKTHSGELFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	6	5	11	13	1	26	37	55	50	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPKTHSGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACAGGGAAGAAACTATGGCTACACCTTCGGTTCG	CSAGQGRNYGYTF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	2	0	4	26	-1	43	35	47		TCRBV20-01,TCRBV20-or09_02												CSAGQGRNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGCAGGGGCAGGGAAGGGTGAAGCTTTCTTTGGACAA	CSAWAGAGKGEAFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	4	10	26	35	45	39	55		TCRBV20-01,TCRBV20-or09_02												CSAWAGAGKGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGTGCCGGGACTAGGGAGTGAGCAGTTCTTCGGGCCA	CASRVPGLGSEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	8	9	6	4	22	33	47	39	51		TCRBV12-03,TCRBV12-04				01,02								CASRVPGLGSEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCGCGGGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.8740220341689284E-4		37	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	2	6	2	0	22	34	-1	36	43		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAACCTAAGGAATGAGCAGTTCTTCGGGCCA	CASSNLRNEQFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	36	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	5	4	7	6	0	24	36	-1	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNLRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCCGGGACAGCGAACGAGCAGTACTTCGGGCCG	CASSPGTANEQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	5	4	3	20	31	42	35	45	TCRBV07,TCRBV23													CASSPGTANEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGAGTTACTGGAGAGACCCAGTACTTCGGGCCA	CASRVTGETQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	10	4	4	2	23	34	41	38	43	TCRBV02,TCRBV09					01,02								CASRVTGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGGCACGGTGGTGAGGGTAGGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	3.033689924956091E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	5	10	5	23	34	49	44	54	TCRBV01,TCRBV05													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGACTAGCGGGAGTCATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	3.033689924956091E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	2	2	4	2	3	26	43	57	45	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCTCCAGGAGCCTACGAGCAGTACTTCGGGCCG	CASSQSPGAYEQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	4	4	2	4	2	26	41	49	45	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSPGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTCCGGACAGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	3.033689924956091E-4		41	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	6	5	0	26	39	-1	44	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACTTAAGGACGGATACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	3.033689924956091E-4		40	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	1	7	3	7	4	26	34	45	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATGGCAGACGAAAACATTCAGTACTTCGGCGCC	CSARMADENIQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	39	TCRBV20						TCRBJ02	TCRBJ02-04	01	2	2	7	5	6	1	26	38	47	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARMADENIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGTTGGGTCAGGAGCCCGGAGATACGCAGTATTTTGGCCCA	CSARLLGQEPGDTQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	4	4	5	9	7	26	38	51	47	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLLGQEPGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAAGCGGGAGTACGAGCAGTACTTCGGGCCG	CSASKREYEQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	2	4	2	0	26	37	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSASKREYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGACAGGGAGGCTTGAAGCTTTCTTTGGACAA	CSASSTGRLEAFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	7	3	5	26	37	47	40	52		TCRBV20-01,TCRBV20-or09_02												CSASSTGRLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGAGGGAGGCACTGAAGCTTTCTTTGGACAA	CSAGEGGTEAFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	4	1	3	26	35	43	36	46		TCRBV20-01,TCRBV20-or09_02												CSAGEGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATATCGTGGGGGGCTACACCTTCGGTTCG	CSAYIVGGYTF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	6	2	8	8	0	26	35	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYIVGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGGACAGGGGCTATGGCTACACCTTCGGTTCG	CATSDPDRGYGYTF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	4	2	0	24	39	-1	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDPDRGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAGGGGGGAAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSSRGEAYNEQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	5	1	2	3	4	24	36	45	39	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGEAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDRGSGANVLTF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	5	2	0	1	0	18	35	-1	36	41	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTTCGGACAGGGGATTCCCGGGGAGCTGTTTTTTGGAGAA	CASSFGQGIPGELFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	6	3	4	23	35	47	38	51	TCRBV02,TCRBV12													CASSFGQGIPGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTACCCAGGGACAGTTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.193357815743254E-4		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	5	3	24	36	48	41	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACGCTCTGTCCCATTTCGTGTTGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.193357815743254E-4		49	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	3	7	5	0	21	26	-1	40	38	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGGGGGTAATGGACACTGAAGCTTTCTTTGGACAA	CSAEGVMDTEAFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	3	2	6	26	34	42	36	48		TCRBV20-01,TCRBV20-or09_02												CSAEGVMDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAGGTTCTTTAGGGTCCTACGAGCAGTACTTCGGGCCG	CSAKGSLGSYEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	5	3	1	12	0	26	34	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGSLGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCGGGACTGGGTGAAGAGACCCAGTACTTCGGGCCA	CSASSGLGEETQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	10	3	3	5	26	37	46	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGLGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCTCGGGACTAGCTTTGGTTGAGCAGTTCTTCGGGCCA	CSALSGLALVEQFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	9	5	6	26	35	49	40	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSALSGLALVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGAGACAGGGGGCGCTGGCTGAAGCTTTCTTTGGACAA	CSAARQGALAEAFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	6	4	5	26	35	49	39	54		TCRBV20-01,TCRBV20-or09_02												CSAARQGALAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAACCCCCAAGCCCGACGAGCAGTACTTCGGGCCG	CASSQTPKPDEQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	7	5	7	3	23	38	48	45	51	TCRBV01,TCRBV04					01,02								CASSQTPKPDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGCGGATTTGGGAGAGACCCAGTACTTCGGGCCA	CASSLADLGETQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV12						TCRBJ02	TCRBJ02-05	01	0	0	9	4	6	0	22	39	-1	45	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADLGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTATAGCTCTCCGAGATACGCAGTATTTTGGCCCA	CASSFIALRDTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	7	5	2	6	22	36	42	38	48		TCRBV12-03,TCRBV12-04				01,02								CASSFIALRDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	3.193357815743254E-4		38	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	8	0	2	0	24	35	-1	37	40		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLSGEETQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	39				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	3	4	0	24	36	-1	40	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGEETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACTAGCGACCCTCAGTACTTCGGGCCA	CASSETSDPQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	36	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	3	6	11	0	5	23	-1	45	38	50		TCRBV06-01,TCRBV06-08				01,02								CASSETSDPQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGACTAGCGGGAGGAAGGTGGTACTTCGGGCCG	CASSLGLAGGRWYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	1	12	0	6	19	-1	48	33	54	TCRBV07,TCRBV11													CASSLGLAGGRWYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCCGACGGGGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSPDGGANEKLFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	0	3	5	0	18	30	-1	35	43	TCRBV07,TCRBV11													CASSPDGGANEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCAAAGATTAACGGGAGGGTTGTACAATGAGCAGTTCTTCGGGCCA	CASSQRLTGGLYNEQFF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	0	4	7	3	20	35	50	42	53	TCRBV11,TCRBV23													CASSQRLTGGLYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGGACTAGCGGGAGGTTCGGGGACCCAGTACTTCGGGCCA	CASSPGLAGGSGTQYF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	1	1	7	3	6	19	31	48	34	54	TCRBV05,TCRBV11													CASSPGLAGGSGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTTGGCTAGCAATAACCTGTCGTGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	20	3.193357815743254E-4		56	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	4	7	1	7	15	25	33	45	40	60		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCAGACAGTCCTGAAGCTTTCTTTGGACAA	CASSADSPEAFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	6	3	2	26	38	46	41	48		TCRBV12-03,TCRBV12-04												CASSADSPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACCTGCAGAAGGGTGGAGCTACGAGCAGTACTTCGGGCCG	CASSQPAEGWSYEQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	2	5	3	3	8	5	23	38	50	46	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPAEGWSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCAGCTTCTACATCTGCAGTGCTAGCCTACGGTGTCAAAAGGACTAGCGATAATTAGACTACGAGCAGTACTTCGGGCCG	CSASLRCQKD*R*LDYEQYF	Stop	VDJ	1	21	3.353025706530417E-4		60	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	6	3	15	9	15	26	50	41	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLRCQKD*R*LDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTCGGGGTTTACGATACGCAGTATTTTGGCCCA	CASSQEVGVYDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	6	3	5	26	43	51	46	56		TCRBV03-01,TCRBV03-02												CASSQEVGVYDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGCAGGGGGGAAACATTCAGTACTTCGGCGCC	CSARDPQGGNIQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	1	6	4	1	26	40	51	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDPQGGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGTCTAGCCGCGAGCAGTACTTCGGGCCG	CSARDRSSREQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	7	6	5	2	26	40	50	45	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRSSREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGTAGCGGGGAGACAAGAGACCCAGTACTTCGGGCCA	CSARGVAGRQETQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	3	2	5	3	26	37	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSARGVAGRQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCGCGCCGGACATAGGGATCAATGAGCAGTTCTTCGGGCCA	CSVAPDIGINEQFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	6	6	7	7	26	33	45	40	52		TCRBV20-01,TCRBV20-or09_02												CSVAPDIGINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCGCTCAGGACCTCGGACCAGATACGCAGTATTTTGGCCCA	CASAQDLGPDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	8	1	7	4	5	7	22	31	40	36	47	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAQDLGPDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTTTGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLAGNTEAFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	2	0	23	37	-1	39	43	TCRBV27,TCRBV28													CASSLAGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCTAGCGGTCTCACAGATACGCAGTATTTTGGCCCA	CATSSGLTDTQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	4	5	2	1	3	24	33	41	34	44		TCRBV24-01,TCRBV24-or09_02				01,02								CATSSGLTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSPSSYNEQFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	0	8	0	24	36	-1	44	47	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSPSSYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATAGGGGAACAGCGCCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	3.353025706530417E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	5	2	0	4	9	24	31	40	35	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTATATGGGGCCAACACAGAACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYMGPTQNLAKNIQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	7	0	0	4	13	18	31	40	35	53	TCRBV05,TCRBV11													CASSYMGPTQNLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGTGGGGGCAGGTCGATCAGCCCCAGCATTTTGGTGAT	CASSPWGQVDQPQHF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	6	0	5	4	6	26	38	48	42	54		TCRBV12-03,TCRBV12-04												CASSPWGQVDQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCGTCGTTATACAGGGGGCGCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	3.512693597317579E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	0	5	11	4	26	36	56	47	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCCATCCCGGAACACTGAAGCTTTCTTTGGACAA	CRPSRNTEAFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	9	4	6	1	2	5	26	31	35	33	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CRPSRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTCATAAAGGCTAGCGGGAGGGCCGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	3.512693597317579E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	6	8	4	22	34	54	42	58	TCRBV12,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGSGACTCRGCTGTGTAYYTCTGTGCCAGCAGTGAGGGACAGGGGAACCCCTACGAGCAGTACTTCGGGCCG	CASSEGQGNPYEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	2	2	4	22	34	46	36	50	TCRBV07,TCRBV12													CASSEGQGNPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGGGTTGACAGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	3.512693597317579E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	3	4	6	0	24	35	-1	41	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCTCCAGGGGGCAAGCAGGGAGCTGTTTTTTGGAGAA	CASSLQGASRELFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	0	9	3	5	23	35	46	38	51	TCRBV06,TCRBV24													CASSLQGASRELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGGGACTAGCGGGAGGACGAATGAGCAGTTCTTCGGGCCA	CASSGTSGRTNEQFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	7	0	3	18	-1	45	30	48	TCRBV05,TCRBV11													CASSGTSGRTNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AAGAAGACTCRGCYSYGTATCTCTGCACCAGCAGCCAAGGGGAGTAACCCGGGACGTCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	3.672361488104742E-4		53	unresolved						TCRBJ01	TCRBJ01-05	01	1	0	7	5	11	4	23	39	55	50	59	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCACCGAGCCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	3.672361488104742E-4		40	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	7	0	4	2	23	35	42	39	44	TCRBV01,TCRBV07,TCRBV17					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAGTTTAGCGGAAAATGAGCAGTTCTTCGGGCCA	CASSQSLAENEQFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	5	7	5	2	26	40	51	45	53		TCRBV03-01,TCRBV03-02				01,02								CASSQSLAENEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGACAGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSLGQANQPQHF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	4	3	1	1	26	39	48	40	49		TCRBV03-01,TCRBV03-02												CASSLGQANQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACTCGGGACAGTAGCTACGAGCAGTACTTCGGGCCG	CSATRDSSYEQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	3	5	3	26	34	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSATRDSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGACAGTCCACGGAGACTATGGCTACACCTTCGGTTCG	CSAGTVHGDYGYTF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	3	1	9	26	34	42	35	51		TCRBV20-01,TCRBV20-or09_02												CSAGTVHGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGACAGGGGAGGCGACTAATGAAAAACTGTTTTTTGGCAGT	CSARVTGEATNEKLFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	2	2	1	5	26	39	48	40	53		TCRBV20-01,TCRBV20-or09_02												CSARVTGEATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCGGGACTAGCGGGACGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARAGTSGTSYNEQFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	3	1	4	2	26	37	54	41	56		TCRBV20-01,TCRBV20-or09_02												CSARAGTSGTSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCATGAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSHEGGNQPQHF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	2	4	0	22	34	-1	38	44	TCRBV09,TCRBV12													CASSHEGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTACGGCAGGGTAGGCGAGAGACCCAGTACTTCGGGCCA	CASSLRQGRRETQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	4	3	6	23	38	46	41	52	TCRBV24,TCRBV27													CASSLRQGRRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCAGGCAACCGGAAAATAATGAAAAACTGTTTTTTGGCAGT	CASRQPENNEKLFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	7	1	8	4	6	3	24	35	44	41	47	TCRBV06,TCRBV10,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRQPENNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAGGGCTGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGLSSYEQYF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	6	5	3	0	3	5	20	31	38	34	43	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCAGGGATTCAGAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSQGFRANEKLFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	3	0	8	19	-1	36	31	44	TCRBV05,TCRBV07													CASSQGFRANEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAGACGGATAACTATGGCTACACCTTCGGTTCG	CASSQTDNYGYTF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	1	8	1	6	0	26	37	-1	43	46		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTDNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGGGCGGTCTGAAGCTTTCTTTGGACAA	CASSYGRSEAFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	36	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	8	0	6	0	3	24	-1	43	39	46		TCRBV06-05,TCRBV06-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGRSEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCCCGGAAGCTACGAGCAGTACTTCGGGCCG	CASSQEPGSYEQYF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	1	8	3	4	2	26	43	50	47	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEPGSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCTCGGGAATGAGCAGTTCTTCGGGCCA	CASSPLGNEQFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	7	4	0	26	39	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSPLGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGAAGGTTGGCGCGGACGGCAAAACACTGAAGCTTTCTTTGGACAA	CSAKEGWRGRQNTEAFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	51	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	1	7	2	16	5	26	34	54	50	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKEGWRGRQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGAAGGTTGGCGCGGACGGTAAAACACTGAAGCTTTCTTTGGACAA	CSAKEGWRGR*NTEAFF	Stop	VDJ	1	24	3.832029378891905E-4		51	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	1	7	2	16	5	26	34	54	50	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKEGWRGR*NTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCACTAGCGGACCAATCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	3.832029378891905E-4		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	5	5	3	8	26	34	45	37	53		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACACCCTACGGGGCGGCCATCAGCCCTAGCATTTTGGTGAT	CSARDTLRGGHQP*HF	Stop	VDJ	1	24	3.832029378891905E-4		48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	7	0	14	8	13	26	40	53	48	66		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTLRGGHQP*HF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCCAAGGAGCGGGAGTTTCATATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	3.832029378891905E-4		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	8	9	6	26	35	52	44	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGACTCTCCAGGCCCCCGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	3.832029378891905E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	7	6	7	24	42	52	48	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGAATCGGACCTTCGAATATAATAGGATGGGAAAAACTGTTTTTTGGCAGT	CSATRIGPSNIIGWEKLFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	57	TCRBV20						TCRBJ01	TCRBJ01-04	01	4	1	7	8	8	20	24	34	46	42	66		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATRIGPSNIIGWEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCACAGGGGGGAGGATCGGGCACTGAAGCTTTCTTTGGACAA	CASSPQGGGSGTEAFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	4	2	10	18	30	40	32	50	TCRBV07,TCRBV11													CASSPQGGGSGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTGGGGACAGGGTACCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWGQGTNTGELFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	2	1	4	19	32	42	33	46	TCRBV07,TCRBV11													CASSWGQGTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGTAGGTGGGGCGCCCCTCGAGCAGTACTTCGGGCCG	CASSEVGGAPLEQYF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	6	5	6	23	39	49	44	55	TCRBV02,TCRBV09													CASSEVGGAPLEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACACCCAAGAGACCCAGTACTTCGGGCCA	CASSRDTQETQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	1	0	1	26	-1	45	39	46		TCRBV03-01,TCRBV03-02												CASSRDTQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGCCCCGGGACAGTGGGCCTACGAGCAGTACTTCGGGCCG	CASSRAPGQWAYEQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	2	7	4	26	39	53	46	57		TCRBV03-01,TCRBV03-02												CASSRAPGQWAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRGGTDTQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	0	3	0	1	26	-1	46	39	47		TCRBV03-01,TCRBV03-02												CASSRGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGGACTCGGAGGTCCCTGAGCAGTTCTTCGGGCCA	CASSWDSEVPEQFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	9	1	10	26	38	45	39	55		TCRBV03-01,TCRBV03-02				01,02								CASSWDSEVPEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGATTACCCGGGACAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAITRDRANTGELFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	0	8	0	26	34	-1	42	51		TCRBV20-01,TCRBV20-or09_02												CSAITRDRANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGGGTGGGGGCAGGACACAGATACGCAGTATTTTGGCCCA	CSATGWGQDTDTQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	6	0	2	6	4	26	36	48	42	52		TCRBV20-01,TCRBV20-or09_02												CSATGWGQDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCCAGCGGGTGGGGAGATACGCAGTATTTTGGCCCA	CSAREASGWGDTQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	4	5	4	5	26	40	50	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREASGWGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGAGGGGGTTCTGGAAACACCATATATTTTGGAGAG	CSARVGGGSGNTIYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV20						TCRBJ01	TCRBJ01-03	01	1	5	1	1	4	1	26	39	49	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGGGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGGAGTTAGCGGGAGGAGGTGAACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	25	3.9916972696790677E-4		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	5	1	2	7	7	26	35	52	42	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACAGCCGAGCGGGAAGCGACAATGAGCAGTTCTTCGGGCCA	CSAYSRAGSDNEQFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	5	8	4	26	35	50	43	54		TCRBV20-01,TCRBV20-or09_02												CSAYSRAGSDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT	CSVTGNNQPQHF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	3	1	2	26	33	41	34	43		TCRBV20-01,TCRBV20-or09_02												CSVTGNNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTATTTGGGGGCTAGCGGCACCTACGAGCAGTACTTCGGGCCG	CASSYLGASGTYEQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	2	4	2	24	42	53	46	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSYLGASGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGGACTAGCGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRD*RSSYEQYF	Stop	VDJ	1	26	4.15136516046623E-4		45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	5	0	2	2	26	37	50	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSRD*RSSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTGGACAGGGACAGTTCTTCGGGCCA	CASSLGQGQFF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	33	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	13	4	1	26	37	49	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGQGQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCGGGACTTACAAGAGACCCAGTACTTCGGGCCA	CASSQGRDLQETQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	10	2	3	2	26	42	51	45	53		TCRBV03-01,TCRBV03-02				01,02								CASSQGRDLQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGACAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	4.15136516046623E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	3	0	1	26	-1	47	40	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACTAGAGGGAAACCAAGAGACCCAGTACTTCGGGCCA	CSALLEGNQETQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	8	0	2	6	26	35	42	37	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSALLEGNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGACAGAGGGCCGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	4.15136516046623E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	5	6	0	8	24	-1	41	35	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTTAGAAGGACAGGGAGCCTCCGAAAACTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	26	4.15136516046623E-4		59	TCRBV25			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	3	7	6	13	22	38	52	44	65		TCRBV25-01,TCRBV25-or09_02												X+TCRBV25-X+TCRBJ01-04	TCRBV25	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGGACTAGCGGGTTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	4.311033051253393E-4		41	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	4	4	1	3	26	37	49	38	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCGCAAAGACTAGCGGACCTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	4.311033051253393E-4		53	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	1	7	4	24	38	54	45	58	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCCGGGCGGCGAACACTGAAGCTTTCTTTGGACAA	CSALRAANTEAFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	8	0	1	5	3	26	34	43	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALRAANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCACGGGAGGTTTGTACAATGAGCAGTTCTTCGGGCCA	CSATTGGLYNEQFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	4	3	4	26	36	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSATTGGLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACGGACAATCAGCCCCAGCATTTTGGTGAT	CSARGTDNQPQHF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	7	3	1	3	26	37	43	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGTDNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSVGGQETQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	9	0	2	1	0	26	33	-1	34	41		TCRBV20-01,TCRBV20-or09_02												CSVGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAAGACAGGTTTGCCCCCCCCTCCAACACTGAAGCTTTCTTTGGACAA	CASSLEDRFAPPSNTEAFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	57	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	4	2	2	15	24	40	48	42	63		TCRBV12-03,TCRBV12-04												CASSLEDRFAPPSNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTCACTAGCGGGACTGCAGATACGCAGTATTTTGGCCCA	CASSLVTSGTADTQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	48	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	3	4	4	3	19	33	47	37	50		TCRBV05-06,TCRBV05-07												CASSLVTSGTADTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGCCCTTTTTGATCCAGCAGTACTTCGGGCCG	CASSEPFLIQQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	3	2	8	8	9	3	23	37	48	46	51	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSEPFLIQQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGACAGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSEDRGNEKLFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	5	4	0	23	34	-1	38	47	TCRBV02,TCRBV09													CASSEDRGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCCCTCTGAACTAGCGGGAGGGTGAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASRPSELAGG*GTYNEQFF	Stop	VDJ	1	28	4.4707009420405557E-4		60	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	3	0	2	9	7	21	32	54	41	61		TCRBV24-01,TCRBV24-or09_02												CASRPSELAGG*GTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAACCCCCGGGGACACCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	4.4707009420405557E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	5	9	3	26	37	52	46	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCAGTTACTCCAGGGAATCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	28	4.4707009420405557E-4		56				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	3	1	11	2	24	38	54	49	56	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGTCAGCAGCCTTATCTCTGGAAACACCATATATTTTGGAGAG	CVSSLISGNTIYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	5	9	0	1	1	26	39	42	40	43		TCRBV03-01,TCRBV03-02				01,02								CVSSLISGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGCCCCATTTCATCTAGCGGGATAGTCAATGAGCAGTTCTTCGGGCCA	CSASPISSSGIVNEQFF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	3	6	14	4	26	34	57	48	61		TCRBV20-01,TCRBV20-or09_02												CSASPISSSGIVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAACTAGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAELASSYNEQFF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	6	0	3	2	26	34	44	37	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAELASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCTCGACTAGCGGGAGGGTCGGTGCAATGAGCAGTTCTTCGGGCCA	CSANLD*REGRCNEQFF	Stop	VDJ	1	28	4.4707009420405557E-4		51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	0	6	5	6	26	36	55	41	61		TCRBV20-01,TCRBV20-or09_02												CSANLD*REGRCNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGAAACCTACGAGCAGTACTTCGGGCCG	CSARAETYEQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	1	8	2	1	2	26	39	43	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAETYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTTCTCGCGGGCGTCCTACGAGCAGTACTTCGGGCCG	CSARVFSRASYEQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	1	7	2	26	39	51	46	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVFSRASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACCTCCGGGACTAGCGGGGGGGCAGTTCTTCGGGCCA	CSAPPPGLAGGQFF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	12	8	0	26	35	-1	43	58		TCRBV20-01,TCRBV20-or09_02												CSAPPPGLAGGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGAGATCCCCGGGACAGGGATCAGGAAACACCATATATTTTGGAGAG	CSAVRSPGQGSGNTIYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	4	11	4	26	35	55	46	59		TCRBV20-01,TCRBV20-or09_02												CSAVRSPGQGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCAGCGGGAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPAGGGTGELFF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	0	4	2	2	23	35	47	37	49	TCRBV24,TCRBV27													CASSPAGGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACCACAGGGGGGATTCCATTCAGTACTTCGGCGCC		Out	VDJ	1	28	4.4707009420405557E-4		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	3	1	9	2	5	24	34	44	36	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCACCGAGGGGGGGAATCTGAACACTGAAGCTTTCTTTGGACAA	CASSTEGGNLNTEAFF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	0	5	4	19	31	43	36	47	TCRBV05,TCRBV07													CASSTEGGNLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGTGAGGGACAGGGTCCGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVRDRVRSTDTQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	0	3	5	23	36	48	39	53	TCRBV02,TCRBV21													CASSVRDRVRSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGAAGGGGGCAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRKGAGSGANVLTF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	5	0	0	4	3	26	41	52	45	55		TCRBV12-03,TCRBV12-04												CASSLRKGAGSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCAGGGGGCTCGGAGACCCAGTACTTCGGGCCA	CASSQDPGGSETQYF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	5	2	3	26	43	53	45	56		TCRBV03-01,TCRBV03-02												CASSQDPGGSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCAAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLQAGGADTQYF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	0	4	4	1	26	39	53	43	54		TCRBV03-01,TCRBV03-02												CASSLQAGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGAGATACGCAGTATTTTGGCCCA	CSARVGDTQYF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	0	9	5	1	0	26	39	-1	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCTATCTGGGTTGACTATGGCTACACCTTCGGTTCG	CSARAIWVDYGYTF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	0	9	3	8	3	26	37	48	45	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAIWVDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTCCCCGGGCTAACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSPG*LAKNIQYF	Stop	VDJ	1	30	4.790036723614881E-4		48	unresolved						TCRBJ02	TCRBJ02-04	01	6	8	0	0	6	5	26	37	47	43	52	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPG*LAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTAAACTATCCGGACAATGAGCAGTTCTTCGGGCCA	CASSQLNYPDNEQFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	9	5	4	5	26	41	49	45	54		TCRBV03-01,TCRBV03-02				01,02								CASSQLNYPDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCCGGGGACGGCTACGAGCAGTACTTCGGGCCG	CASSQAGDGYEQYF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	0	7	3	5	2	26	40	50	45	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGDGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGCCCCGGGACAGTAGGCCTACAAACAGTACTTCGGGCCG	CASSRAPGQ*AYKQYF	Stop	VDJ	1	30	4.790036723614881E-4		48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	10	7	12	26	39	53	46	65		TCRBV03-01,TCRBV03-02												CASSRAPGQ*AYKQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCGGGATAGCCAAAAACATTCAGTACTTCGGCGCC	CSATGIAKNIQYF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	8	3	0	3	1	26	34	42	37	43		TCRBV20-01,TCRBV20-or09_02												CSATGIAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCACAAGAGACCCAGTACTTCGGGCCA	CSARPQETQYF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	6	2	1	0	26	38	-1	39	41		TCRBV20-01,TCRBV20-or09_02												CSARPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGTGAACAATCAGCCCCAGCATTTTGGTGAT	CSARGVNNQPQHF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	2	3	0	4	26	-1	42	39	46		TCRBV20-01,TCRBV20-or09_02												CSARGVNNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGAGGAATACACTGAAGCTTTCTTTGGACAA	CSASGEEYTEAFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	1	3	4	3	26	37	45	41	48		TCRBV20-01,TCRBV20-or09_02												CSASGEEYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTAGGGGGGACTGAAGCTTTCTTTGGACAA	CASSLGGTEAFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	6	5	1	5	2	1	24	36	44	38	45	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGACCCATTTTAGCGGGAGGTGCTCAATGAGCAGTTCTTCGGGCCA	CASSLDPF*REVLNEQFF	Stop	VDJ	1	30	4.790036723614881E-4		54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	1	6	8	4	18	34	52	42	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												CASSLDPF*REVLNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCGGATCAGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGSDSSYNEQFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	5	0	6	0	19	28	-1	34	39	TCRBV05,TCRBV11													CASGSDSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCACGAGGGACAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CATRDRGQETQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	1	2	3	0	26	33	-1	36	47		TCRBV03-01,TCRBV03-02												CATRDRGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGGCCTTTACGCTACGAGCAGTACTTCGGGCCG	CASSSRPLRYEQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	9	0	3	4	7	26	38	45	42	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRPLRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCGTTTGAACGGCTACACCTTCGGTTCG	CSARRLNGYTF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	2	8	8	8	2	26	35	45	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRLNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGCCAGGGTCTGGTTGAAGTTTTCTTTGGACAA		Out	VDJ	1	31	4.949704614402044E-4		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	13	3	12	24	35	43	38	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGCAGTAACTATGGCTACACCTTCGGTTCG	CASSLGSNYGYTF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	4	5	1	5	0	24	36	-1	41	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTAACAGCCCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	4.949704614402044E-4		46	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	2	4	5	19	33	41	37	46		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGGGGAGCGGCCAAAACTAGCGGGAGTTGAATTTGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	4.949704614402044E-4		59	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	3	2	6	17	8	22	30	58	47	66		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTAGTGGACAGAACAACAGAGATACGCAGTATTTTGGCCCA	CASSSGQNNRDTQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	5	4	8	23	34	44	38	52	TCRBV02,TCRBV09													CASSSGQNNRDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCGAGCTAGGGATACGCAGTATTTTGGCCCA	CASSQARARDTQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	8	6	6	1	26	42	52	48	53		TCRBV03-01,TCRBV03-02				01,02								CASSQARARDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTCAGATACGCAGTATTTTGGCCCA	CASSQGSDTQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	36	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	0	10	4	0	1	26	-1	44	42	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSARGRGENTEAFF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	1	2	1	26	39	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARGRGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATACCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	5.109372505189206E-4		44							TCRBJ02	TCRBJ02-02	01	0	3	7	0	1	1	18	35	38	36	39	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02			TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCCATCCGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSHPESTDTQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	2	0	5	0	18	30	-1	35	39	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASSHPESTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAGATGGAATAGCCGGAGGGGGAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	5.109372505189206E-4		56	TCRBV05						TCRBJ02	TCRBJ02-01	01	4	5	1	3	17	2	19	31	54	48	56		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-01	TCRBV05		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATTCGGAGGAGCAGATACGCAGTATTTTGGCCCA	CASSQEFGGADTQYF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	1	4	4	2	26	43	52	47	54		TCRBV03-01,TCRBV03-02												CASSQEFGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCACAGGCGGAATGGCAGGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CSTTGGMAGGYQETQYF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	1	0	16	2	26	32	55	48	57		TCRBV20-01,TCRBV20-or09_02												CSTTGGMAGGYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGTAGGGTCGGTCCAAGAGACCCAGTACTTCGGGCCA	CSASVGSVQETQYF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	5	3	1	5	5	26	35	44	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVGSVQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACACTTCCTTTAACACTGAAGCTTTCTTTGGACAA	CASSQDTSFNTEAFF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	10	2	1	6	23	40	44	41	50	TCRBV01,TCRBV04					01,02								CASSQDTSFNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCCTCTCACTGTTTTTTGGCAGT	CSARDILSLFF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	4	10	13	4	3	26	40	46	44	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDILSLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGTATCGGGGACAGGGGGGTCGGGGAGCTGTTTTTTGGAGAA	CSASSIGDRGVGELFF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	1	7	8	2	26	37	56	45	58		TCRBV20-01,TCRBV20-or09_02												CSASSIGDRGVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAACGGGACAGATCACAGATACGCAGTATTTTGGCCCA	CSAETGQITDTQYF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	5	2	26	35	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSAETGQITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGAGATACGGGAGCTGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	5.428708286763532E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	1	5	4	23	34	45	39	49	TCRBV09,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGACGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSFDGTSTDTQYF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	1	8	0	4	3	26	40	47	44	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGTSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGACTAGCGGGAGAATAGGGTCAGATACGCAGTATTTTGGCCCA	CSAETSGRIGSDTQYF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	2	4	3	8	26	34	49	37	57		TCRBV20-01,TCRBV20-or09_02												CSAETSGRIGSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCAGCCGAACAGCCTGGCTTTCTTTGGACAA	CSARAQPNSLAFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	11	9	4	26	39	52	48	56		TCRBV20-01,TCRBV20-or09_02												CSARAQPNSLAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTAGGATCCACCTCCGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	5.588376177550695E-4		44	unresolved						TCRBJ02	TCRBJ02-01	01	3	1	8	8	2	11	18	32	37	34	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCGGGGGGGAGAAGAGGTGAAAAACTGTTTTTTGGCAGT	CASSSGGRRGEKLFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	0	7	0	8	19	-1	40	32	48	TCRBV07,TCRBV11													CASSSGGRRGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTCGGTAAGATACAGGGTATCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	5.588376177550695E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	2	10	6	24	36	52	46	58	TCRBV02,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTGGGACTAGCGGGAGGGCCGGGCATTCAGTACTTCGGCGCC		Out	VDJ	1	36	5.748044068337857E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	0	0	9	2	5	26	39	57	41	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGACTAGCGGGAGGGTGGGCGAGCAGTACTTCGGGCCG	CSASGTSGRVGEQYF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	0	0	6	1	4	26	37	54	38	58		TCRBV20-01,TCRBV20-or09_02												CSASGTSGRVGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGAGGTCCCGGGTGGCGAGCAGTACTTCGGGCCG	CASSEVPGGEQYF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	6	7	3	23	35	46	42	49	TCRBV01,TCRBV04					01,02								CASSEVPGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTTTCAGGGAGGCGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	36	5.748044068337857E-4		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	4	4	3	23	37	47	41	50	TCRBV24,TCRBV27													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTTATAGCGGGATTAGTTCCTACGAGCAGTACTTCGGGCCG	CASSSYSGISSYEQYF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	3	1	4	5	18	31	43	35	48	TCRBV07,TCRBV11													CASSSYSGISSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCATCACCCGGACCGGGACCTCTGGCGAGCAGTACTTCGGGCCG	CASSITRTGTSGEQYF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	4	0	7	6	12	6	19	31	48	43	54	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSITRTGTSGEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCGGGGCCGGAACACTGAAGCTTTCTTTGGACAA	CASSRGRNTEAFF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	7	0	1	2	2	26	37	44	39	46	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGRNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARRSYNEQFF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	5	1	0	0	26	-1	-1	38	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGTTGGTCGGAGACCCAGTACTTCGGGCCA	CSARRWSETQYF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	0	10	5	4	3	26	38	44	42	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRWSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGCAGGGGAAACTATGGCTACACCTTCGGTTCG	CSARDPGRGNYGYTF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	2	6	1	26	40	52	46	53		TCRBV20-01,TCRBV20-or09_02												CSARDPGRGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACAAGCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	37	5.90771195912502E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	6	1	1	3	26	37	42	38	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCGAGGGTTTGATCGAGCAGTACTTCGGGCCG	CASSQAEGLIEQYF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	0	6	2	6	26	42	49	44	55		TCRBV03-01,TCRBV03-02												CASSQAEGLIEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGTAGCCTACGAGCAGTACTTCGGGCCG	CASSQGQVAYEQYF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	2	0	3	26	-1	48	42	51		TCRBV03-01,TCRBV03-02												CASSQGQVAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGCGGGAGACTCCTACAATGAGCAGTTCTTCGGGCCA	CSARVAGDSYNEQFF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	2	0	0	1	26	-1	48	39	49		TCRBV20-01,TCRBV20-or09_02												CSARVAGDSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCCCGGGACAGGGGGCCCGGGAGACTGAAGCTTTCTTTGGACAA	CSARPPGQGARETEAFF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	5	6	7	26	37	55	43	62		TCRBV20-01,TCRBV20-or09_02												CSARPPGQGARETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATGCCGGGACGACAGATACGCAGTATTTTGGCCCA	CSADAGTTDTQYF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	7	3	6	1	26	35	46	41	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADAGTTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAAACGACAGGGCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	38	6.067379849912182E-4		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	2	3	6	3	1	24	31	41	34	42		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGAGGGCGGACGGCGCCCAGGCGCAGTATTTTGGCCCA		Out	VDJ	1	38	6.067379849912182E-4		43	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	3	1	7	10	5	10	23	36	45	41	55	TCRBV02,TCRBV09			TCRBD01,TCRBD02										X+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAAAGTCGAGACAGGGGCGGTTTTGTGCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	39	6.227047740699345E-4		62	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	2	2	7	11	18	35	50	42	61	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCACTGGACAGCCCTTGGACCTACGAGCAGTACTTCGGGCCG	CSARPLDSPWTYEQYF	In	VDJ	1	40	6.386715631486508E-4	7.885036172603442E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	2	5	8	26	38	49	43	57		TCRBV20-01,TCRBV20-or09_02												CSARPLDSPWTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCACTCCGGAGCACTGAAGCTTTCTTTGGACAA	CSARDPLRSTEAFF	In	VDJ	1	40	6.386715631486508E-4	7.885036172603442E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	4	8	0	26	40	-1	48	52		TCRBV20-01,TCRBV20-or09_02												CSARDPLRSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGAGAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	40	6.386715631486508E-4		40	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	2	2	24	38	43	40	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATCCCGGGACAGGGTACAATCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSSRDRVQSGANVLTF	In	VDJ	1	40	6.386715631486508E-4	7.885036172603442E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	3	4	7	8	24	36	52	43	60		TCRBV03-01,TCRBV03-02												CASSSSRDRVQSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGYGACTCKGCTGTGTATYTCTGTGCCAGCAGCATTGGTAGAAACTACAATGAGCAGTTCTTCGGGCCA	CASSIGRNYNEQFF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	8	3	5	3	19	31	39	36	42	TCRBV03,TCRBV07					01,02								CASSIGRNYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTGCTATTCTTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	42	6.706051413060834E-4		50	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	9	0	5	15	3	26	38	56	53	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGACAGCTGGAGCACAGATACGCAGTATTTTGGCCCA	CSARGDSWSTDTQYF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	0	2	4	26	37	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSARGDSWSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAGTGGGCTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSEWASGTDTQYF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	3	7	0	22	34	-1	41	49	TCRBV09,TCRBV12					01,02								CASSEWASGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTACGCCCACCTTACACTGAAGCTTTCTTTGGACAA	CASSLRPPYTEAFF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	6	3	7	3	2	9	24	36	40	38	49	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPPYTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGCGGACTCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRGLAYNEQFF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	10	2	4	2	18	35	44	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDRGLAYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGGTCCGACAGGGGCGTACGAGCAGTACTTCGGGCCG	CASSQGPTGAYEQYF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	4	6	2	23	37	51	43	53	TCRBV01,TCRBV04													CASSQGPTGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGACGCGCCTCTCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	6.865719303847997E-4		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	9	11	0	26	37	-1	48	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGCGGAAGGGGCACAGATACGCAGTATTTTGGCCCA	XASSRGRGTDTQYF	In	VDJ	1	43	6.865719303847997E-4	8.4764138855487E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	4	5	3	1	5	0	23	36	-1	41	45	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSRGRGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCGGTCGGGACAGGGACTCAACAATCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	6.865719303847997E-4		52				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	6	4	11	22	34	47	38	58	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACACTAGCGGGGGGGACAATGAGCAGTTCTTCGGGCCA	CASSQDTSGGDNEQFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	5	1	0	26	43	-1	44	57		TCRBV03-01,TCRBV03-02												CASSQDTSGGDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCTCCACTTTTCCCCGGTCCCCTACGAGCAGTACTTCGGGCCG	CASSQGLHFSPVPYEQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	54	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	9	0	2	0	18	26	-1	45	42	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGLHFSPVPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGGGGATGCCGGGGAGCTGTTTTTTGGAGAA	CSARDTGDAGELFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	2	6	1	3	26	40	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDTGDAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGAGGTCACAGATACGCAGTATTTTGGCCCA	CSVEVTDTQYF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	11	1	2	2	1	26	33	39	35	40		TCRBV20-01,TCRBV20-or09_02												CSVEVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACAGGGAGTGAAAAACTGTTTTTTGGCAGT	CASSPGTGSEKLFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	3	2	24	36	48	39	50		TCRBV24-01,TCRBV24-or09_02												CASSPGTGSEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGTCGACCAGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGSTSNTGELFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	3	2	0	9	26	-1	44	39	53		TCRBV03-01,TCRBV03-02												CASSPGSTSNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGGACAGGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSLGQGANEKLFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	1	3	2	0	26	39	-1	41	51		TCRBV03-01,TCRBV03-02												CASSLGQGANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGGGGACCCCTGTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGRGPLSYNEQFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	1	2	7	26	35	43	37	50		TCRBV20-01,TCRBV20-or09_02												CSAGRGPLSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCTTAGCGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLSGPSYNEQFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	4	0	2	2	24	39	48	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLSGPSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCTGACAGGGGAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQALTGESSGANVLTF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	2	2	0	4	4	24	40	52	44	56		TCRBV03-01,TCRBV03-02												CASSQALTGESSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGDSSYNEQFF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	3	0	8	0	0	3	23	-1	40	36	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CASSGDSSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAATGGGCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSEWASGSTDTQYF	In	VDJ	2	45	7.185055085422321E-4	8.870665694178872E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	0	8	0	23	34	-1	42	50	TCRBV09,TCRBV12					01,02								CASSEWASGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTTTGGAGGAGCCACTGAAGCTTTCTTTGGACAA	CASSFGGATEAFF	In	VDJ	2	46	7.344722976209484E-4	9.067791598493958E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	4	1	3	22	36	42	37	45	TCRBV09,TCRBV12													CASSFGGATEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACAGGAGGGCAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	47	7.504390866996647E-4		37	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	10	0	6	2	3	24	34	42	36	45	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTATACAGATCGGACTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	47	7.504390866996647E-4		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	6	10	0	24	37	-1	47	61	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGATCGGGTGACTTACTATACGAGCAGTACTTCGGGCCG	CATSDRSGDLLYEQYF	In	VDJ	2	47	7.504390866996647E-4	9.264917502809045E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	4	10	5	24	38	52	48	57		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDRSGDLLYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGATCGACAGGCAGTAATGAAAAACTGTTTTTTGGCAGT	CASGSTGSNEKLFF	In	VDJ	2	47	7.504390866996647E-4	9.264917502809045E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	4	4	5	3	23	32	43	37	46	TCRBV06,TCRBV10													CASGSTGSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGTCTCTGGATGGGGCTACACCTTCGGTTCG	CSARVVSGWGYTF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	1	8	8	8	3	26	39	50	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVVSGWGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGGGTGTTCCCCGAGAAGGGCAGTTCTTCGGGCCA	CSARLGVPREGQFF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	0	9	12	2	15	26	38	43	40	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGVPREGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACACCTGGGACAGTTTACCGAACACTGAAGCTTTCTTTGGACAA	CSASHTWDSLPNTEAFF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	1	8	6	26	37	52	45	58		TCRBV20-01,TCRBV20-or09_02												CSASHTWDSLPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTAAGGGGCTCAACACTGAAGCTTTCTTTGGACAA	CASSLSKGLNTEAFF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	2	7	3	24	36	48	43	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSKGLNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTACCGTTGCGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLPLRGQETQYF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	3	1	8	0	23	35	-1	43	49	TCRBV06,TCRBV10													CASSLPLRGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTGGGACAGGGAGGGCGAGCAGTACTTCGGGCCG	CSATWDREGEQYF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	6	3	4	26	36	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSATWDREGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGACTACAATGAGCAGTTCTTCGGGCCA	CSARGLADYNEQFF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	5	3	0	1	26	-1	48	39	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLADYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCCGACCGGCCTCCACAGATACGCAGTATTTTGGCCCA	CASSSRPASTDTQYF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	2	7	2	3	7	19	32	38	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRPASTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTCAGATTACTGAACACTGAAGCTTTCTTTGGACAA	CASSFRLLNTEAFF	In	VDJ	2	50	7.983394539358135E-4	9.856295215754302E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	0	0	5	19	-1	36	33	41	TCRBV05,TCRBV07													CASSFRLLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGCAACTAGCGGGAGGGCTTCATGAGCAGTTCTTCGGGCCA	CSAPQLAGGLHEQFF	In	VDJ	2	51	8.143062430145298E-4	0.0010053421120069389	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	0	8	5	4	26	35	53	40	57		TCRBV20-01,TCRBV20-or09_02												CSAPQLAGGLHEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACGACTAGCGGGAGGGCCCAACGAGCAGTACTTCGGGCCG	CASSPRLAGGPNEQYF	In	VDJ	2	51	8.143062430145298E-4	0.0010053421120069389	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	0	5	4	4	24	36	54	40	58		TCRBV24-01,TCRBV24-or09_02												CASSPRLAGGPNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGACTAGCGTTGAGCAATGAGCAGTTCTTCGGGCCA	CSAKGLALSNEQFF	In	VDJ	2	52	8.30273032093246E-4	0.0010250547024384475	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	6	3	5	26	34	47	37	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKGLALSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTAGCGGGGTTCACAATGAGCAGTTCTTCGGGCCA	CASSEFSGVHNEQFF	In	VDJ	2	53	8.462398211719623E-4	0.001044767292869956	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	3	5	2	3	23	38	48	40	51		TCRBV06-01,TCRBV06-08												CASSEFSGVHNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
RGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTACCCTAAGATTCAGCAAGACCCCCTGGCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	53	8.462398211719623E-4		59	unresolved						TCRBJ02	TCRBJ02-03	01	5	2	7	3	18	9	22	33	54	51	63	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTCGGGACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSQVGTSGYNEQFF	In	VDJ	2	54	8.622066102506786E-4	0.0010644798833014646	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	3	4	0	26	40	-1	44	55		TCRBV03-01,TCRBV03-02				01,02								CASSQVGTSGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTACGACTAGCGGGGGTAACACAGATACGCAGTATTTTGGCCCA	CASSTTSGGNTDTQYF	In	VDJ	2	54	8.622066102506786E-4	0.0010644798833014646	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	2	2	3	22	34	48	36	51		TCRBV12-03,TCRBV12-04												CASSTTSGGNTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGAGGGGCAGGCGGGGAGCTGTTTTTTGGAGAA	CASSQGRGAGGELFF	In	VDJ	2	56	8.941401884081111E-4	0.0011039050641644817	45	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	5	2	7	4	4	26	42	51	46	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRGAGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTGGCTAGCGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSPLASGVTDTQYF	In	VDJ	2	56	8.941401884081111E-4	0.0011039050641644817	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	6	3	26	39	52	45	55		TCRBV03-01,TCRBV03-02				01,02								CASSPLASGVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGACTAGCGGGAGCAACTCCAGATGGGGGGACCCAGTACTTCGGGCCA	CASSQRLAGATPDGGTQYF	In	VDJ	2	56	8.941401884081111E-4	0.0011039050641644817	57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	2	2	7	1	16	24	39	52	40	68		TCRBV03-01,TCRBV03-02												CASSQRLAGATPDGGTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGCGGGGCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQEGGAANTEAFF	In	VDJ	2	57	9.101069774868274E-4	0.0011236176545959904	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	1	2	4	26	43	51	45	55		TCRBV03-01,TCRBV03-02												CASSQEGGAANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTAGCGCCCGGGGAGCTGTTTTTTGGAGAA	CASSLALAPGELFF	In	VDJ	2	58	9.260737665655437E-4	0.001143330245027499	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	6	6	1	1	18	35	42	36	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALAPGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATCCTAGCGGGACGTGAGACGAGCAGTACTTCGGGCCG	CATNPSGT*DEQYF	Stop	VDJ	2	59	9.4204055564426E-4		42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	4	3	5	3	6	24	34	46	37	52		TCRBV24-01,TCRBV24-or09_02												CATNPSGT*DEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTCCGGGACAGGGAAGGCGCGAGCAGTACTTCGGGCCG	CSARSPGQGRREQYF	In	VDJ	2	60	9.580073447229762E-4	0.0011827554258905162	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	6	5	6	26	38	52	43	58		TCRBV20-01,TCRBV20-or09_02												CSARSPGQGRREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGTAGCCTCCATAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	62	9.899409228804087E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	7	4	3	12	26	38	45	41	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCCGGGATCCTACGAGCAGTACTTCGGGCCG	CASSQEPGSYEQYF	In	VDJ	2	62	9.899409228804087E-4	0.0012221806067535335	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	1	2	0	26	43	-1	45	50		TCRBV03-01,TCRBV03-02												CASSQEPGSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGCCTGGGCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CATSDLGLGLAKNIQYF	In	VDJ	2	62	9.899409228804087E-4	0.0012221806067535335	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	8	0	0	5	2	24	42	51	47	53		TCRBV24-01,TCRBV24-or09_02												CATSDLGLGLAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGACCAGCGGAGCAAAGGTCGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	63	0.001005907711959125		50	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	5	8	8	12	24	35	48	43	60		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCAGTAAGCCTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	63	0.001005907711959125		43							TCRBJ01	TCRBJ01-04	01	3	4	5	4	1	7	18	31	35	32	42	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04			TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTAAGGGACAGGGGGCCGGGGGTGACCAGTACTTCGGGCCG	CASSKGQGAGGDQYF	In	VDJ	2	63	0.001005907711959125	0.0012418931971850422	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	10	3	10	24	35	50	38	60	TCRBV02,TCRBV21													CASSKGQGAGGDQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCAGGGGGAATGTTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGGMFSYNEQFF	In	VDJ	2	67	0.0010697748682739901	0.0013207435589110766	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	1	0	7	26	-1	49	43	56		TCRBV12-03,TCRBV12-04												CASSLAGGMFSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGGGACCTTGGAGTTTCGACAGACACTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	67	0.0010697748682739901		58	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	0	7	0	1	22	23	34	40	35	62		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGTTCTGGAGGGAGGAATGAGCAGTTCTTCGGGCCA	CASSFGSGGRNEQFF	In	VDJ	2	67	0.0010697748682739901	0.0013207435589110766	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	7	12	0	24	36	-1	48	54		TCRBV24-01,TCRBV24-or09_02												CASSFGSGGRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGGGGTTCAGGTGGTAACTATGGCTACACCTTCGGTTCG	XASRGSGGNYGYTF	In	VDJ	2	68	0.0010857416573527064	0.001340456149342585	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	1	5	3	23	34	43	39	46	TCRBV01,TCRBV17													XASRGSGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTAGGGCCGGGGGAGACCCAGTACTTCGGGCCA	CSASLGPGETQYF	In	VDJ	2	69	0.0011017084464314227	0.0013601687397740937	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	3	5	8	0	26	37	-1	45	50		TCRBV20-01,TCRBV20-or09_02												CSASLGPGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAAGACGTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDVSSYNEQFF	In	VDJ	2	71	0.0011336420245888553	0.001399593920637111	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	2	7	0	4	5	26	34	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEDVSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTCAGCGGAGGTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	71	0.0011336420245888553		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	7	6	5	0	4	4	24	35	44	39	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAAAGGGGTCTCTGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	73	0.0011655756027462876		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	5	2	1	3	6	26	38	46	41	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAATAGCGGGAGGTGTGACAGATACGCAGTATTTTGGCCCA	CASSQIAGGVTDTQYF	In	VDJ	3	73	0.0011655756027462876	0.0014390191015001281	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	1	3	4	4	18	30	44	34	48	TCRBV05,TCRBV11													CASSQIAGGVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGTGCTTTCGTGTTAGACGAGCAGTACTTCGGGCCG	CASSSAFVLDEQYF	In	VDJ	3	74	0.001181542391825004	0.0014587316919316368	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	13	0	26	38	-1	51	54		TCRBV03-01,TCRBV03-02				01,02								CASSSAFVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCACCTCACCGGACTTAGCACAGATACGCAGTATTTTGGCCCA	CASSHLTGLSTDTQYF	In	VDJ	3	75	0.0011975091809037202	0.0014784442823631454	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	10	0	9	1	24	36	50	45	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSHLTGLSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGCCACTAGCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSATSGYQETQYF	In	VDJ	3	79	0.0012613763372185853	0.0015572946440891799	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	4	0	4	1	23	34	47	38	48	TCRBV02,TCRBV21					01,02								CASSATSGYQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGACAGCGGGAGGGCATCCTACGAGCAGTACTTCGGGCCG	CSAPDSGRASYEQYF	In	VDJ	3	80	0.0012773431262973016	0.0015770072345206883	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	0	1	7	2	26	34	51	41	53		TCRBV20-01,TCRBV20-or09_02												CSAPDSGRASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTGTCCCGGTGGATGAGCAGTTCTTCGGGCCA	CASSLVPVDEQFF	In	VDJ	3	81	0.001293309915376018	0.001596719824952197	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	5	8	6	3	23	36	45	42	48	TCRBV01,TCRBV04					01,02								CASSLVPVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTCTTACGAGCAGTACTTCGGGCCG	CASSHSYEQYF	In	VDJ	3	81	0.001293309915376018	0.001596719824952197	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	10	4	2	0	26	40	-1	42	44		TCRBV03-01,TCRBV03-02				01,02								CASSHSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGACTAGCGGGAGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQGGLAGEAGELFF	In	VDJ	3	85	0.001357177071690883	0.0016755701866782314	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	0	2	6	1	3	26	42	57	43	60		TCRBV03-01,TCRBV03-02												CASSQGGLAGEAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAAAAGGACAGGGTGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	87	0.0013891106498483156		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	4	5	4	24	39	52	44	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTCCCAAGAGGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFPRGTVNTGELFF	In	VDJ	3	89	0.001421044228005748	0.0017544205484042658	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	5	1	7	1	18	32	46	39	47	TCRBV07,TCRBV11													CASSFPRGTVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACGACTAGCGGGAGGGCCGAGGTTCCCACAGATACGCAGTATTTTGGCCCA	CASSTTSGRAEVPTDTQYF	In	VDJ	3	90	0.0014370110170844642	0.0017741331388357745	57	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	0	2	3	10	24	35	52	38	62		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTTSGRAEVPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCGGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSLAGGGETQYF	In	VDJ	3	93	0.001484911384320613	0.0018332709101303002	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	0	4	1	2	24	36	48	37	50		TCRBV24-01,TCRBV24-or09_02												CASSLAGGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
SGACTCGGCYRTGTATCTCTGTGCCAGAAGCTTACAGGCTAAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	3	95	0.0015168449624780457		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	4	0	5	19	-1	38	34	43	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGCCCTCTGGACTAGTGGGTGGTGAGACCCAGTACTTCGGGCCA	CSASPSGLVGGETQYF	In	VDJ	3	96	0.001532811751556762	0.001892408681424826	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	8	5	9	8	26	35	51	44	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPSGLVGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGAGGGCAGGGATAATGAAAAACTGTTTTTTGGCAGT	CSAREGRDNEKLFF	In	VDJ	3	99	0.0015807121187929108	0.0019515464527193518	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	4	3	4	9	1	26	34	48	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGRDNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGCTGGGGGCCCCGATATGGACACTGAAGCTTTCTTTGGACAA	CASSEAGGPDMDTEAFF	In	VDJ	3	100	0.001596678907871627	0.0019712590431508604	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	3	7	10	23	34	47	41	57	TCRBV02,TCRBV09													CASSEAGGPDMDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGACCCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDPSSYNEQFF	In	VDJ	4	103	0.001644579275107776	0.0020303968144453864	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	8	0	7	0	26	35	-1	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEDPSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGCCAGCCCAAAGGTGGATAAGCCCTAAACATCCCGGGGACTAGCGGGAGGGCCTCAGACCCAGTACTTCGGGCCA	CASPKVDKP*TSRGLAGGPQTQYF	Stop	VDJ	4	106	0.0016924796423439246		72				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	0	0	6	29	4	-1	7	52	36	56	TCRBV06,TCRBV12	TCRBV06-01,TCRBV06-02,TCRBV06-03,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV12-03,TCRBV12-04												CASPKVDKP*TSRGLAGGPQTQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGAGGCCTGGGGACTGAAGCTTTCTTTGGACAA	CSARDRGGLGTEAFF	In	VDJ	4	112	0.0017882803768162223	0.0022078101283289635	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	1	5	3	7	26	40	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDRGGLGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCACGGACTAGACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	4	127	0.002027782212996966		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	1	8	2	6	1	26	38	51	44	52		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAATCAGGACAGGGGAATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	129	0.0020597157911543987		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	0	5	4	26	36	50	41	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTGGGCGACAGTCAATGAGCAGTTCTTCGGGCCA	CASSWATVNEQFF	In	VDJ	5	131	0.0020916493693118312	0.002582349346527627	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	6	6	1	20	31	42	37	43	TCRBV07,TCRBV23													CASSWATVNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACTAGCGGGAGGTTACAATGAGCAGTTCTTCGGGCCA	CASSQVLAGGYNEQFF	In	VDJ	5	134	0.0021395497365479803	0.002641487117822153	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	1	4	1	1	26	42	55	43	56		TCRBV03-01,TCRBV03-02												CASSQVLAGGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATGGACGGGACAGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSAWTGQGGNTEAFF	In	VDJ	5	149	0.0023790515727287243	0.002937175974294782	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	1	6	1	26	34	51	40	52		TCRBV20-01,TCRBV20-or09_02												CSAWTGQGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCTTAGTTGAAGTTGGCGAGCAGTACTTCGGGCCG	CASSLVEVGEQYF	In	VDJ	5	156	0.002490819096279738	0.0030751641073153424	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	0	10	6	8	0	22	38	-1	46	48	TCRBV03,TCRBV07			TCRBD01,TCRBD02										CASSLVEVGEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGGGGGTACTACCCGGGCGGGGACCCAGTACTTCGGGCCA	CASGGTTRAGTQYF	In	VDJ	6	158	0.0025227526744371707	0.0031145892881783597	42	unresolved						TCRBJ02	TCRBJ02-05	01	8	6	1	7	0	15	23	-1	37	32	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGGTTRAGTQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCTGAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	6	159	0.0025387194635158867		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	1	0	5	0	23	35	-1	40	44	TCRBV09,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAGTATCAATAGGGGGGGAGGATGAAAAACTGTTTTTTGGCAGT	CSARRVSIGGEDEKLFF	In	VDJ	6	164	0.0026185534089094684	0.0032328648307674113	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	9	0	6	12	3	26	38	57	50	60		TCRBV20-01,TCRBV20-or09_02												CSARRVSIGGEDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
TTCTGTGCCAGCAGTTGGTTACTCACCCGGGACTAGCGGGAGGGCCGTCACAGAGAGACCCAGTACTTCGGGCCA	CASSWLLTRD*REGRHRETQYF	Stop	VDJ	6	172	0.0027462877215391986		66	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	0	4	13	9	3	15	44	28	53		TCRBV24-01,TCRBV24-or09_02												CASSWLLTRD*REGRHRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGACGTCACGCGAGCAGTACTTCGGGCCG	CASSQETSREQYF	In	VDJ	6	175	0.0027941880887753473	0.0034497033255140057	39	unresolved						TCRBJ02	TCRBJ02-07	01	0	2	7	6	0	6	23	-1	43	40	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQETSREQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTGACAGGGGGAACGAACACTGAAGCTTTCTTTGGACAA	CSALTGGTNTEAFF	In	VDJ	6	181	0.002889988823247645	0.0035679788681030576	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	3	3	26	34	46	37	49		TCRBV20-01,TCRBV20-or09_02												CSALTGGTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTGTCTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLLSSGYNEQFF	In	VDJ	7	190	0.0030336899249560913	0.0037453921819866347	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	3	5	0	26	40	-1	45	52		TCRBV12-03,TCRBV12-04				01,02								CASSLLSSGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGATGAGGACAGGGACCCTACGAGCAGTACTTCGGGCCG	CASSPG*GQGPYEQYF	Stop	VDJ	7	192	0.003065623503113524		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	9	2	18	30	47	39	49	TCRBV07,TCRBV11													CASSPG*GQGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCGGACAGGGTAGCTATGGCTACACCTTCGGTTCG	CSAPGQGSYGYTF	In	VDJ	7	214	0.0034168928628452817	0.004218494352342841	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	4	4	3	26	34	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPGQGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTATTCGGACACAAACAATGAGCAGTTCTTCGGGCCA	CASSFYSDTNNEQFF	In	VDJ	8	216	0.0034488264410027143	0.004257919533205859	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	6	5	6	3	26	40	51	46	54		TCRBV12-03,TCRBV12-04												CASSFYSDTNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTAGCGGGAGTGCGTTAGAGCAGTACTTCGGGCCG	CASSSSGSALEQYF	In	VDJ	15	420	0.006706051413060833	0.008279287981233613	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	7	1	7	24	36	47	37	54		TCRBV24-01,TCRBV24-or09_02												CASSSSGSALEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGAGACAGGCGGACGAGCAGTACTTCGGGCCG	CSARRQADEQYF	In	VDJ	19	540	0.008622066102506785	0.010644798833014647	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	5	5	3	26	34	45	39	48		TCRBV20-01,TCRBV20-or09_02												CSARRQADEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGTAGAGACCCAGTACTTCGGGCCA	CASSQEVETQYF	In	VDJ	31	893	0.014258342647293629	0.017603343255337182	36	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	0	10	4	0	1	26	-1	45	43	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTGGGGCAGGGGGCTGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLWGRGLTNEKLFF	In	VDJ	57	1648	0.026313268401724415	0.03248634903112618	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	0	2	6	2	26	40	54	46	56		TCRBV12-03,TCRBV12-04												CASSLWGRGLTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGACAATCTACACAAATCCCGAGTTCTTCGGGCCA	CASSPTIYTNPEFF	In	VDJ	153	4388	0.070062270477407	0.08649884681345976	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	6	14	1	16	23	36	41	37	57	TCRBV01,TCRBV04													CASSPTIYTNPEFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCACGTAGCGGGAGCTTTGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	1.4370110170844642E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	6	6	5	23	34	49	40	54														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGATACAGGGCCTCTAACACTGAAGCTTTCTTTGGACAA	CASRGYRASNTEAFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	2	5	5	23	34	45	39	50														CASRGYRASNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGATTTACGGGCATGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	1.4370110170844642E-4		52	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	8	0	1	9	3	23	40	53	49	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGGCGACCTACAATGAGCAGTTCTTCGGGCCA	CASSYQGATYNEQFF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	2	0	2	23	-1	46	38	48														CASSYQGATYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCCTCACTATGGCTACACCTTCGGTTCG	CASSYGPHYGYTF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	3	0	3	23	-1	42	38	45														CASSYGPHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGGGCGGGGCGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CAIGGGATGANVLTF	In	VDJ	1	9	1.4370110170844642E-4	1.7741331388357743E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	10	6	0	2	2	7	23	30	38	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIGGGATGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAACCTCGGACAGGGGGACCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKTSDRGTPNTGELFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	1	0	7	4	23	33	50	40	54														CASKTSDRGTPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAATTCCCGGATACGCAGTATTTTGGCCCA	CASREFPDTQYF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	1	8	6	0	7	23	-1	37	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREFPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCAGTTTGGGGGGAACCCCCCCGCCGAGCAGTACTTCGGGCCG	CASRPQFGGNPPAEQYF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	1	6	10	11	23	34	50	44	61														CASRPQFGGNPPAEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.7563467986587896E-4		37	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	1	8	0	0	4	23	-1	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGCATAACAATGAGCAGTTCTTCGGGCCA	CASSRHNNEQFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	9	0	5	1	3	23	35	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRHNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGTTACTCGCGAGACAGGGGAGTTTAAGCTTTCTTTGGACAA	CASSYSRDRGV*AFF	Stop	VDJ	1	11	1.7563467986587896E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	9	4	5	23	40	52	44	57														CASSYSRDRGV*AFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGGTGGGGAGCTGTTTTTTGGAGAA	CASSYWGGELFF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	1	6	2	8	0	1	23	-1	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGAGGGCCGCCATCCTACGAGCAGTACTTCGGGCCG	CAISRGPPSYEQYF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	1	2	6	23	34	41	36	47														CAISRGPPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGACTAGCGGGAGGGCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.075682580233115E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	0	0	4	2	23	34	52	38	54														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAGTTACTCCGGCTAGCGGGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	2.2353504710202778E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	3	4	3	0	23	40	-1	43	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATCCCCCGTGGACTAGCGGGATGGATGAGCAGTTCTTCGGGCCA	CASNPPWTSGMDEQFF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	1	3	8	9	3	23	33	54	42	57														CASNPPWTSGMDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTTGGACTAGCGGGAACCTCCTACGAGCAGTACTTCGGGCCG	CASRFGLAGTSYEQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	3	0	4	2	23	34	50	38	52														CASRFGLAGTSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGACAGGTAGGGGAGTTACCGCATTTTGGTGAT	CASSDGQVGELPHF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	15	3	13	23	35	45	38	58														CASSDGQVGELPHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGAGTCTCCAAGAGACCCAGTACTTCGGGCCA	CASSGSLQETQYF	In	VDJ	1	14	2.2353504710202778E-4	2.7597626604112044E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	2	1	0	3	23	-1	40	35	43														CASSGSLQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACGCACGGGGCACTGAAGCTTTCTTTGGACAA	CASNARGTEAFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	4	5	0	23	33	-1	38	43														CASNARGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTCTAAGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSRLRGSYEQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	0	6	0	23	35	-1	41	46														CASSRLRGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGACAACGCTTATATGGCTACACCTTCGGTTCG	CASSAGQRLYGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	6	5	2	7	23	35	43	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGQRLYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTGGGGAGGGGCGCAGGATGAGCAGTTCTTCGGGCCA	CASSVWGGAQDEQFF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	8	5	7	23	35	47	40	54														CASSVWGGAQDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAGGCGGGGATGGCTACACCTTCGGTTCG	CASSYTGGDGYTF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	3	6	4	0	23	38	-1	42	48														CASSYTGGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCCGGTGCAGCAGATACGCAGTATTTTGGCCCA	CASSYSGAADTQYF	In	VDJ	1	15	2.3950183618074404E-4	2.9568885647262904E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	3	4	5	4	8	0	23	37	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGAADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCATTCGGGTCGTTGGAAACACCATATATTTTGGAGAG	CASSPIRVVGNTIYF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	4	3	6	4	23	35	45	41	49						01,02								CASSPIRVVGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGACAGGGGTAGGCTACACCTTCGGTTCG	CASSVGTGVGYTF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	8	3	2	23	35	48	38	50														CASSVGTGVGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATTGGGGGGGTAGGAACTGAAGCTTTCTTTGGACAA	CASSYSIGGVGTEAFF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	5	4	5	23	40	51	44	56														CASSYSIGGVGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCAGGGACGGACGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	2.714354143381766E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	0	0	7	8	3	4	23	40	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGACTAGCGGGGGGGTCGCGTTCTTCGGGCCA	CASSPGTSGGVAFF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	15	4	4	23	34	54	38	58														CASSPGTSGGVAFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACAGGGGGTTGATACGCAGTATTTTGGCCCA	CASSRQGVDTQYF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	6	1	2	23	35	45	36	47														CASSRQGVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATGCCTGACGGGACCCCGAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	2.8740220341689284E-4		56	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	2	0	7	2	10	7	23	38	53	48	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCATCTTTGGACGGGAATCAGCCCCAGCATTTTGGTGAT	CASSYSPSLDGNQPQHF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	1	7	4	9	3	23	40	53	49	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPSLDGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGTTAGGGATGCGCGAGGAGAAAGGATGAGCAGTTCTTCGGGCCA	CASKG*GCARRKDEQFF	Stop	VDJ	1	20	3.193357815743254E-4		51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	0	8	8	7	16	23	33	44	40	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKG*GCARRKDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCCCCATCGGACAGGTCTACGGGCTGGCTACACCTTCGGTTCG	CASSSPHRTGLRAGYTF	In	VDJ	1	20	3.193357815743254E-4	3.942518086301721E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	7	9	9	23	36	52	45	61														CASSSPHRTGLRAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCAGCTTCGAGAGACCCAGTACTTCGGGCCA	CASSPQLRETQYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	4	5	4	3	5	23	35	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQLRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGTTAAACTCAATGAGCAGTTCTTCGGGCCA	CASSYVVKLNEQFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	10	6	8	0	23	38	-1	46	49						01,02								CASSYVVKLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCTACTCTATGAGCAGTTCTTCGGGCCA	CASSYLLYEQFF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	10	8	3	2	23	37	43	40	45						01,02								CASSYLLYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGTGGACAGGGGGAAGTATGGGTGGCTACACCTTCGGTTCG	CAISPWTGGSMGGYTF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	7	4	9	23	35	49	39	58														CAISPWTGGSMGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTGCCACCTCTGGAAACACCATATATTTTGGAGAG	CAISGATSGNTIYF	In	VDJ	1	21	3.353025706530417E-4	4.139643990616807E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	0	10	0	0	6	23	-1	37	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGATSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCACAGCGGGAGGGCCCTCTTATCTACGAGCAGTACTTCGGGCCG	CASSSQREGPLIYEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	0	3	5	9	23	34	49	39	58														CASSSQREGPLIYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACAGAGAACTATGGCTACACCTTCGGTTCG	CASSETENYGYTF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	2	2	2	23	35	42	37	44														CASSETENYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAGAAGGACTAGGGGGCACAGATACGCAGTATTTTGGCCCA	CAIREGLGGTDTQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	8	1	4	3	23	34	45	38	48						01,02								CAIREGLGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAACCGGGACTAGCGGGAGCTGTCTACAATGAGCAGTTCTTCGGGCCA	CASEPGLAGAVYNEQFF	In	VDJ	1	23	3.672361488104742E-4	4.533895799246979E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	2	3	5	4	23	32	51	37	55														CASEPGLAGAVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTAGCGGGAGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	3.672361488104742E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	5	1	0	1	0	23	32	-1	33	43														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCAGACCGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRPDRSSYNEQFF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	2	7	0	4	5	23	34	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPDRSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGGGATACTATGGCTACACCTTCGGTTCG	CASSPGGYYGYTF	In	VDJ	1	24	3.832029378891905E-4	4.731021703562065E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	2	3	3	2	23	34	43	37	45														CASSPGGYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCCGGGACAGGGTTACGAGCAGTACTTCGGGCCG	CASSTPGQGYEQYF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	5	1	23	35	49	40	50														CASSTPGQGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGTCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSPNTGELFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	5	5	0	0	2	23	-1	37	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCTACTGGAGAGGCTAGCGGTACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	3.9916972696790677E-4		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	2	14	2	23	35	56	49	58						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGCGATGACAGTAGGGACCTTCGGTTCG	CASSYSAMTVGTF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	14	6	5	23	40	51	46	56														CASSYSAMTVGTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGGCCAGGGTCATGAGCAGTTCTTCGGGCCA	CASSSGQGHEQFF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	8	5	2	23	36	46	41	48														CASSSGQGHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGACGGGGGCCGGGTGAACTATGGCTACACCTTCGGTTCG	CASDGGRVNYGYTF	In	VDJ	1	25	3.9916972696790677E-4	4.928147607877151E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	9	6	0	2	4	6	23	31	41	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASDGGRVNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACTTCTAGCGCCACAGATACGCAGTATTTTGGCCCA	CASRTSSATDTQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	6	2	5	1	23	34	45	39	46						01,02								CASRTSSATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAACTGGCAGGGATCCCAGCCCCAGCATTTTGGTGAT	CASSYSNWQGSQPQHF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	7	7	4	23	40	52	47	56														CASSYSNWQGSQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCTAGAGACCCAGTACTTCGGGCCA	CASSYPLETQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	10	4	1	2	23	38	41	39	43						01,02								CASSYPLETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAAGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSDSKGSTDTQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	5	3	0	2	1	23	40	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSKGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAISAGSGANVLTF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	7	4	0	0	0	23	-1	-1	35	40						01,02								CAISAGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAATCATACACGGGACAGGGTCACGAGCAGTACTTCGGGCCG	CASSQSYTGQGHEQYF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	12	2	23	34	55	46	57														CASSQSYTGQGHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	30	4.790036723614881E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	2	4	0	5	0	23	33	-1	38	48						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATAAAGTTCGAGGACACTGAAGCTTTCTTTGGACAA	CASSIKFEDTEAFF	In	VDJ	1	30	4.790036723614881E-4	5.913777129452581E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	3	9	0	23	35	-1	44	48														CASSIKFEDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGACTAGCGGGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	4.790036723614881E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	3	3	1	0	23	38	-1	39	51														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	4.949704614402044E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	6	0	0	1	23	-1	40	38	41														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGACAGGGAAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	5.109372505189206E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	6	2	3	23	34	43	36	46														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCACGGGACAGGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSATGQGAGANVLTF	In	VDJ	1	33	5.269040395976369E-4	6.50515484239784E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	3	2	5	2	23	35	49	40	51														CASSATGQGAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGACAGTTTGAACACTGAAGCTTTCTTTGGACAA	CASNDSLNTEAFF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	5	0	2	2	23	33	40	35	42														CASNDSLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGCCGGGACTCCACAGATACGCAGTATTTTGGCCCA	CASCRDSTDTQYF	In	VDJ	1	34	5.428708286763532E-4	6.702280746712925E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	10	2	4	1	23	32	42	36	43						01,02								CASCRDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACTAGCGGGAGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRLAGGNTGELFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	2	1	2	1	1	23	35	49	36	50														CASSRLAGGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCATGGCGACGAGCAGTACTTCGGGCCG	CASSYSHGDEQYF	In	VDJ	1	36	5.748044068337857E-4	7.096532555343097E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	9	0	5	4	1	23	40	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSHGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGGGAGGGAGATACAGATACGCAGTATTTTGGCCCA	CASSPGEGDTDTQYF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	3	4	4	23	35	46	39	50														CASSPGEGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACCAGGCGGCAGGGTTTGGCTACACCTTCGGTTCG	CASSYDQAAGFGYTF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	7	10	2	23	38	53	48	55														CASSYDQAAGFGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	39	6.227047740699345E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	5	3	2	0	23	38	-1	40	43						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACGAGGTCGGTCGGGCGCGGATATGGCTACACCTTCGGTTCG	CASSYSTRSVGRGYGYTF	In	VDJ	1	39	6.227047740699345E-4	7.687910268288356E-4	54	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	8	0	5	13	5	23	40	57	53	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTRSVGRGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCGGGACAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	6.386715631486508E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	1	4	0	23	37	-1	41	48														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCGCTGGGAGAACTGAAGCTTTCTTTGGACAA	CAISAAGRTEAFF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	5	6	1	23	35	46	41	47														CAISAAGRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRTGANVLTF	In	VJ	2	44	7.025387194635158E-4	8.673539789863786E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	6	0	0	2	0	2	23	-1	34	-1	36														CASRTGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGAAGCGAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPEASSNQPQHF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	6	6	0	6	2	23	34	44	40	46						01,02								CASSPEASSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAACCCCGTATTGGGATACGCAGTATTTTGGCCCA	CASSLTPYWDTQYF	In	VDJ	2	57	9.101069774868274E-4	0.0011236176545959904	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	0	10	6	12	0	23	36	-1	48	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPYWDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGACACAGGCCCGAATGAGCAGTTCTTCGGGCCA	CASSYEDTGPNEQFF	In	VDJ	2	60	9.580073447229762E-4	0.0011827554258905162	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	6	7	2	8	23	38	45	40	53														CASSYEDTGPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCCAAAGTAGGGGGCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	62	9.899409228804087E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	5	0	2	9	0	23	30	-1	39	46														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACACGGGGGGTTCCGGGACAGAACCTACGAGCAGTACTTCGGGCCG	CASRHGGFRDRTYEQYF	In	VDJ	2	64	0.0010218745010378413	0.0012616057876165506	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	5	2	14	2	23	34	55	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRHGGFRDRTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGAACAGGCGCAAAGGGCTGAAGCTTTCTTTGGACAA	CASTEQAQRAEAFF	In	VDJ	3	79	0.0012613763372185853	0.0015572946440891799	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	4	6	4	9	23	33	42	37	51														CASTEQAQRAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCAAGTGTCAGTATAAGTGGCTACACCTTCGGTTCG	CAISASVSISGYTF	In	VDJ	3	99	0.0015807121187929108	0.0019515464527193518	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	5	7	8	6	23	35	46	43	52														CAISASVSISGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTGGACAGGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASTWTGSTGELFF	In	VDJ	4	115	0.0018361807440523711	0.0022669478996234895	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	3	4	3	2	23	33	44	36	46														CASTWTGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTCTACGGCGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVYGGNTGELFF	In	VDJ	6	167	0.002666453776145617	0.003292002602061937	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	5	2	8	1	23	34	46	42	47						01,02								CASSVYGGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGAATAGCGTCTCCATATGAGCAGTTCTTCGGGCCA	CASSPRIASPYEQFF	In	VDJ	6	183	0.0029219224014050776	0.0036074040489660745	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	8	7	7	23	35	47	42	54						01,02								CASSPRIASPYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACTCCCGGGATAAATTACGAGCAGTACTTCGGGCCG	CASSVTPGINYEQYF	In	VDJ	7	202	0.0032252913939006867	0.003981943267164738	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	4	8	5	23	35	48	43	53														CASSVTPGINYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAAAGGTAGGGGGCGCGACCGCACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	9	268	0.004279099473095961		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	5	0	0	8	8	23	33	48	41	56														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGGGGGCTCTTGGGGCGGCCTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	9	1.4370110170844642E-4		59	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	1	6	0	1	2	14	22	38	46	40	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACTACCCATGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	1.596678907871627E-4		49	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	9	4	0	8	24	-1	46	39	54						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTAGGGTCGGGTTGGGACAAAGCTTTCTTTGGACAA	CASSPLGSGWDKAFF	In	VDJ	1	10	1.596678907871627E-4	1.9712590431508604E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	9	14	0	24	38	-1	52	58													Vb 18	CASSPLGSGWDKAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGTACTGAACACTGAAGCTTTCTTTGGACAA	CASSLVLNTEAFF	In	VDJ	1	11	1.7563467986587896E-4	2.1683849474659464E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	0	10	0	2	3	24	36	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLVLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCAGGGGGCGATCAGCCCCAGCATTTTGGTGAT	CASSPSGGDQPQHF	In	VDJ	1	12	1.9160146894459524E-4	2.3655108517810325E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	0	5	1	1	24	39	48	40	49													Vb 18	CASSPSGGDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCGACCGGCGACAATGAGCAGTTCTTCGGGCCA	CASSPSTGDNEQFF	In	VDJ	1	13	2.075682580233115E-4	2.562636756096119E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	2	7	5	3	5	24	38	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSTGDNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTCACGGACCTTGAAACTACTACGAGCAGTACTTCGGGCCG	CASSPVHGP*NYYEQYF	Stop	VDJ	1	15	2.3950183618074404E-4		51	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	1	7	3	6	10	24	39	49	45	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVHGP*NYYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGCCAGGGGGATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRQGDSSYNEQFF	In	VDJ	1	16	2.554686252594603E-4	3.1540144690413765E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	1	0	3	4	24	33	43	36	47													Vb 18	CASRQGDSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGACAAGTTAGAGGAGTACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	2.714354143381766E-4		49	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	2	6	7	2	13	24	38	44	40	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTTGACAGGGGATGGCTACACCTTCGGTTCG	CASSLLTGDGYTF	In	VDJ	1	17	2.714354143381766E-4	3.3511403733564626E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	6	4	0	24	37	-1	41	49													Vb 18	CASSLLTGDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGCAGGTGGGGACTCTGGGGCCAACGTTTTGACTTTCGGGGCC	CASSPGAGGDSGANVLTF	In	VDJ	1	18	2.8740220341689284E-4	3.5482662776715486E-4	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	3	6	0	17	0	26	24	-1	44	38	70				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGAGGDSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAGGGGGAGGCCCAGTACTTCGGGCCA	CASSPQGEAQYF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	9	1	3	24	38	46	39	49													Vb 18	CASSPQGEAQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCAGAGGGACTAGCGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPSRGTSVYNEQFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	6	3	7	1	24	38	55	45	56						01,02							Vb 18	CASSPSRGTSVYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTACGTGCGGGAGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLRAGAGTGELFF	In	VDJ	1	19	3.033689924956091E-4	3.7453921819866347E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	2	4	6	4	24	36	49	42	53													Vb 18	CASSLRAGAGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGGCCCGGGTACGAGCAGTACTTCGGGCCG	CASSRPGYEQYF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	4	5	0	24	36	-1	41	45						01,02							Vb 18	CASSRPGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGTCGACAGGGGGCCAAGGAGTTGGCACTGAAGCTTTCTTTGGACAA	CASSPESTGGQGVGTEAFF	In	VDJ	1	22	3.512693597317579E-4	4.336769894931893E-4	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	0	4	6	11	24	38	54	44	65													Vb 18	CASSPESTGGQGVGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCCCCGTTTTCGGTTGAGACCCAGTACTTCGGGCCA	CASSPPFSVETQYF	In	VDJ	1	26	4.15136516046623E-4	5.125273512192238E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	5	5	11	2	24	35	49	46	51						01,02							Vb 18	CASSPPFSVETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAGGACTACCAAACCGGGGAGCTGTTTTTTGGAGAA	CASSPKDYQTGELFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	1	9	5	2	4	24	39	47	41	51						01,02							Vb 18	CASSPKDYQTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGAGACCGGGACCGAGAATGAAAAACTGTTTTTTGGCAGT	CASSPMETGTENEKLFF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	2	0	7	5	9	4	24	39	53	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMETGTENEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCCGGGACAGGGTACCAGATACGCAGTATTTTGGCCCA	CASSLRDRVPDTQYF	In	VDJ	1	27	4.311033051253393E-4	5.322399416507323E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	4	3	3	24	37	49	40	52													Vb 18	CASSLRDRVPDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGACTAGTACAGTATCAGATACGCAGTATTTTGGCCCA	CASSPQTSTVSDTQYF	In	VDJ	1	28	4.4707009420405557E-4	5.519525320822409E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	8	4	1	8	24	40	47	41	55						01,02							Vb 18	CASSPQTSTVSDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGACAGGGACACTGAAGCTTTCTTTGGACAA	CASSPTDRDTEAFF	In	VDJ	1	29	4.6303688328277185E-4	5.716651225137495E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	3	2	0	24	39	-1	41	49													Vb 18	CASSPTDRDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTTCGCTAGGGGGAGTAGTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	4.6303688328277185E-4		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	1	4	8	7	24	37	51	45	58													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCATACCGGGACTAGCGCCCTACGAGCAGTACTTCGGGCCG	CASSTIPGLAPYEQYF	In	VDJ	1	31	4.949704614402044E-4	6.110903033767667E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	2	8	1	24	36	54	44	55						01,02							Vb 18	CASSTIPGLAPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGCGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPARLSGNTIYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	7	6	0	0	5	24	-1	42	39	47						01,02							Vb 18	CASSPARLSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01	TCRBJ01-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGAGGGGGCTGGAGACTACGAGCAGTACTTCGGGCCG	CASSPEGAGDYEQYF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	0	3	2	6	24	38	47	40	53													Vb 18	CASSPEGAGDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTAGGAGGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRRESSYNEQFF	In	VDJ	1	32	5.109372505189206E-4	6.308028938082753E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	0	3	4	24	37	46	40	50													Vb 18	CASSLRRESSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGGGACAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRDRAYNEQFF	In	VDJ	1	35	5.588376177550695E-4	6.899406651028012E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	2	2	0	24	38	-1	40	49													Vb 18	CASSPRDRAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACCTAGGGGGCGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSDLGGGLNTEAFF	In	VDJ	1	37	5.90771195912502E-4	7.293658459658184E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	0	5	4	24	36	48	41	52													Vb 18	CASSDLGGGLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCTATATGGTGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSPLYGGGTDTQYF	In	VDJ	1	38	6.067379849912182E-4	7.490784363973269E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	2	1	10	0	24	38	-1	48	52													Vb 18	CASSPLYGGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTATCGGGACAGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSPLSGQGGNEQFF	In	VDJ	1	39	6.227047740699345E-4	7.687910268288356E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	1	6	5	1	24	39	55	44	56													Vb 18	CASSPLSGQGGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCCCTTCTGGGAGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSRPSGSYTGELFF	In	VDJ	1	40	6.386715631486508E-4	7.885036172603442E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	2	3	8	2	24	37	50	45	52													Vb 18	CASSRPSGSYTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCTGACCGAAGATACGCAGTATTTTGGCCCA	CASSPPLTEDTQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	2	7	5	3	3	24	41	47	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPLTEDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCGGACAGGACTACGAGCAGTACTTCGGGCCG	CASSPSGQDYEQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	4	3	3	1	24	39	49	42	50													Vb 18	CASSPSGQDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCCGGGACAGGGGTCGAGCAGTACTTCGGGCCG	CASSPGTGVEQYF	In	VDJ	1	41	6.546383522273671E-4	8.082162076918528E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	6	1	1	24	38	49	39	50													Vb 18	CASSPGTGVEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAATATCCGGGGTTACATTCAGTACTTCGGCGCC	CASSPNIRGYIQYF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	3	8	6	2	24	39	50	45	52													Vb 18	CASSPNIRGYIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAATAGCGGGTTTTACTACGAGCAGTACTTCGGGCCG	CASSPNSGFYYEQYF	In	VDJ	1	42	6.706051413060834E-4	8.279287981233614E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	4	3	3	5	24	38	48	41	53						01,02							Vb 18	CASSPNSGFYYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCTTTCACCGGGATCGACACTGAAGCTTTCTTTGGACAA	CASSPFTGIDTEAFF	In	VDJ	2	44	7.025387194635158E-4	8.673539789863786E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	3	3	9	3	24	35	49	44	52													Vb 18	CASSPFTGIDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSPGTGSYEQYF	In	VDJ	2	48	7.66405875778381E-4	9.46204340712413E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	1	0	0	24	-1	-1	39	48													Vb 18	CASSPGTGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
AGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCATGGCACACAGGCCGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	57	9.101069774868274E-4		59	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	3	4	0	10	5	22	36	51	46	56													Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	58	9.260737665655437E-4		47	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	1	0	0	1	24	-1	47	41	48													Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCACCAGGGAAGGGCCCTTTGGCTACACCTTCGGTTCG	CASSLTREGPFGYTF	In	VDJ	2	59	9.4204055564426E-4	0.0011630428354590077	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	7	4	10	24	37	46	41	56													Vb 18	CASSLTREGPFGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCGGGACAGGGAAAATTCACAATGAGCAGTTCTTCGGGCCA	CASSPSGTGKIHNEQFF	In	VDJ	2	62	9.899409228804087E-4	0.0012221806067535335	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	5	4	7	24	38	51	42	58													Vb 18	CASSPSGTGKIHNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCCTGAACACTGAAGCTTTCTTTGGACAA	CASSTLNTEAFF	In	VDJ	2	64	0.0010218745010378413	0.0012616057876165506	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	3	7	0	0	2	24	-1	38	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSTLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTACCAGCTCCGGAGGGCAGGGGCATCCAACTAATGAAAAACTGTTTTTTGGCAGT	CTSSGGQGHPTNEKLFF	In	VDJ	4	109	0.0017403800095800734	0.002148672357034438	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	6	4	2	0	7	4	24	35	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CTSSGGQGHPTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGTGAGGGGGCGGGTGAAGAGACCCAGTACTTCGGGCCA	CASSPSEGAGEETQYF	In	VDJ	10	301	0.004806003512693597	0.00593348971988409	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	0	3	4	5	24	39	50	43	55													Vb 18	CASSPSEGAGEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3114B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment				2421	1960	410	49	0	1132	867	228	37	0	62630	50729	10612	1289	0	0.211715296	7.69357061	0.187973857	8.23772717				13174	0.154955611	0.0988586396	0.080073446	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:25	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Post-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 760,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 582,treatment:nact,type of chemo:carbo/taxol	0.8095827949514306	MSKCC- Snyder- P01-01		2041.0	
